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Summary 
 
Candida albicans is a diploid polymorphic fungus, which can be found as part of the normal 
microbial flora in the majority of the healthy human population. Normally a harmless coloniser of 
mucosal surfaces, it can however cause serious disease in case the host’s immune system is 
compromised or epithelial barriers are disrupted, e.g. through gastrointestinal surgery or 
intravenous catheters. The morphological transition from a budding yeast to a filamentous hyphal 
growth form is considered as one of the most important virulence traits, as hyphae contribute to 
epithelial invasion and tissue damage. This transition is accompanied by the expression of a 
variety of hypha-associated proteins, which strongly contribute to the virulent properties of 
hyphae. Such a protein is Ece1 (extent of cell elongation 1), whose expression is strictly 
correlated to the formation of hyphae. While mutants lacking the gene ECE1 are still able to form 
proper hyphae, activation of the epithelial danger response pathways by these mutants is 
impaired, demonstrating that Ece1 may play an important role in the recognition of C. albicans by 
epithelial cells. However, the biological role of Ece1 is unknown. The aim of this study therefore 
was to elucidate the so far unknown function of this protein. Using a set of ece1Δ/Δ mutants, the 
importance of Ece1 for adherence to, invasion into and damage of epithelial cells was examined. 
Furthermore, the eight Ece1 peptides that were predicted to result from intracellular processing of 
the full length protein and to become secreted were examined for their damaging potential on 
human epithelial cells and erythrocytes. 
It was found that only one of the eight Ece1 peptides was highly cytolytic on all cell types tested, 
i.e. peptide Ece1-III. Closer examination of this short peptide revealed membrane-permeabilising 
properties and resulted in the identification of this peptide as the first known cytolytic toxin of a 
human fungal pathogen. Host cell lysis by this toxin, which was named “Candidalysin”, was 
demonstrated to be rapid and efficient, while host cell death was found to be most probably 
caused by an ion-dependent mechanism. Identifying the phospholipid phosphatidylserine as an 
interaction partner of Candidalysin within the host cell’s membrane allowed the establishment of 
a theoretical model of pore formation by this toxin. 
In summary, this study provides insight into the as yet unknown function and role of Ece1 in 
infection-associated epithelial damage and demonstrates the importance of the characterisation of 
all C. albicans genes, including those of unknown function, for the identification of further fungal 
virulence factors. 
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Zusammenfassung 
 
Candida albicans ist ein diploider polymorpher Pilz, welcher als Bestandteil der normalen Mikroflora 
im Großteil der gesunden menschlichen Bevölkerung gefunden werden kann. Während dieser Pilz im 
Regelfall einen harmlosen Besiedler von Schleimhäuten darstellt, kann er im Falle eines geschwächten 
Immunsystems oder einer Zerstörung der epithelialen Barriere, beispielsweise durch gastrointestinale 
Eingriffe oder intravenöse Katheter, schwere Infektionen hervorrufen. Der morphologische Wechsel 
vom Wachstum als sprossender Hefe zu einer filamentösen Hyphenform wird als eine der wichtigsten 
virulenten Eigenschaften angesehen, da diese Wachstumsform zum Eindringen in Epithelzellen und 
der Schädigung des Gewebes beiträgt. Der Wechsel von der Hefe- zur Hyphenform wird von der 
Expression verschiedener hyphenassoziierter Proteine begleitet, welche in großem Ausmaß zu den 
virulenten Eigenschaften dieser Wachstumsform beitragen. Solch ein Protein ist Ece1 (extent of cell 
elongation 1), dessen Expression streng mit der Bildung von Hyphen korreliert. Während Mutanten 
ohne das Gen ECE1 weiterhin in der Lage sind normale Hyphen auszubilden, führen diese nicht zur 
Aktivierung des epithelialen „danger response pathway“, was darauf hindeutet, dass Ece1 eine 
wichtige Rolle bei der Erkennung von C. albicans durch Epithelzellen spielen könnte. Die darüber 
hinaus gehende biologische Rolle von Ece1 ist unbekannt. Das Ziel dieser Arbeit bestand daher darin, 
die bisher unbekannte Funktion dieses Proteins aufzuklären. Mithilfe eines ece1Δ/Δ Mutantensets 
wurde zunächst untersucht, welche Bedeutung Ece1 während der Adhäsion an, Invasion in sowie der 
Schädigung von Epithelzellen zukommt. Des Weiteren wurden die acht Peptide, welche durch die 
intrazelluläre Prozessierung des ganzen Proteins entstehen und anschließend sekretiert werden, auf 
ihre lytischen Eigenschaften gegenüber humanen Epithelzellen und Erythrozyten hin untersucht. 
Die Ergebnisse zeigten, dass nur eines der acht Ece1-Peptide eine hoch lytische Wirkung auf alle 
getesteten Zelltypen ausübte, nämlich das Peptid Ece1-III. Eine eingehendere Untersuchung dieses 
kurzen Peptides ließ Membran-permeabilisierende Eigenschaften erkennen und führte zur 
Identifizierung dieses Peptides als erstes bekanntes zytolytisches Toxin eines humanpathogenen 
Pilzes. Es konnte gezeigt werden, dass die Schädigung von Wirtzellen durch dieses Peptid, welches als 
„Candidalysin“ bezeichnet wurde, schnell und effizient erfolgt und dass der Tod der Wirtszelle mit 
großer Wahrscheinlichkeit durch einen ionenabhängigen Mechanismus bewirkt wird. Die 
Identifizierung des Phospholipids Phosphatidylserin als Bindungspartner von Candidalysin innerhalb 
der Wirtszellmembran ermöglichte die Erstellung eines theoretischen Modells für die durch dieses 
Peptid induzierte Porenbildung. 
Zusammengefasst gibt diese Arbeit Einblicke in die bisher unbekannte Funktion von Ece1 und dessen 
Rolle in infektions-assoziierter Zellschädigung und demonstriert weiterhin die Wichtigkeit der 
Charakterisierung aller C. albicans Gene, einschließlich derer mit unbekannter Funktion, zur 
Identifizierung weiterer fungaler Virulenzfaktoren. 
Introduction | 3 
 
1 Introduction 
 
1.1 Human pathogenic fungi 
 
Including approximately 611,000 species, fungi are estimated to account for 7% of all eukaryotic 
organisms found on earth [1]. Therefore, fungi are ubiquitous in our environment and have a great 
impact on both plant and animal life. The spectrum of fungal species that we are regularly 
exposed to consists of mostly innocuous environmental organisms and commensal species. There 
is, however, among them, a small percentage of opportunistic pathogens that can actively cause 
disease by infecting warm-blooded animals and humans [2]. The approximately 150 species 
known to be human pathogens account for only 0.02% of all fungal species [3]. Many of these 
species only cause harmless, albeit unpleasant infections, e.g. superficial infections such as 
athlete’s foot or ringworm, mainly caused by dermatophytes and Malassezia species [2]. On the 
other hand, several fungi are able to cause life-threatening systemic disease, e.g. Aspergillus 
fumigatus, Histoplasma capsulatum, Candida albicans and Cryptococcus neoformans. These 
pathogens are able to disseminate into deeper tissue and organs, including the lung, liver, kidney 
and central nervous system [4]. Such invasive infections, however, go hand in hand with 
immunosuppression, so while our lungs are constantly exposed to airborne spores of moulds such 
as Aspergillus or Fusarium and our skin and mucosal surfaces are densely colonised by 
Malassezia or Candida species, only those with predisposing immunosuppressive conditions (e.g. 
HIV-positive individuals or those undergoing chemotherapy or organ transplantation) are 
susceptible [2]. Potent antifungal treatments are available today, nevertheless mortality rates often 
exceed 50%, and it is estimated that more people worldwide are killed by fungal infections every 
year than by tuberculosis or malaria [5], strongly demonstrating the need for prevention and better 
treatment of these infections.  
 
1.1.1 The genus Candida 
 
The genus Candida belongs to the class of hemiascomycetes [4] and is comprised of 
approximately 200 yeast species, of which only 20 species have been associated with disease in 
humans [6, 7]. These species are able to cause both superficial infections of the skin and mucosa, 
as well as systemic infections. While superficial infections are mainly harmless, the establishment 
of a systemic infection by dissemination of the fungus through the bloodstream and subsequent 
solid organ colonisation, is life-threatening, which is demonstrated by mortality rates being as 
high as 40% [8].  Candida species represent the fourth-greatest cause of nosocomial bloodstream 
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infections in the United States, and the most common human fungal pathogens, with an estimated 
80% of all fungal infections being caused by Candida species [9, 10]. The majority of infections 
are caused by C. albicans, although non-albicans species, mostly C. glabrata, C. tropicalis and 
C. parapsilosis, are also frequently isolated [7, 11]. Species such as C. krusei, C. dubliniensis, 
C. guillermondii, C. lusitaniae, C. rugosa, C. orthopsilosis and C. metapsilosis are less frequently 
causing infections, while C. famata, C. inconspicua, C. kefyr, C. lipolytica, C. norvegensis, 
C. sake and C. zeylanoides are very rarely found to be the cause of disease. It is noticeable, that 
many of the medically important species do belong to the so called “CTG-clade”, which describes 
a group of Candida species translating the codon CTG as serine instead of leucine [12]. 
 
1.1.2 Candida albicans 
 
The diploid, polymorphic fungus C. albicans is a constituent of the normal human microbiota and 
can be isolated from the skin, gastrointestinal and urogenital tract of the majority of the human 
population [10, 13]. A unique characteristic of this fungus is its ability to grow as a unicellular 
budding yeast, a pseudohyphal or true hyphal form, depending on environmental triggers [14]. 
True hyphae differ from pseudohyphae in forming long narrow filaments with parallel sides and 
no constrictions at the site of septation, while pseudohyphae are generally shorter and wider with 
obvious constrictions showing at the septation sites [15]. Further morphological forms are white 
and opaque yeast cells and chlamydospores [16, 17]. While the switch from white to opaque cells 
plays a role in the mating process, chlamydospores can only be observed under in vitro conditions 
when grown on nutrient-poor media and may therefore present a dormant growth form developing 
under harsh environmental conditions [17, 18]. A phenotypic switch to GUT (Gastrointestinally 
IndUced Transition) cells is triggered by the exposure of C. albicans to the mammalian gut. These 
cells are better adapted to the digestive tract and promote fungal commensalism [19]. The 
different morphological forms are depicted in Figure 1. 
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Figure 1: C. albicans morphologies. (A) yeast cells, (B) opaque cells, (C) pseudohyphal cells, (D) 
hyphal cells, (E) chlamydospores, (F) GUT cells. Pictures (A), (B), (D) and (E) taken from Hickman et 
al. 2013 [20]; picture (C) taken from Sudbery 2011 [15]; picture (F) taken from Pande et al. 2014 [19]. 
 
C. albicans is one of the most important human fungal pathogens and therefore the genome of the 
clinical isolate SC5314 was the first genome of a human pathogenic fungus to be sequenced [21]. 
The genome is made up of 14.88 Mb in total size and the > 6,000 genes are distributed over eight 
different chromosomes, labelled chromosome 1-7 and chromosome R [22]. Based on data 
provided by the Candida Genome Database (CGD) as of January 2016, the C. albicans genome 
contains a total number of 6,218 open reading frames (ORFs), of which only 1,581 ORFs (~25%) 
are defined as characterised. While 152 ORFs (~2.5%) are listed as dubious, the vast majority of 
C. albicans ORFs (~72%) is stated as uncharacterised. In contrast, only 660 ORFs (10%) of the 
well-studied model-organism Saccharomyces cerevisiae remain uncharacterised (Figure 2). The 
genomes of C. albicans and S. cerevisiae can be accessed through CGD [23] or the 
Saccharomyces Genome Database, respectively.  
In the United States and most European countries, C. albicans is responsible for about 50% of 
invasive Candida infections [24]. The prevalence of this fungal pathogen is supposed to be 
connected to a stronger adherence potential of both C. albicans yeast and hyphal cells in 
comparison to non-albicans Candida species and only C. dubliniensis has been reported to exhibit 
an adherence comparable to that of C. albicans [25, 26]. 
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Figure 2: S. cerevisiae and C. albicans genomes. Total number of S. cerevisiae ORFs: 6604, verified 
ORFs: 5151, dubious ORFs: 793, uncharacterised ORFs: 660. Total number of C. albicans ORFs: 
6218, verified ORFs: 1581, dubious ORFs: 152, uncharacterised ORFs: 4485. Based on data provided 
by the Saccharomyces Genome Database and Candida Genome Database, respectively (January 
2016). 
 
1.2 C. albicans infection types  
 
In addition to skin infections, there are three major infection types in humans that are caused by 
C. albicans: infection of the oral cavity (oral candidiasis), infections of the vaginal tract 
(vulvovaginal candidiasis) and infection of the bloodstream and organs (invasive candidiasis). 
 
1.2.1 Oral candidiasis 
 
C. albicans is responsible for different types of oral infections, including oropharyngeal 
candidiasis (OPC) or thrush, and denture stomatitis (DS) [27]. OPC is particularly common in 
HIV patients and often one of the first signs of an underlying HIV infection [4]. Although a 
number of different immunocompromising conditions may result in the development of OPC, the 
probability for an HIV-infected person to get OPC is as high as 90% [28]. OPC manifests as 
infection of the hard and soft palate, tongue, buccal mucosa, and floor of the mouth [4]. These 
infections can present as either reddened patches (erythematous) or white curd-like lesions 
(pseudomembranous) [29]. Besides HIV infection, the existence of a genetic disorder may be the 
reason for recurrent Candida infections of the mouth, skin and other mucosal surfaces. Mutations 
in the gene “signal transducer and activator of transcription 1” (STAT1) as well as diseases 
resulting in the presence of specific auto-antibodies against Th17 cytokines can lead to the 
Introduction | 7 
 
development of chronic mucocutaneous candidiasis (CMC) [30–34]. Both OPC and CMC 
generally do not progress to life-threatening fungaemia [27]. 
DS is the most common form of oral candidiasis and affects approximately 50-75% of denture 
wearers, with xerostomia being an additional risk factor, as saliva does contain various proteins 
which exhibit direct antifungal activity [35–38]. DS manifests as an infection of tissues 
underlying the maxillary denture-bearing surfaces [37]. In comparison to healthy denture wearers, 
the saliva of DS patients was found to show increased levels of cystatins, immunoglobulins, and 
lactotransferrin [39]. While the presence of cystatins and immunoglobulins may be indicative for 
a host defence reaction in response to Candida, lactotransferrin has both antifungal and 
antibacterial activity [27]. Furthermore, the presence of bacterial species in denture biofilms 
differs between DS patients and healthy denture wearers, most probably elicited by the interplay 
of Candida with specific bacterial species of the oral microbiota [40]. To study the interactions 
taking place between C. albicans and oral epithelia, several in vitro infection models have been 
established, including the commonly used cell line for monolayer infection experiments TR-146, 
a buccal epithelial cell line originally derived from a human squamous cell carcinoma. 
 
1.2.2 Vulvovaginal candidiasis 
 
Affecting almost 75% of reproductive-age women, vulvovaginal candidiasis (VVC) is one of the 
most frequent forms of Candida infections, and with up to 7-8% of the patients suffering from the 
most severe form, known as recurrent vulvovaginal candidiasis (RVVC), it presents major quality 
of life issues for these women [41, 42]. Around 90% of all cases are caused by C. albicans, while 
the remaining 10% can mainly be attributed to C. glabrata [43]. VVC is the second most common 
cause of vaginal infections, only exceeded by bacterial vaginosis [44]. While the yeast form of 
C. albicans can be found in the vagina of >50% of healthy, asymptomatic women, the hyphal 
form is invariably connected to pathologic conditions and can be isolated from invaded tissues 
[45]. In contrast to other mucosal or invasive Candida infections, which mostly occur in patients 
with immunological deficits or underlying severe illnesses, predisposing factors for women to 
develop VVC rather include conditions like uncontrolled diabetes, use of antibiotics, oral 
contraception, pregnancy and hormone replacement therapy [45, 46]. It is now clear, that an 
overwhelming rather than a deficient immune response is the main cause of symptoms [47, 48]. 
VVC involves infections of the vaginal lumen as well as the vulva and typical symptoms and 
clinical signs include burning, itching, an abnormal vaginal discharge, an erythematous vulva and 
dyspareunia [29]. VVC infections are generally treated via the administration of antifungal drugs, 
such as clotrimazole, fluconazole, or ketoconazole. Regarding the high incidence of RVVC, 
however, the ultimate aim for immunotherapy would be the development of an anti-Candida 
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vaccine. The two most promising vaccines up to date are directed against the Als3 adhesin and 
Sap2, a member of the secreted aspartic protease family [49, 50]. Both vaccines have been 
successfully tested in mouse and rat models of vaginal infection and have passed phase I clinical 
trials, with one of them entering a phase II clinical trial [45]. 
 
1.2.3 Invasive candidiasis (IC) 
 
When C. albicans penetrates and breaches the epithelial barriers and enters the bloodstream, 
infections can become life-threatening [7, 51]. From the bloodstream, the fungus can disseminate 
to virtually every organ, e.g. kidney, liver, but also the central nervous system [4]. Most cases of 
systemic Candida infection are believed to arise from an endogenous source, as the 
gastrointestinal tract harbours a variety of Candida species [52, 53]. Indeed, commensal and 
infecting isolates of C. albicans are most often genetically similar, supporting the notion that 
infecting strains generally originate from the patient’s own flora [54, 55]. There are, however, 
exceptions, in which a systemic infection may also arise by introducing C. albicans via external 
routes, e.g. via central venous catheters [56–58]. Further risk factors include gastrointestinal 
surgery and parenteral nutrition. Physical alterations of the anatomical barrier function may result 
in damage of the gut, thus easing the transfer of C. albicans from the gut into the bloodstream, 
while parenteral nutrition may cause alterations of the commensal organism burden [59]. Even 
supposedly minor health issues, such as the use of antibiotics, can result in an increased risk for 
developing systemic candidiasis due to the overgrowth of bacterial members of the gut microflora 
by Candida [60]. The mortality rate of systemic candidiasis is significantly higher than that of 
other bloodstream infections (e.g. by Staphylococcus aureus) [61]. However, regarding the fact 
that most patients who develop systemic candidiasis are already severely ill before, the mortality 
rate that can directly be attributed to IC cannot be determined exactly, but is estimated to range 
from 14.5% [62] – 49% [61]. An important factor contributing to the outcome of an IC infection 
also lies in a timely diagnosis. Fungal diagnostics are generally difficult, due to a high rate of 
false-negative blood cultures [4]. Particularly in case of Candida, colonisation and infection have 
to be discriminated and the infectious Candida species specified, often leading to a late diagnosis 
and delayed start of antifungal treatment or an inappropriate choice of antifungals (e.g. in the case 
of C. glabrata or C. krusei, which both tolerate high azole concentrations) [63]. With mortality 
rates increasing from 15% (antifungal treatment initiated immediately after a positive blood 
culture) to 40% when treatment is delayed by only 72 hours, a fast and reliable diagnosis is of 
utmost importance [64]. Similar to the other forms of candidiasis, C. albicans is most frequently 
identified as the infectious species, being responsible for an estimated 50 to 60% of IC cases [24, 
65]. Besides C. albicans, only C. glabrata, C. parapsilosis, C. tropicalis and C. krusei are 
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regularly isolated from IC patients, with the second most common species responsible for IC 
noticeably varying depending on the country [24, 65]. While in North America and Europe 
C. glabrata is the second most common species, in South America C. parapsilosis is most 
commonly isolated after C. albicans [66–71]. 
 
1.3 Virulence factors  
 
C. albicans possesses a number of virulence factors and fitness attributes that contribute to its 
virulence when shifting from a commensal to a pathogenic state. Virulence traits of great 
importance include the ability of the fungus to reversibly change its morphology from a budding 
yeast to a filamentous form, expression of adhesins and invasins on the cell surface, the ability to 
damage host cells, the formation of biofilms, thigmotropism (contact sensing), phenotypic 
switching, and the secretion of hydrolytic enzymes [72]. Fitness attributes on the other hand allow 
the fungus to physiologically adapt to changing environments within the host during colonisation 
and infection. Therefore, the ability of C. albicans to adapt to changing environmental conditions, 
such as pH, and an elaborate stress response, are prerequisites to successfully colonise a host, 
disseminate throughout the bloodstream, tissues and organs, and evade and resist the host’s 
immune response [73]. 
 
1.3.1 Morphogenesis 
 
The morphological transition from a budding yeast to a filamentous growth form is considered to 
represent the most important virulence factor of C. albicans [74]. Therefore, mutants which are 
unable to form hyphae under in vitro conditions are generally attenuated in virulence [75]. 
Nevertheless, both morphological forms have been ascribed an important role in pathogenicity 
[76]. While hyphae are more invasive and therefore contribute to the gross of tissue damage, yeast 
cells are believed to play a role in dissemination [76–78]. There are a number of environmental 
stimuli leading to the yeast-to-hypha transition in vitro, which include the presence of serum at 
37°C, N-acetyl-D-glucosamine (GlcNAc), neutral pH, 5% CO2, starvation, and microaerophilic 
conditions [79–83]. These stimuli induce either the cAMP/PKA or MAPK signalling pathway via 
stimulation by the GTPase Ras1, eventually resulting in the expression of master activators of 
hyphal formation, i.e. the transcription factors Efg1 and Cph1 [15, 84–86]. Further transcription 
factors which promote the yeast-to-hypha transition are Cph2, Tec1, Flo8, Czf1, Rim101 and 
Ndt80, while a complex consisting of the general transcriptional co-repressor Tup1 in association 
with Nrg1 or Rox1p-like regulator of filamentous growth (Rfg1) has been shown to repress the 
morphological change [15]. The C. albicans adenylyl cyclase CYR1 plays a central role in 
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integrating and forwarding hypha-inducing signals. Cyr1 is either stimulated in a Ras1-dependent 
manner by serum, or directly and Ras1-independent by bacterial peptidoglycan, which may be 
present in the serum [87, 88]. Direct binding of either CO2 or HCO3 to the catalytic domain will 
also lead to Cyr1 activation [89]. The quorum sensing molecule farnesol, on the contrary, exhibits 
repressing effects on hypha formation via the repression of Cyr1 [90]. Furthermore, farnesol may 
act through the negative regulators Tup1 and Nrg1, as deletion mutants lacking the respective 
genes do not respond to the presence of farnesol and maintain their characteristic, constitutively 
pseudohyphal phenotype [91]. Environmental cues and subsequent pathways leading to the 
induction of hypha formation are schematically shown in Figure 3. Hypha formation is 
characterised by the expression of specific hypha-associated proteins, namely the hyphal wall 
protein Hwp1, the agglutinin-like sequence protein Als3, the secreted aspartic proteases Sap4, 
Sap5 and Sap6, and the hypha-associated proteins Ece1 and Hyr1 [15, 72]. These proteins are not 
required for hypha formation and maintenance, but contribute to the special properties of hyphae 
that are important for virulence, e.g. by aiding in adhesion to and invasion into host cells. 
Therefore, genes controlling morphogenesis are transcriptionally co-regulated with genes 
encoding virulence factors [75, 92]. It might be possible, that some of these hypha-associated 
genes contribute to the modulation of the hyphal structure, e.g. by increasing the chitin content in 
the cell wall, which is doubled during hyphal growth [93]. The ability of C. albicans hyphae to 
exhibit a directional growth when encountering a solid surface (thigmotropism) facilitates the 
invasion of an epithelium, as the fungus can specifically identify and invade intercellular 
junctions as well as small ridges and grooves associated with weakened integrity of the epithelial 
cells [83, 94–96]. 
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Figure 3: Signalling pathways involved in the regulation of hypha formation. Environmental cues 
and triggers are sensed via specific receptors and forwarded by different signalling pathways, finally 
resulting in the expression of activating transcription factors (Efg1, Cph1, Cph2, Tec1, Flo8, Czf1, 
Rim101, Ndt80) or repressors of hyphal growth (Tup1/Nrg1 or Tup1/Rfg1). Picture taken from 
Sudbery 2011 [15]. 
 
1.3.2 Adhesion, invasion and damage 
 
During both commensalism and pathogenicity, adhesion of C. albicans to host cells, other 
microorganisms or abiotic surfaces is essential for colonisation and survival within the host. As 
opposed to initial cell-cell contact, which is mediated by passive forces such as van der Waals 
forces and hydrophobic interactions, active adhesion requires specific proteins, adhesins, which 
are able to interact with receptors on the host cell’s surface [97, 98]. Although the initial adhesion 
is likely to occur between yeast cells and epithelial surfaces, many adhesins of dominant 
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significance are specifically associated with the hyphal form, which is induced after the first 
contact with a host cell surface [97]. The group of hypha-associated adhesins include the Als 
(agglutinin-like sequence) family, consisting of eight members that are encoded by the ALS gene 
family (ALS1-7 and ALS9) and which present the best studied group of all known C. albicans 
adhesins [72]. The ALS genes encode for glycosylphosphatidylinositol (GPI)-linked cell surface 
glycoproteins, which are characterised by three distinctive domains: a substrate-binding N-
terminal domain containing a signal peptide, an immunoglobulin-like domain and a threonine-rich 
domain, a central serine/threonine-rich domain consisting of several 36-amino acid tandem repeat 
sequences, and a C-terminal domain that is predicted to be cleaved when the protein is exported to 
the cell surface due to its GPI-anchorage sequence [99–103]. Of the eight Als proteins, Als3 does 
play the most significant role in the adhesion process. This protein directly promotes adhesion, 
presumably by binding of the immunoglobulin-domains in its N-terminal region to the 
extracellular immunoglobulin-like domain of either E-cadherin on epithelial cells or N-cadherin 
on endothelial cells, thereby mimicking the mechanism responsible for cadherin-cadherin binding 
[104]. 
Another key protein for mediating adhesion to host cells is the hyphal wall protein (Hwp1), a 
hypha-associated GPI-linked protein [105]. Via cross-linking of glutamine residues of the N-
terminal region of Hwp1 to as yet unidentified host proteins, C. albicans is able to covalently 
attach to host epithelial cells [97, 106]. While Hwp1 does not seem to play a direct role in 
disseminated infection, this adhesin is evidently important for the colonisation of the oral cavity, 
as C. albicans strains defective in HWP1 do not cause oropharyngeal candidiasis in mice [107]. 
In addition to hypha-associated adhesins, there are several morphology-independent proteins that 
may contribute to adhesion. These include Eap1, Iff4, Ecm33 and Mp65. The putative ß-
glucanase Mp65 facilitates adhesion of C. albicans by mediating attachment to various substrates. 
Furthermore, this protein can modify the cell wall structure via its glucanase activity, which may 
have a positive effect on the expression or function of other adhesins [108, 109]. 
 
During both commensalism and pathogenicity a certain degree of host cell invasion is required in 
order to maintain a foothold on the cell surface or to invade an epithelium, respectively [56]. For 
the purpose of invasion, it is of importance that the hyphae invade the epithelium at a rate faster 
than the rate of desquamation, to prevent being shed along with the epithelial cells [110, 111]. 
C. albicans is able to invade host cells by utilisation of two distinct mechanisms: induced 
endocytosis and active penetration [112]. Induced endocytosis is a completely passive, host cell-
driven process independent of the viability of the Candida cell and can mainly be observed during 
the early stages of invasion (~4h) [92, 113–115]. The process itself is actin-dependent and 
clathrin-mediated [116, 117]. Invasins localised on the hyphal surface interact with target host cell 
receptors, thereby triggering engulfment of the fungal cell into the host cell [72, 104, 109]. Two 
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invasins that have been identified so far are the before-mentioned Als3 (which also functions as 
an adhesin) and Ssa1. Ssa1 belongs to the Hsp70 family of heat shock proteins, containing an N-
terminal ATPase domain and a C-terminal peptide binding domain [118]. Both als3Δ/Δ and 
ssa1Δ/Δ mutants showed attenuated endocytosis due to the inability to correctly bind E- and N-
cadherin [119–121]. Besides E-cadherin on epithelial cells and N-cadherin on endothelial cells, 
the receptor tyrosine kinases, EGF receptor (EGFR) and HEGF receptor 2 (HER2) have been 
identified to serve as receptors on the host side [104, 120, 122]. After the establishment of a 
strong cell-cell contact due to receptor-ligand interaction, clathrin, dynamin and cortactin are 
recruited to the site of hyphal entry, resulting in cytoskeleton reorganisation such as filament 
assembly and polymerisation to surround the fungus during the endocytic uptake [119]. 
The alternative invasion route of active penetration is a fungal-driven process mediating 
penetration of both killed and living host cells. As C. albicans frequently encounters stratified, 
squamous epithelium with terminally differentiated, non-proliferative cells forming the uppermost 
layer, host-driven induced endocytosis is not possible, while active penetration allows the fungus 
to directly invade into a cell or pass through the intercellular junction between epithelial cells [56, 
115]. Furthermore, enterocytes are only invaded by active penetration [123]. This process requires 
different factors, e.g. the elongation of hyphae, physical force exerted by extending hyphae and 
the secretion of hydrolytic enzymes [112, 121, 124]. It still remains unclear which proteins are 
involved in this invasion route, but secreted aspartic proteases (Saps) have been implicated as 
being crucial contributors [97]. These proteases may be involved in the degradation of E-cadherin 
within the intercellular junctions between epithelial cells, eventually resulting in the loss of 
epithelial integrity [124–126]. However, the two other groups of C. albicans hydrolytic enzymes, 
namely phospholipases and lipases, have not yet been shown to be involved in the process of 
active penetration. The invasion route ultimately utilised by this fungus to gain access to the host 
cell is dependent on many different factors, e.g. the invasion stage, fungal morphology and the 
epithelial lineage to be invaded. 
 
Upon invasion of the tissue by C. albicans, damage can occur. Proteolytic degradation of E-
cadherin results in the loss of epithelial integrity and finally leads to the destruction and loss of 
the superficial epithelium [124, 125]. Induced endocytosis is not per se responsible for damage to 
the host cell, as dead C. albicans cells are as readily endocytosed as living cells without host cell 
damage, suggesting further processes to be involved in inducing damage [113]. Extensive damage 
is mainly associated with filamentation and active penetration and therefore it is most likely that 
damage occurring during induced endocytosis is mediated by active penetration of the endocytic 
compartment into which the C. albicans cell has been taken up [97]. Mutant strains reverting back 
to yeast cell growth after the initial germ tube formation and invasion of the host cell (e.g. 
eed1Δ/Δ) thereby get trapped inside the host cell, demonstrating that not only hypha formation 
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but also the maintenance of hyphal growth is of significance for host cell damage [127]. Damage 
to the host cell may be caused by necrosis, induced by the mechanical disruption of host cell 
integrity by piercing hyphae, or via the activation of specific epithelial cell-death pathways by 
C. albicans [128]. The anti-apoptotic proteins Bcl-2 and Bcl-xL, present in macrophages and 
neutrophils, can be inactivated by the fungus, thereby inducing apoptosis [129, 130]. It is 
estimated that approximately 50% of epithelial cells induce apoptosis in response to C. albicans. 
However, only 15% of these cells move from early to late apoptotic events, suggesting that 
epithelial cells may possess specific response pathways which contribute to limiting the pathways 
that cause progression of apoptosis [97, 131]. Considering these numbers and the fact that anti-
apoptotic signalling pathways are activated at later time points of a C. albicans infection, it can be 
assumed that final epithelial cell death is caused by necrosis [114, 131].  
 
1.3.3 Biofilm formation and drug resistance 
 
Biofilms are defined by structured microbial communities, which are attached to a surface and 
surrounded by a self-produced extracellular matrix [132]. C. albicans is able to form biofilms on 
both abiotic surfaces, e.g. dentures and catheters, and on biotic substrates, such as mucosal cell 
surfaces [133]. The process of biofilm formation can be divided into four different stages, which 
are (1) cell-wall mediated adherence of yeast cells to the substrate, (2) proliferation of these cells 
into a thin layer, (3) maturation of the biofilm by development of both pseudohyphal and hyphal 
cells and secretion/accumulation of extracellular matrix material, and finally (4) the dispersion of 
yeast cells from the mature biofilm, possibly with the purpose to disseminate into different niches 
within the host [134–137]. Important transcription factors that have been identified to play a role 
in controlling biofilm formation are Bcr1, Tec1, Efg1, Ndt80, Rob1 and Brg1, and mutants being 
deficient in any of these major regulators exhibit a defective biofilm formation, as was shown in 
vivo using a rat infection model [138]. 
One of the most challenging characteristics of a C. albicans biofilm is the high resistance of the 
cells against antifungal compounds, making treatment rather difficult and putting hospitalised 
patients at high risk of establishing a Candida infection, as biofilms are estimated to establish on 
30% of catheters [133, 139]. There are numerous factors responsible for this increased resistance, 
including a reduced growth rate of the cells, up-regulation of drug efflux pumps, the presence of 
persister cells, and an impermeable extracellular matrix [140–146]. ATP-binding cassette (ABC) 
transporters encoded by the CDR (Candida drug resistance) genes and the MDR1 (multidrug 
resistance) gene of the major facilitator (MF) superfamily are involved in conferring drug 
resistance to C. albicans and several members of these gene families could be shown to be up-
regulated in the presence of azoles [147–150]. Persister cells are phenotypically variant cells 
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within a biofilm and present a difficult target to even high concentrations of antifungal drugs due 
to their metabolically dormant state [151]. Even though they account for only approximately 1% 
of all cells within a biofilm, killing these cells is crucial for treatment of a Candida infection 
[144]. Mature C. albicans biofilms are embedded in an extracellular matrix. While the thickness 
of the extracellular matrix only seems to play a minor role in restricting penetration of drugs, the 
composition of the matrix material seems to be significant, as ß-1,3-glucans are able to bind 
fluconazole in biofilm structures [143, 152]. Mutants lacking one of several genes (BGL2, PHR1, 
XOG1) involved in ß-1,3-glucan production, delivery to the matrix and accumulation into the 
matrix material show an increased susceptibility to fluconazole [153]. The two transcriptional 
regulators Rlm1 and Zap1 are also known to contribute to matrix production. Rlm1 is involved in 
antifungal drug resistance via the regulation of FKS1 expression, a gene encoding for a ß-1,3-
glucan synthase [154]. Correspondingly, heterozygous deletion of FKS1 results in a 30% 
reduction of ß-1,3-glucan [152].  
 
1.3.4 Metabolic adaptation 
 
The colonisation of different host organs and dissemination throughout the body during infection 
are accompanied by a dramatic change of available nutrients. As indicated by the ability of 
C. albicans to proliferate in numerous niches of the human host, this fungus is metabolically 
flexible [155]. While the bloodstream is relatively rich of glucose (6 – 8 mM), which is the 
preferred carbon source of C. albicans, other niches harbour nutrient-starving conditions, e.g. 
inside phagosomes of phagocytic cells, or C. albicans has to compete for the nutrients with other 
microbes, e.g. in the gastrointestinal tract [155–157]. In addition, essential micronutrients, such as 
iron, are only available in very low concentrations and are almost completely associated with host 
proteins in sterile body niches [158]. Therefore, C. albicans needs to quickly adapt to the local 
nutrients provided in a specific niche, and also needs mechanisms to actively sequester 
micronutrients from host proteins. Following uptake into a phagolysosome after ingestion by a 
macrophage or neutrophil, C. albicans switches from glycolysis to gluconeogenesis and activates 
fatty acid ß-oxidation and the glyoxylate cycle [159–161]. In order to provide non-glucose carbon 
sources, C. albicans secretes a number of hydrolases. Lipases and phospholipases B are involved 
in the degradation of host lipids, while secreted aspartic proteases (Saps) break down host 
proteins, resulting in the release of amino acids and oligopeptides [155]. Interestingly, C. albicans 
cells grown on lactate as an alternative carbon source, were found to be more resistant to 
environmental stresses and showed a higher virulence potential [162]. Furthermore, in contrast to 
the diauxic growth, observed e.g. in the non-pathogenic yeast Saccharomyces cerevisiae, 
C. albicans is able to assimilate lactate even in the presence of glucose [163]. Therefore, the 
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diauxic shift, which is characterised by a lag phase of microbial growth during which the enzymes 
needed for the catabolisation of the second carbon source are produced, cannot be observed in 
C. albicans. This allows the fungus a faster adaptation to changing carbon sources and provides 
advantageous benefits during both commensal and pathogenic growth [155]. The growth on 
unfavourable carbon sources can also result in C. albicans actively changing the surrounding 
environmental conditions. The utilisation of amino acids and polyamines as carbon sources will 
inevitably lead to an increased excretion of nitrogen in the form of ammonia. Thus, the outside 
environment will ultimately become more alkaline, thereby providing a trigger for hypha 
formation [164]. Besides macronutrients, C. albicans also needs to acquire trace metals such as 
iron, zinc, manganese and copper from its host, as these serve as essential cofactors of many 
enzymes required for fungal growth [165]. Inside the host, those trace metals are associated with 
proteins, due to the toxicity of free metals and to prevent microbial growth, a process which has 
been given the name of “nutritional immunity” [166, 167]. To effectively overcome this nutrient 
withdrawal and access the micronutrients bound within the host proteins, C. albicans has evolved 
elaborate strategies. For iron, the most abundant trace metal, three different uptake systems have 
been described: the siderophore-uptake system, the reductive pathway, and the haemoglobin 
uptake and degradation system [168]. In contrast to many other microbial species, C. albicans 
lacks the ability to produce iron-binding siderophores. However, siderophores produced by other 
species can be taken up by C. albicans via the Sit1/Arn1 transporter [169, 170]. The reductive 
pathway is utilised to take up iron from transferrin, ferritin, and free iron from the environment 
[72]. This pathway consists of several ferric reductases, multicopper oxidases and iron permeases, 
which are localised inside the plasma membrane [171, 172]. The hyphal protein Als3 has been 
identified as the receptor for binding host ferritin [173]. In order to utilise haem-derived iron from 
haemoglobin, haemolysis needs to be induced by the expression of specific haemolysins. One of 
these as yet unidentified haemolysins is hypothesised to be a secreted mannoprotein [174]. After 
the release of haemoglobin from the erythrocyte, uptake is mediated by the haem-receptor gene 
family members RBT5, RBT51, CSA1, CSA2, and PGA7 [175]. Once inside the cell, further 
degradation is carried out by the haem oxygenase encoded by HXM1, resulting in release of iron 
from the molecule [176, 177]. A siderophore-like mechanism has been described for zinc 
acquisition. Extracellular zinc is bound by the secreted protein Pra1 (pH regulated antigen 1), 
which then re-associates with the cell surface via the Pra1 receptor Zrt1, which also serves as a 
zinc transporter [178, 179]. 
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1.3.5 Stress response 
 
Inside the human body, C. albicans is constantly exposed to a variety of environmental and 
immune-derived stresses. Therefore, the ability to cope with these stresses presents a prerequisite 
for life inside the human host – during both commensalism and pathogenicity. Mitogen-activated 
protein kinase (MAPK) pathways play a crucial role in sensing environmental and stress signals, 
and activation leads to a phosphorylation cascade, eventually resulting in the activation of specific 
transcription factors [180]. Three MAPK pathways are known to get activated in C. albicans, 
each being characterised by a specific kinase, namely Mkc1, Hog1 and Cek1. The Mkc1 (MAP 
Kinase from C. albicans) pathway is involved in cell wall salvage and maintaining cellular 
integrity and is phosphorylated upon oxidative and osmotic stress conditions [180, 181]. The 
Hog1 (High Osmolarity Glycerol response) pathway is considered to be the core response to 
many types of stresses, including oxidative, osmotic, heavy metal, cell wall and thermal stresses, 
and also plays a role in cell wall formation and morphogenesis [180]. Activation of Hog1 induces 
an accumulation of glycerol within the cell, which acts protectively during osmotic stress by 
counteracting the loss of water connected to the high osmotic gradient building up between the 
inside and outside of the fungal cell [180]. The Cek1 (Candida ERK-like kinase) pathway is 
involved in filamentation, mating, and possibly also the adaptation to thermal stress [180, 182]. 
This pathway is regulated by growth signals and quorum sensing. As would be expected of factors 
exhibiting this kind of importance, the loss of either Mkc1, Hog1 or Cek1 results in attenuated 
virulence in the mouse model [183–185]. 
When phagocytosed by an immune cell of the human host, C. albicans is exposed to both reactive 
oxygen species (ROS) and reactive nitrogen species (RNS). Enzymes detoxifying these molecules 
are pivotal in response to these stresses. ROS, such as hydroxyl radicals and peroxide, can be 
rendered inactive by the enzymes catalase (Cta1) and superoxide dismutases (Sod1-5), while the 
flavohaemoglobin enzyme Yhb1 may be utilised to detoxify RNS [161, 186–191]. 
A great flexibility in terms of pH tolerance is also of importance for the colonisation of the human 
host, as pH values within the human body vary from neutral (~pH 7.4) in the blood and tissues, 
acidic in the vaginal lumen (~pH 4) and range from highly acidic to alkaline (pH 2-8) inside the 
digestive system [192]. The environmental pH influences processes such as protein stability, 
enzyme function, nutrient uptake and the availability of micronutrients [192, 193]. Therefore, the 
sensing of the environmental pH and an appropriate response are of importance. An alkaline pH is 
sensed via the Rim101 signal transduction pathway [192]. The membrane receptors Dfg16 and 
Rim21 activate a signalling cascade upon sensing of an alkaline pH, which will result in the 
activation of Rim101 through C-terminal proteolytic cleavage [192]. Rim101 will then enter the 
nucleus and induce pH-appropriate transcriptional responses [192]. As mentioned earlier, 
C. albicans is also able to actively alkalinise the immediate environment via the excretion of 
18 | Introduction 
 
ammonia resulting from intracellular cleavage of amino acids and other alternative carbon 
sources. This is exported by the transporter Ato (ammonia transport outward) [164]. 
Heat shock proteins (Hsps) act as chaperones, preventing proteins from misfolding or aggregation 
during thermal and oxidative stress [194, 195]. They also play a role under non-stress conditions, 
as Hsps also mediate the correct folding of newly synthesised polypeptides [196]. Further roles 
include the assembly and disassembly of proteins in oligomeric structures, the transport of client 
proteins across the plasma membrane and the labelling of proteins via ubiquitylation for 
proteasome-mediated degradation. Until now, six major and six small heat shock proteins have 
been identified in C. albicans [72]. Hsps of importance are Hsp90, which is activated via the 
Hog1, Cek1 and Mkc1 pathways and is involved in temperature-dependent morphological 
changes [197, 198], and the small heat shock protein Hsp21, which is involved in stress 
adaptation and virulence and activated via the Cek1 pathway [182]. 
 
1.4 Host response 
 
Upon first contact with C. albicans, the host’s innate immune system is rapidly activated [60]. 
Immune cells involved in this primary response are particularly phagocytes, such as macrophages 
and neutrophils, and also epithelial cells of the mucosal surfaces. This primary response is 
characterised by direct antifungal activities, such as phagocytosis and the release of antimicrobial 
peptides [199]. This is followed by the more specific, albeit much slower, immune response of the 
adaptive immune system, which is mediated by T lymphocytes (cellular immunity) and B 
lymphocytes (humoral immunity) [60]. The generation of mature antigen-specific T and B 
lymphocytes may take as long as several days after first contact with a pathogen [200]. 
 
1.4.1 Innate immunity 
 
The first step to combat an intruding pathogen is recognition. Therefore, epithelial cells of 
mucosal surfaces, which are the first cells to come into contact with C. albicans, express pattern 
recognition receptors (PRRs). Additionally, PRRs are also expressed by polymorphonuclear 
leukocytes (PMNs), dendritic cells, monocytes, macrophages, B cells and T cells. These receptors 
interact with specific pathogen associated molecular patterns (PAMPs) on the fungal cells, 
leading to recognition of the fungus. PAMPs specific for C. albicans are e.g., cell wall 
components (ß-glucan and mannan) and nucleic acids [7]. PRRs are divided into the three major 
groups of toll-like receptors (TLRs), C-type lectin receptors (CLRs), and nod-like receptors 
(NLRs) [201, 202]. TLRs involved in the recognition of C. albicans are TLR2 (recognising the 
phospholipomannan component of the cell wall), TLR4 (recognising short linear O-linked 
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mannans), and TLR9 (recognising fungal DNA) [203]. The binding of a PAMP by a PRR leads to 
the activation of a signal transduction pathway, finally activating a downstream adaptor molecule 
(mainly MyD88; myeloid differentiation primary response gene 88) and stimulating the release of 
pro-inflammatory cytokines [204]. CLRs, including the mannose receptor (MR), dectin-1, 
dectin-2, DC-SIGN, and Mincle, recognise C. albicans via binding of specific fungal 
polysaccharide structures [205]. Dectin-1 does have an extracellular carbohydrate recognition 
domain (CRD), which binds ß-glucan [206]. Dectin-2 can recognise high mannose structures on 
hyphae as well as α-mannan on both yeast and hyphae [207–209]. DC-SIGN is mainly expressed 
on dendritic cells and the binding of N-linked mannan to this receptor triggers the uptake of 
C. albicans into the cell [56, 209, 210]. MBL (mannose-binding lectin), in contrast to the other 
receptors, is a soluble and circulating CLR. Binding of this receptor to carbohydrates on microbial 
cell walls results in the activation of the complement system and subsequent opsonisation and 
uptake of the Candida cell [211]. The family of NLRs are intracellular receptors containing 
leucine-rich repeats and a nucleotide-binding domain [212]. The NLR NLRP3 forms an 
inflammasome complex with ASC (apoptosis-associated, speck-like protein) and the pro-enzyme 
pro-caspase-1 [45]. Once this complex gets activated, pro-caspase-1 is processed into an active 
caspase-1, which after being released results in the processing of pro-IL-1ß and pro-IL-18 and the 
secretion of the active cytokines IL-1ß and IL-18 [213]. As the first line of defence, epithelial 
cells are able to secrete antimicrobial peptides (AMPs) upon recognition of microbial pathogens 
via their PRR receptors. AMPs are small soluble molecules consisting of 10-50 amino acids and 
function by either killing or inhibiting the growth of the pathogen [214, 215]. AMPs known to be 
of importance for the interaction between C. albicans and human cells are the cathelicidin LL-37, 
histatins, and defensins [214]. The ß-1,3-exoglucanase Xog1 of the C. albicans cell wall serves as 
a receptor for LL-37 [216]. Binding of this AMP to Xog1 leads to an increased activity of this 
enzyme, thus hindering C. albicans in its ability to adhere to the host cell [216, 217]. Histatin 5 
uses the cell envelope proteins Ssa1 and Ssa2 as receptors and enters the fungal cell via the 
transporters Dur3 and Dur31 [218–220]. Intracellular accumulation of this AMP, as well as the 
induction of reactive oxygen species (ROS) formation and an efflux of ions and ATP, contribute 
to the killing of the fungal cell [221, 222]. The group of human ß-defensins (hBD1- hBD3) 
permeabilise the membrane of intruding pathogens [223].  
Phagocytic cells are key players of the innate immune system and these cells are recruited to the 
site of infection by pro-inflammatory cytokines released upon activation of the mucosal PRRs 
[224–226]. Neutrophils can directly kill C. albicans through phagocytosis and degranulation 
[227]. After uptake into these cells, C. albicans is exposed to ROS and an array of granule 
products, e.g. lactoferrin, myeloperoxidase, defensins and azurophil [228, 229]. Degranulation, 
accompanied by the release of antimicrobial peptides, and the formation of neutrophil 
extracellular traps (NETs) allows neutrophils to also kill pathogens extracellularly. Such NETs 
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are composed of a web of chromatin fibres containing serine proteases and antimicrobial proteins 
[227]. The role of mononuclear phagocytes during an infection is not known in detail so far, it is 
however clear that the secretion of pro-inflammatory cytokines by monocytes in the blood and 
macrophages in the tissues plays a role in recruitment and activation of PMNs [60]. Dendritic 
cells (DCs) represent the bridge between the innate and adaptive arms of the immune system. 
These cells recognise Candida via the C-type lectin receptors MR and DC-SIGN, which is 
followed by internalisation of the fungus and subsequent traffic to a local lymph node [115]. 
Processed Candida-specific antigens are eventually presented to T cells, initiating the response of 
the adaptive immune system [115, 230]. Besides cell-mediated antifungal responses, soluble 
factors also play a role in clearing fungal infections. The complement system, an amplifying 
cascade of protein cleavages consisting of over 60 small proteins and protein fragments, labels 
cells for phagocytosis via opsonisation [231–233]. The complement factor C3b is deposited on the 
C. albicans cell surface, making these cells recognisable for the complement receptor 3 on the 
surface of phagocytic cells, which will engulf, endocytose and finally kill the fungal cell [234]. 
 
1.4.2 Adaptive immunity 
 
The adaptive immune response against Candida is mediated by T lymphocytes and B cells. The 
presentation of Candida-specific antigens by DCs triggers the priming of T cells into a specific 
subset. Depending on different factors such as molecular structures and morphology of the 
fungus, naïve CD4+ Th precursor cells differentiate into one of three lineages of effector T helper 
cells: Th1, Th2, and Th17 cells [235]. Each subset is characterised by a different set of cytokines 
being secreted [236]. A Th1 response is associated with the secretion of inflammatory interferon-γ 
(IFN-γ), leading to the activation of neutrophils and subsequent phagocytosis and killing of the 
pathogen [60, 237, 238]. Therefore, the Th1 response primarily mediates the control of 
disseminated and established infections. Th2 cells on the other hand produce IL-4, IL-5, and 
IL-13 and this immune response is involved in promoting allergy and protecting against 
helminths, while it is considered to be non-protective against disseminated infections [236, 239, 
240]. Th17 cells assist in controlling initial growth of Candida and preventing invasion of the 
tissue and are mainly involved in mucosal host defences [236, 241]. Th17 cells are specifically 
directed to mucosal areas, where they release the cytokines characteristic for a Th17 response, 
namely IL-17A, IL-17F, and IL-22, thereby inducing the recruitment of neutrophils to the site of 
infection and driving the production of pro-inflammatory cytokines, chemokines, and 
antimicrobial peptides by epithelial cells [8, 242]. The important role of the Th17 subset is 
highlighted by the fact, that excessive growth of Candida on the skin and mucosa of patients with 
hyper-IgE syndrome (HIES) or CMC results from the inability to induce a Th17 response. As a 
Introduction | 21 
 
consequence, the deficiency of IL-17 will lead to an insufficient recruitment of neutrophils from 
the bloodstream [243]. 
 
1.4.3 Candida immune escape strategies 
 
Invasion of a host cell by C. albicans is followed by a constant battle between the host’s immune 
responses and mechanisms evolved by C. albicans to escape these attacks. One of these 
mechanisms is to hide from recognition by the host via shielding of important PAMPs on the 
fungal cell surface. Detection by the PRR dectin-1 for example is avoided by shielding the 
receptor’s ligand ß-glucan with the outer mannoprotein layer of the cell wall [244]. Antifungal 
drugs (e.g. echinocandins) or activity of host enzymes leading to the disturbance of the fungal cell 
wall structure therefore result in a better recognition of the pathogen by phagocytic cells [245–
247]. White budding yeast cells release a chemoattractant for neutrophils. By phenotypically 
switching from a white to a mating-competent, oblong and opaque phenotype, the fungal cell 
makes itself invisible for neutrophils [248]. Indeed, when confronted with both white and opaque 
cells, neutrophils selectively engulf the white cells, while on encounter of opaque cells no 
phagocytosis can be observed. A further immune evasion mechanism exhibited by C. albicans is 
the inactivation of the host’s complement system. This is accomplished either via the degradation 
of specific complement factors or the expression of complement inhibitors. It could be shown in 
vitro, that C3b, C4b and C5 are cleaved by secreted aspartic proteases [249]. The surface protein 
Pra1 (pH regulated protein 1), present in both yeast and hyphae, can also get secreted, resulting in 
the binding of human immune regulators and plasma proteins like factor H and the C4b-binding 
protein [250–252]. Even after phagocytosis by host immune cells, C. albicans is able to escape. 
Hyphal growth inside the immune cell after activation of the hyphal regulator Efg1 via the 
cAMP/PKA pathway will result in the piercing and eventually killing of the immune cell [253, 
254]. Furthermore, C. albicans is able to intervene into the intracellular membrane trafficking, 
thereby inhibiting the fusion of lysosomes with the pathogen-containing phagosome [255, 256]. 
An array of fungal enzymes (e.g., a catalase and a surface superoxide dismutase) additionally 
counteract the oxidative stress induced by ROS production in phagocytes [199, 257]. The 
antifungal activities executed by the secretion of AMPs is overcome via secretion of peptide 
effectors, AMP efflux pumps, and regulation of signalling pathways [258]. The salivary AMP 
histatin 5 for example can either be degraded by the proteases Sap9 and Sap10, or get excluded 
from the cytoplasm via the polyamine transporter Flu1, a member of the MDR family [27, 259, 
260]. In addition, the plasma membrane-bound signalling mucin Msb2 can shed its extracellular 
glycodomain Msb2*, which is able to counteract the antifungal activity of the cathelicidin LL-37, 
histatin 5 and human ß-defensin 1 [258, 261, 262]. Last but not least, C. albicans is able to 
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actively modulate the host’s T cell response, by avoiding TLR4 recognition and thus inhibiting a 
pro-inflammatory Th1 response [263]. The favoured TLR2 activation instead leads to a non-
protective Th2 response and to the induction of anti-inflammatory cytokines [264–266]. 
Moreover, the release of tryptophan metabolism products of C. albicans hyphal cells results in the 
down-modulation of the important Th17 response [267]. 
 
1.4.4 Discrimination of commensal and pathogenic C. albicans 
 
The fact that C. albicans is part of the normal microbiota of most healthy humans demands the 
ability of the host’s immune system to discriminate between harmless colonising cells and 
invading pathogenic cells, as both an overreaction of the immune system against the constantly 
present colonising yeast cells as well as a too weak response against invading hyphal cells may 
result in a fatal outcome. One essential step that was observed to be different between yeast and 
hyphae is the activation of the inflammasome, which is activated by PAMPs that vary between the 
different morphologies [238]. The important PAMP ß-glucan for example is thought to be 
expressed only on the bud scars of yeasts, but on the whole surface of hyphal cells, resulting in a 
different cytokine stimulation [244]. Furthermore, mannan fibrils present on hyphae are shorter 
and less abundant compared to the ones found on yeast cells. As the outer mannan layer serves to 
shield the cells from recognition by PRRs, hyphae are an easier target for recognition due to the 
loss of shielding of the underlying ß-glucan [268]. Additionally, it has been suggested that the 
biochemical structure of the mannan varies between yeast and hyphae, resulting in a differential 
recognition by dectin-2 [269]. Recognition of these PAMPs will lead to the activation of the 
inflammasome and subsequent processing and secretion of IL-1ß and IL-18, thereby inducing a 
Th17 or Th1 response, respectively. IL-1ß production is only induced by hyphae, while yeast cells 
or C. albicans mutants locked in the yeast form are unable to trigger activation of the 
inflammasome and thus the secretion of IL-1ß [111, 268]. Upon recognition of any morphological 
form of the fungus, three different intracellular signalling pathways get activated: the three main 
MAPK pathways p38, JNK and ERK1/2, the phosphatidylinositide-3-kinase (PI3K) pathway and 
the nuclear factor-kappa-enhancer of B cell function (NF-κB) pathway [226, 270–272]. The host 
defence mechanism of epithelial cells is triggered by a variety of danger signals, including the 
yeast-to-hypha transition and an increase in fungal burden. Moyes and colleagues were able to 
distinguish two distinct phases of signal pathway activation in response to C. albicans. The first 
phase is induced independent of the fungal morphology. The activation of NF-κB and PI3K 
signalling along with an initial, transient activation of the three MAPK pathways p38, JNK and 
ERK1/2 will lead to the activation of the transcription factor c-Jun via JNK and ERK1/2. This 
first phase displays an early response and can be observed as early as 5 min post-infection. If no 
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further signal is received, however, the signalling fades and disappears within 1h. In the presence 
of hyphae and in case the fungal burden exceeds a specific threshold, a second, stronger activation 
of the MAPK pathways is triggered, resulting in a p38-driven activation of the transcription factor 
c-Fos and ERK1/2-mediated phosphorylation of the MAPK phosphatase MKP1. c-Fos activation 
will lead to an up-regulated production of cytokines, chemokines and other inflammatory 
mediators, while the phosphatase MKP1 serves as a negative feedback regulator by deactivating 
both JNK and p38, thus inhibiting further MAPK signalling. Neither yeast nor hyphal cells below 
a certain threshold do trigger this second phase of MAPK signalling, allowing the immune system 
to remain quiescent and protecting against an immune overreaction [97]. 
 
1.5 Pore forming proteins  
 
Pore-forming proteins (PFPs) are soluble proteins that generate pores inside membranes [273]. 
These are found in organisms from all kingdoms, including non-pathogenic bacteria, but even 
vertebrates [274]. In vertebrates, PFPs are utilised to kill bacteria (e.g. the complement membrane 
attack complex, MAC), to kill infected and malignant cells (e.g. perforin) or to permeabilise 
mitochondria, resulting in the triggering of apoptosis (e.g. members of the Bak family) [274]. 
PFPs are, however, also common in human pathogens, the best characterised being those of 
bacterial origin. A major class of PFPs are indeed pore-forming toxins (PFTs) of proteinaceous 
origin, which present the largest class of bacterial toxins [275]. The advantages of such protein 
toxins are obvious, as they may help in direct killing of the host cell or other bacteria, escaping 
from phagosomal immune cells and gaining access to intracellularly stored nutrients [276]. 
Depending on the structure of the peptide and the type of pore formed, PFTs can be divided into 
two different groups. While α-PFTs are generally rich in α-helices and pore-formation is induced 
via insertion of the α-helical domains into a membrane, ß-PFTs contain mainly ß-sheets and 
create pores by building ß-barrels inside the membrane [273, 277, 278]. In both cases, these 
proteins are generally produced in a soluble monomeric form that can assemble into oligomeric 
complexes [275]. Therefore, the toxin needs to undergo a conformational change that generates 
hydrophobic patches, as this is a prerequisite for allowing insertion into a lipid bilayer [274]. The 
process of oligomerisation is promoted by an increased toxin concentration and thus a higher 
chance of monomer-monomer-interaction on the host cell surface, due to the presence of specific 
PFT receptors [274]. Many of the receptors that have been identified so far are either lipid raft 
components or are associated with such rafts, although there are also non-lipid receptors, e.g. the 
GPI-anchored protein CD59, the integrin CD11b/CD18, certain claudins, and the metalloprotease 
ADAM10 [279–283]. ß-PFTs also strongly interact with sugar moieties protruding from the target 
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membrane, such as glycans that are covalently attached to membrane-associated proteins [275]. 
The general mechanism of pore formation is depicted in Figure 4. 
 
 
 
Figure 4: Mechanism of pore formation. Soluble pore-forming toxins (PFTs) bind to receptors 
and/or lipid components of the membrane. The concentration of PFTs on the cell surface will induce 
oligomerisation of the toxin monomers, resulting in membrane insertion and pore formation. 
 
 
Different models exist to describe how peptide monomers insert into a membrane and 
eventually form a pore (see  
Figure 5). One of these models is the so-called barrel-stave model, which has been originally 
established for the peptide alamecithin [284]. In this model, it is hypothesised that the hydrophilic 
faces of the monomers come together to form a hydrophilic pore. The more monomers aggregate, 
the larger the pore will become in size. The toroidal model on the other hand is based on the 
assumption that the hydrophilic parts of the peptides remain in contact with the hydrophilic head 
groups of the membrane lipids [285]. Aggregation of several peptides will therefore result in a 
bending of the associated lipids, leading to the formation of a pore that is lined by both peptides 
and head groups of the lipids [286]. Finally, the carpet model predicts a rather loose arrangement 
of peptides on the surface of the lipid bilayer, which after reaching a sufficient concentration will 
eventually result in a disruption of the bilayer in a detergent-like manner, due to the amphipathic 
nature of the peptides [287–289]. The type of pore formed predicted by the carpet model is in 
accordance to the toroidal model. 
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Figure 5: Models of pore formation. Different models have been proposed to explain membrane 
permeabilisation. In the barrel stave model, the hydrophilic peptide regions form the inside of the pore, 
while the hydrophobic regions interact with the lipid core of the membrane bilayer. In the toroidal 
model, bending of the lipid bilayer is induced, resulting in a pore lined by both the peptides and the 
polar lipid head groups. In the carpet model, peptides accumulate on the membrane surface, eventually 
disrupting the bilayer in a detergent-like manner. 
 
 
The formation of a proper pore inside the membrane is followed by changes of the ion 
concentration inside the host cell’s cytosol, which is mostly characterised by a massive influx of 
calcium into the cell, as well as an efflux of potassium ions and ATP [274, 280]. As a potent 
second messenger, calcium can activate various signalling cascades, e.g. the release of even more 
calcium from intracellular stores and the activation of proteolytic cascades [274]. The strong 
decrease of the intracellular potassium level on the other hand causes the host cell to enter a 
quiescence-like state, during which activation of autophagy, the formation of lipid droplets and a 
reduced anabolic activity can be observed [290, 291]. Furthermore, PFTs trigger the activation of 
phosphorylation cascades and activate all three MAP kinases, i.e. p38, JNK and ERK [290, 292]. 
Various toxins have also been reported to activate the inflammasome, resulting in the downstream 
activation of caspase-1 and cleavage of IL-1ß [275]. The decreased levels of both potassium and 
ATP finally result in a deregulation of mitochondrial activity and death of the cell [293, 294]. 
Despite the ubiquitous existence of PFTs among human pathogens, no PFTs have been described 
for human fungal pathogens until now. 
 
1.6 Ece1 (Extent of cell elongation 1) 
 
The C. albicans protein Ece1 is one of the most abundantly expressed proteins during hypha 
formation, being up-regulated to an at least 22-fold level in a C. albicans wild type strain when 
grown under hypha-inducing conditions [173] (Figure 6 B). Furthermore, expression is notably 
rapid, with the first transcripts being detectable as early as 30 min after stimulation of hyphal 
growth [295]. Although the first characterisation of this protein dates back to 1993, the function 
of Ece1 so far remained unknown [295]. Birse et al. were able to show that ECE1 expression is 
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associated with cell morphology, but that the gene product is not necessary for hypha formation 
per se, as an ECE1 null mutant was still capable of forming regular hyphae [295]. Despite its 
unknown function inside the cell, ECE1 is regularly used as a marker for hyphal growth, due to 
the striking correlation between hypha formation and expression and the high expression levels 
that can be observed.  
Ece1 is a unique protein of 271 amino acids (28.9 kDa), with the primary structure showing an 
unusual composition. The protein consists of a signal peptide and eight tandem repeats of a 
degenerate 34-amino acid sequence, which are separated by lysine-arginine (KR) residues [295] 
(Figure 6 A). Bader et al. could show, that these KR motifs present cleavage sites for the 
proprotein-converting protease Kex2, which is localised in the late trans-Golgi network [296]. 
Processing by Kex2 usually hints to an integration of the protein into the plasma membrane or cell 
wall, or to a subsequent secretion. Complete cleavage of Ece1 by Kex2 was hypothesised to result 
in a signal peptide and eight other peptides, with seven of these peptides ending in KR [296] 
(Figure 6 C). However, it could be shown by liquid chromatography/mass spectrometry (LC/MS) 
performed in our laboratory at a later time point during the study, that the final peptides secreted 
by the fungus under hypha-inducing conditions slightly vary from the proposed peptides. This 
may be due to further processing by different proteases after the initial cleavage by Kex2. The 
fact that a kex1Δ/Δ mutant does indeed secrete peptides of the proposed amino acid sequence, 
does assign this intracellular protease a role in further processing. 
In silico analysis showed that the polypeptide precursor structure of Ece1 resembles that of the 
repellent  protein Rep1 of the pathogenic plant fungus Ustilago maydis, the causative organism 
for corn smut disease [297]. UmRep1 consists of twelve tandem repeats of a 37-amino acid 
sequence and is known to be processed by UmKex2, resulting in small peptides which are 
integrated into the cell wall [297].  
Under laboratory conditions, expression of ECE1 is dependent on the transcription factors EFG1 
and BCR1 [298–300]. The dependency on the major regulator for biofilm formation, BCR1, led to 
the hypothesis that Ece1 may play a role in biofilm formation [299]. Nobile et al. were able to 
show that while Ece1 is not required for biofilm formation in vitro, overexpression of the Bcr1 
target ECE1 does partially rescue biofilm formation in a bcr1Δ/Δ mutant, ascribing Ece1 a 
possible role in adhesion. 
A screen of > 120 mutants, performed in the laboratory of Dr Julian Naglik at King’s College 
London (UK), identified the ece1Δ/Δ mutant as the only mutant that despite being capable of 
forming normal hyphae was unable to induce the epithelial danger response pathways, 
characterised by the activation of MAPK-p38/c-Fos [301]. ECE1 therefore may represent a 
candidate gene for the epithelial mechanism of discrimination between commensal and 
pathogenic C. albicans cells. 
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Figure 6: Properties of the hypha-associated protein Ece1. (A) Ece1 consists of 271 amino acids, 
containing a signal peptide (red box), a hypothesised transmembrane region (blue box) and eight 
tandem repeats separated by lysine-argine (KR)-motifs (green box). Modified from Birse et al. 1993 
[295]. (B) Expression of ECE1 is highly up-regulated during infection of epithelial cells. Expression 
levels increase up to 30-fold within a few hours and remain up-regulated during the course of 
infection. Data generated by K. Zakikhany (2007). (C) Complete cleavage of Ece1 is proposed to 
result in a signal peptide and eight short peptides ranging in size from 1.5 – 4.5 kDa.  
 
 
1.7 Aims of this study 
 
Given the major health and economic problems associated with C. albicans infections, especially 
regarding the ever rising number of immunocompromised patients in succession to modern 
medical therapies, the identification of possible virulence factors as well as the establishment of 
effective antifungal treatments is of utmost importance. 
The strong correlation between Ece1 expression and hypha formation and the identification of this 
protein as a possible activator of epithelial damage response pathways, hints at Ece1 being a 
virulence factor involved in epithelial damage. Thus, the aim of this study was the elucidation of 
the so far unknown function of this hypha-associated protein. 
In silico analyses, using BLAST and the protein structure prediction programme PHYRE2, were 
performed to identify potential homologies to other known protein sequences, thereby gaining 
further insight into a probable function of Ece1.   
Using a set of existing ece1Δ/Δ mutants, the role of the Ece1 protein during virulent behaviours, 
such as adhesion to, invasion into and damage of host epithelial cells was analysed. Considering 
the fact that Ece1 is most probably processed by the protease Kex2 in the late trans-Golgi network 
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and secreted in the form of short peptides, recombinantly expressed Ece1 digested with 
recombinant Kex2, as well as synthetically produced peptides corresponding to the proposed 
peptide sequences have been tested for their damage potential on different epithelial lineages. 
Furthermore, mycological researchers have long been aware of C. albicans producing a 
haemolytic factor. The exact identity of this haemolytic factor, however, remained unknown so 
far. Hypothesising that Ece1 may be involved in the lysis of erythrocytes, a theory which is 
supported by the finding that ECE1 expression is induced in the presence of haemoglobin, the 
ece1Δ/Δ mutant strains as well as the Ece1-derived peptides were also examined for their ability 
to lyse red blood cells. 
Based on the findings of the above experiments, a possible mode of action for Ece1 as a virulence 
factor was to be determined. This included the identification of a possible interaction site on the 
surface of the human host cell. 
With Ece1 seemingly being important for C. albicans-induced host cell damage, the protein 
represents a promising target for the development of new anti-candidal therapeutics. Therefore, 
antibodies targeting either the full length Ece1 protein or a single peptide within the protein 
sequence have been produced and tested for their ability to abolish Ece1-induced cell damage on 
red blood cells. 
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2 Material and Methods 
 
2.1 Materials  
2.1.1 Strains 
 
Candida albicans, Candida glabrata, Saccharomyces cerevisiae, Pichia pastoris and Escherichia 
coli strains used in this study are listed in Table 1. 
 
Table 1: Yeast and bacterial strains used in the study. 
Strain Genotype Reference 
C. albicans   
SC5314 isogenic wild type [302] 
BWP17/CIp30 isogenic wild type [303] 
 
ece1Δ/Δ 
 
ura3::λimm434/ura3::λimm434 
arg4::hisG/arg4::hisG his1::hisG/his1::hisG   
ece1::HIS1/ece1::ARG4  
RPS10/rps10::CIp10-URA3 
[301] 
ece1Δ/ECE1 ura3::λimm434/ura3::λimm434 
arg4::hisG/arg4::hisG his1::hisG/his1::hisG   
ece1::HIS1/ece1::ARG4  
RPS10/rps10::CIp10-URA3-ECE1 
[301] 
 
ece1Δ/ECE1[ΔECE1-III62-93] 
clones1-3, 3-1, 3-3 
 
ura3::λimm434/ura3::λimm434 
arg4::hisG/arg4::hisG his1::hisG/his1::hisG   
ece1::HIS1/ece1::ARG4  
RPS10/rps10::CIp10-URA3-ECE1Δ184-279 
[301] 
   
ece1Δ/ECE1[ΔECE1-VII195-228] 
clones K3, K6, K9, K12 
ura3::λimm434/ura3::λimm434 
arg4::hisG/arg4::hisG his1::hisG/his1::hisG   
ece1::HIS1/ece1::ARG4  
RPS10/rps10::CIp10-URA3-ECE1Δ583-684 
A. Franke 
   
kex2Δ/Δ Δkex2::hisG / Δkex2::hisG [304] 
eed1Δ/Δ Δipf946::HIS1/ Δipf946::ARG4+CIp10 [127] 
cph1Δ/efg1Δ Δcph1::hisG / cph1::hisG     Δefg1::hisG / 
Δefg1::hisG-URA3-hisG 
[305] 
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C. glabrata 
ATCC2001 clinical isolate [306, 307] 
   
S. cerevisiae   
BY4741 MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 [308] 
   
P. pastoris   
ScKex2 Expression of ScKex2 [309] 
   
E. coli   
DH5α F– Φ80lacZΔM15 Δ(lacZYA-argF) U169 
recA1 endA1 hsdR17 (rK–, mK+) phoA 
supE44 λ– thi-1 gyrA96 relA1 
[310] 
 
BL21(DE3) 
 
F– ompT gal dcm lon hsdSB(rB- mB-) λ(DE3 
[lacI lacUV5-T7 gene 1 ind1 sam7 nin5]) 
 
[311] 
 
 
2.1.2 Cell lines 
 
The cell line TR-146 was used as an in vitro model to study the interaction between C. albicans 
and oral epithelial cells. This cell line originally derived from a squamous cell carcinoma of 
buccal epithelial cells and was obtained from Cancer Research Technology, London. The cells 
were routinely grown in Dulbecco’s Modified Eagle Medium (DMEM) supplemented with 10% 
heat-inactivated FBS. After thawing, the cells were maintained in a humidified incubator at 37°C 
in presence of 5% CO2, routinely split after confluency was reached, and used in experiments for 
15 passages. 
The vaginal epithelial cell line A-431 was commercially obtained from the Deutsche Sammlung 
von Mikroorganismen und Zellkulturen GmbH (DSMZ) and used as an in vitro model of vaginal 
C. albicans infection. The A-431 cell line is derived from an epidermoid carcinoma of an 85-year 
old female patient. This cell line was cultured in RPMI 1640 medium with the addition of 10% 
heat-inactivated FBS. In accordance with the cultivation of the TR-146 cells, the vaginal cell line 
was also maintained at 37°C in 5% CO2 and used for 15 passages after initial thawing. 
The Caco-2 gastrointestinal epithelial cell line originally derived from a human colorectal 
adenocarcinoma of a 72-year old male patient. These cells were maintained in DMEM culture 
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medium supplemented with 10% heat-inactivated FBS and non-essential amino acids. Cultivation 
was also carried out at 37°C in a humidified incubator in 5% CO2. 
For experiments carried out in 24-well plates (e.g. adhesion and invasion assays), 1x105 cells of 
the respective cell line were seeded on a 12 mm glass coverslip placed inside each well and kept 
in the incubator for up to 48h until infection with C. albicans. For assays carried out in 96-well 
plates (e.g. damage assays), 2x104 cells of the respective cell line were seeded per well, and the 
cells were incubated for 24-48h prior to infection. 
 
2.1.3 Peptides   
 
The eight peptides hypothesised to result from complete cleavage of Ece1 at the KR sites (Ece1-I-
Ece1-VIII), as well as the peptides that have been verified by LC-MS/MS to be secreted by 
C. albicans in vivo, have been synthesised by the company ProteoGenix (Schiltigheim/France). 
The peptides were delivered in a lyophilised form and 1.5 mM aliquots of each peptide were 
prepared in DPBS and stored at -20°C. The synthetic peptides used during the course of this study 
are specified in Table 2. 
 
 
Table 2: Amino acid sequences and molecular weights of the synthetic peptides used in this 
study. 
Peptide Sequence MW 
(Da) 
Ece1-I19-31 AIIHHAPEFNMKR 1564 
Ece1-II32-61 DVAPAAPAAPADQAPTVPAPQEFNTAITKR 3016 
Ece1-III62-93 SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKR 3466 
Ece1-IV94-126 EDIDSVVAGIIADMPFVVRAVDTAMTSVASTKR 3466 
Ece1-V127-160 DGANDDVANAVVRLPEIVARVATGVQQSIENAKR 3577 
Ece1-VI161-194 DGVPDVGLNLVANAPRLISNVFDGVSETVQQAKR 3580 
Ece1-VII195-228 DGLEDFLDELLQRLPQLITRSAESALKDSQPVKR 3882 
Ece1-VIII229-271 DAGSVALSNLIKKSIETVGIENAAQIVSERDISSLIEEYFGKA 4567 
Ece1-III62-93RÆA SIIGIIMGILGNIPQVIQIIMSIVKAFKGNKA 3381 
Ece1-III62-93KRÆAA SIIGIIMGILGNIPQVIQIIMSIVKAFKGNAA 3324 
Ece1-III62-92 SIIGIIMGILGNIPQVIQIIMSIVKAFKGNK_  3310 
Ece1-III62-92(KÆA) SIIGIIMGILGNIPQVIQIIMSIVKAFKGNA 3253 
Melittin GIGAVLKVLTTGLPALISWIKRKRQQ 2848 
MW = molecular weight in Dalton; underlined amino acids: modified C-termini 
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2.1.4 Media and chemicals 
 
Unless otherwise stated, all chemicals were obtained from Carl Roth (Karlsruhe), Sigma 
(Munich), Merck (Darmstadt) or Roche (Mannheim). Cell culture media were purchased from 
Gibco.  
 
 
Table 3: Media used in the study. 
Medium Composition Application 
YPD 1% yeast extract, 1% peptone, 2% glucose Candida spp. growth 
RPMI 1640 commercially obtained from Gibco Hyphal induction 
LB 1% tryptone, 0.5% yeast extract, 1% NaCl E. coli growth 
SOC 2% tryptone, 0.5% yeast extract, 10 mM NaCl, 
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM 
glucose 
 
E. coli transformation 
BMG/BMM 100 mM potassium phosphate buffer (pH 6); 1.34% 
YNB with ammonium sulphate; 4x10-5% biotin; 
1% glycerol (BMG) or 0.5% methanol (BMM) 
P. pastoris growth 
To obtain solid media, all media were supplemented with 2% agar (Roth) or 2% pure agar (Oxoid, 
defined media). 
 
 
Table 4: Buffers used in the study. 
Buffer Composition Application 
PBS II 140 mM NaCl; 2.7 mM KCl; 10 mM 
Na2HPO4; 1.8 mM KH2PO4; pH 7.4 
all experiments 
PBSKMT 1xPBS II, 3 mM KCl, 2.5 mM MgCl2, 0.1% 
TritonX-100 
protein isolation 
Binding buffer 20 mM Na2HPO4, 500 mM NaCl, 10 mM 
imidazole, pH7.5 
protein purification 
Elution buffer 20 mM Na2HPO4, 500 mM NaCl, 500 mM 
imidazole, pH7.5 
protein purification 
DPBS commercially obtained from Gibco blood experiments 
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HBSS commercially obtained from PAA blood experiments 
TBS 50 mM Tris-HCl, 150 mM NaCl; pH 7.6 Western Blot, PIP 
strips 
Stacking gel buffer 1 M Tris-HCl; pH 6.8 SDS-PAGE 
Separating gel buffer 1 M Tris-HCl; pH 8.8 SDS-PAGE 
4xLaemmli 240 mM Tris-HCl pH 6.8, 8% (w/v) SDS, 
40% (v/v) glycerol, 0.01% (w/v) 
bromophenol blue, 28% (v/v) H2O 
SDS-PAGE 
Tris glycine buffer 25 mM Tris, 200 mM glycine, 0.1% SDS SDS-PAGE 
 
 
Table 5: Chemicals used in the study. 
Chemical Company Application 
Human serum albumin Sigma blood experiments 
Methyl-ß-cyclodextrin Carbosynth (UK) blood experiments 
Bovine serum albumin (BSA) Serva Western Blot, PIP strips 
IPTG Peqlab rEce1 expression in 
E. coli 
 
 
Table 6: Antibodies used in the study. 
Antibody Target Produced in 
Ece1-III polyclonal (Eurogentec) Ece1-III62-93 rabbit 
anti-rabbit-HRP (Dako) rabbit IgG swine 
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2.2 Methods 
2.2.1 Cultivation and storage of microorganisms 
 
For long term storage, all microorganisms were kept at -80°C in their preferred growth media 
supplemented with 50% (v/v) glycerol. The glycerol stocks were used to inoculate fresh plates 
every 2-3 weeks. For short time storage, all yeast strains (C. albicans, C. glabrata, S. cerevisiae, 
P. pastoris) were maintained on YPD plates at 4°C. For use in experiments, cells from a single 
colony were incubated overnight (~16h) in liquid YPD in a shaking incubator at 30°C 
(C. albicans, S. cerevisiae) or 37°C (C. glabrata). Cells were harvested by centrifugation and, 
after counting with the help of a Neubauer counting chamber (Neubauer improved, Roth), diluted 
to the desired cell concentration. 
P. pastoris, used for the overexpression of the recombinant protease Kex2 from S. cerevisiae, was 
precultured in BMG medium overnight. The following day, the preculture was used for 
inoculation of a larger volume of BMG. After 24h of further incubation, the cells were harvested 
by centrifugation and transferred into BMM medium to induce expression of ScKex2. All cultures 
were incubated in a shaking incubator at 30°C, using large flasks to allow adequate aeration of the 
cultures. 
E. coli strains were routinely grown in Luria-Bertani (LB) broth at 37°C. For strains carrying a 
plasmid-conferred ampicillin resistance, the media was supplemented with 50 μg/ml ampicillin. 
 
2.2.2 Growth kinetics of C. albicans strains 
 
The effect of complete deletion of the ECE1 gene or partial deletion of sequences coding for a 
single peptide on the growth of the respective strains was analysed by growth assays. Therefore, 
cells grown overnight were diluted into YPD medium to an optical density OD600 = 0.2 and 
transferred to a 96-well plate. Growth was continuously monitored by measuring the optical 
density every 30 min in an Infinite M200 plate reader [Tecan, Austria]. Measurements were 
carried out automatically by use of the following programme: constant incubation at 37°C, 
interrupted by 30 s shaking intervals (orbital, 6 mm amplitude) and subsequent OD measurement 
at 600 nm every 30 min. The cells were incubated for a total of 100 kinetic cycles (50h). 
The influence of the synthetic Ece1-derived peptides and melittin on the growth of different 
C. albicans mutant strains and further yeast species was determined by the addition of the 
respective peptides to the growth medium. 
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2.2.3 Adhesion assay 
 
To determine the ability of different C. albicans strains to adhere to epithelial cells, oral TR-146 
epithelial cells were grown on 12 mm coverslips and inoculated with 1x105 C. albicans cells for 
1h in DMEM without FBS. After the incubation period, non-adherent cells were removed via 
extensive rinsing with PBS, followed by fixation of the cells with 4% paraformaldehyde. The 
adherent C. albicans cells were stained using 10μg/ml Calcofluor White. Next, the coverslips 
were mounted on glass slides and adherence evaluated via fluorescence microscopy. For this 
purpose, the number of adherent cells in 100 randomly chosen squares à 200 μm2 was assessed 
and the percentage of adherent cells calculated based on the total area of the coverslip and total 
amount of seeded cells. The adherence of each C. albicans strain was tested in four technical 
replicates and three biological replicates. 
 
2.2.4 Invasion assay 
 
The number of invading C. albicans cells was determined based on a protocol from Park et al 
[113]. Oral epithelial TR-146 cells were grown for 2 days on 12 mm glass coverslips in DMEM 
with 10% FBS. The resulting epithelial monolayers were infected with 5x104 stationary Candida 
cells for either 3h or 6h in DMEM cell culture medium without FBS. After the incubation period, 
non-adherent Candida cells were removed via extensive rinsing with PBS and the cells were 
fixated using 4% paraformaldehyde. To distinguish invasive from non-invasive parts of the 
Candida hyphal cells by fluorescence microscopy, a differential staining was carried out. For this 
purpose, the non-invasive parts of the hyphae were stained first by incubating the cells with a 
primary anti-Candida antibody (from rabbit), followed by incubation with a secondary goat anti-
rabbit, Alexa488-coupled antibody. This was followed by a permeabilisation step, in which 0.5% 
Triton X-100 was used to lyse the membranes of the epithelial cells. Both intracellular and 
extracellular parts of the invasive Candida hyphae were subsequently stained with 10 μg/ml 
Calcofluor White solution. Next, the coverslips were mounted on glass slides and invasiveness 
evaluated via fluorescence microscopy. The percentage of invasive Candida cells was determined 
by dividing the number of [partly] invasive cells by the total number of adherent cells. At least 
100 hyphae were counted for each C. albicans strain. In addition to determining the percentage of 
invasive cells, the lengths of Candida hyphae were measured using the Leica Application 
Software. Invasion and hyphal length after 3h and 6h were tested in quadruple for each strain and 
in three independent experiments. 
 
36 | Material and Methods 
 
2.2.5 Damage assay 
 
Epithelial cell damage caused by different C. albicans strains and Ece1-derived peptides during 
their interaction with epithelial monolayers was measured by assessing the release of lactate 
dehydrogenase (LDH) into the surrounding medium. Epithelial cells were grown to confluency in 
a 96 well microtitre plate and infected with 2x104 C. albicans cells and/or varying concentrations 
of Ece1-derived peptides in cell culture medium without FBS. Uninfected epithelial cells in cell 
culture medium were used to assess the spontaneous LDH-release of the cells during the 
incubation period. A positive control containing the highest possible LDH content was obtained 
by lysing the appropriate monolayers using 0.1% Triton X-100 following the incubation period. 
After 24h at 37°C, LDH activity was determined using the Cytotoxicity Detection Kit from Roche 
Applied Science according to the manufacturer’s instructions. Briefly, a catalyst solution 
containing diaphorase and NAD+, and a dye solution containing iodotetrazolium (INT) and 
sodium lactate were added to the sample supernatants. LDH-catalysed conversion of lactate to 
pyruvate results in the reduction of NAD+ to NADPH/H+. H/H+ from the NADPH/H+ are then 
transferred to the tetrazolium salt INT, which is catalysed by diaphorase and results in the 
reduction of the tetrazolium salt to the water-soluble dye formazan. Absorption of this dye can be 
measured spectrophotometrically at 490 nm. The percentage of lysis of epithelial cells was 
calculated relatively to the 100% lysis control, while the concentration of released LDH (in 
ng/ml) was determined using an LDH standard curve ranging from 3.8 ng/ml to 500 ng/ml. All 
experiments were performed at least in triplicate for each condition and repeated at least three 
times. 
 
2.2.6 Haemolysis experiments 
 
2.2.6.1 Human erythrocyte preparation 
 
Whole human blood donated by healthy volunteers within the HKI was collected in 9 ml EDTA 
K3 tubes [Sarstedt], containing 1.6 mg Ethylene Diamine Tetra Acetic Acid (EDTA) to prevent 
the blood from coagulating.  
Depending on the type of experiment, the preparation of erythrocytes was carried out using two 
different protocols. Blood that was to be tested for lysis by synthetic peptides was first centrifuged 
at 2000 x g for 5 min at room temperature (RT). Afterwards, the serum was removed and replaced 
by the same volume of sterile Dulbecco’s PBS (DPBS [Gibco]) to wash the remaining serum 
from the cells. Following a second centrifugation step at 2000 x g, DPBS at a slightly smaller 
volume than the original volume of serum was added, to obtain the erythrocytes at an as high 
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concentration as possible. A sample of this blood preparation was analysed in the Auto 
Hematology Analyzer BC-5300 Vet [Mindray] to obtain the red blood cell count. For use in the 
experiments, the red blood cell concentration was adjusted to 5x108 cells/ml. 
Aliquots of whole blood, which were to be used for peptide lysis experiments and prepared by the 
described protocol, were stored refrigerated for up to 3 days. 
A different type of blood preparation was applied when C. albicans strains were tested for their 
ability to lyse human red blood cells. For this purpose, whole blood was first centrifuged at 
2000 x g for 10 min at RT, followed by the removal of the plasma layer as well as the top layer of 
the red blood cells, in order to eliminate as many white blood cells as possible from the sample. 
The remaining cell pellet was then resuspended to the starting volume in DPBS containing 2% 
heat-inactivated FBS [Gibco]. Following another centrifugation step at 2000 x g for 10 min, the 
supernatant and top layer of red blood cells was again removed and the remaining cells 
resuspended to starting volume, this time in DPBS without FBS. After a last round of 
centrifugation (2000 x g, 10 min) and removal of the top layer, the remaining cell pellet was 
resuspended in clear RPMI 1640 medium [Gibco] to starting volume. 
During blood preparation, 500 μl samples of both whole blood (“pre-wash”) and washed blood 
cells (“post-wash”) were kept and used for a differential count with the Auto Hematology 
Analyzer to verify successful diminishment of white blood cells and to determine the red blood 
cell concentration. For use in the experiments, the red blood cell concentration was adjusted to 
5x108 cells/ml. 
 
To investigate the influence of the cholesterol content of the erythrocyte membrane on lysis by 
Ece1, the membranes were depleted of cholesterol using the compound methyl-ß-cyclodextrin. To 
obtain cholesterol-depleted erythrocytes, the cells were incubated in DPBS containing 5 mM 
methyl-ß-cyclodextrin for 30 min at 37°C and under light shaking (70 rpm). Afterwards, the 
erythrocytes were washed several times with DPBS, and finally diluted to a concentration of 
5x108 cells/ml for use in experiments. As a control, a second aliquot of erythrocytes was prepared 
identically, but incubation was carried out in DPBS without added methyl-ß-cyclodextrin. 
 
For the preparation of human serum to be used in experiments, whole blood was collected in 
serum syringes [Sarstedt] containing silicate beads coated with a clotting activator. After blood 
collection, the content of the syringe was transferred into a 50 ml test tube and left undisturbed 
until clotting of the blood could be observed (approximately 30 min). The tube was then 
centrifuged at 4000 x g for 10 min in order to remove the clotted blood components. The serum 
was aliquoted and stored at -20°C until needed. 
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2.2.6.2 Erythrocyte lysis by synthetic Ece1-peptides 
 
To test the eight synthetic peptides corresponding to the peptides resulting from complete 
cleavage of the Ece1 protein for their ability to lyse red blood cells, these peptides were incubated 
in blood prepared after the protocol described above. For a standard experiment, 9 μM of each 
peptide were mixed with DPBS to a final volume of 130 μl. After the addition of 20 μl red blood 
cell suspension at a concentration of 5x108 cells/ml, the cells were incubated for 1h at 37°C. 
Afterwards, the cells were centrifuged at 2000 x g for 3 min and 100 μl of the supernatant were 
transferred to a 96 well plate. Evaluation was carried out by measuring the absorbance of the 
released haemoglobin at 541 nm in a microplate reader. 
To test the influence of different factors like e.g. pH value, ion concentrations, or the presence of 
specific substances on the efficiency of peptide lysis, the assay was adapted respectively.  
 
2.2.6.3 Erythrocyte lysis by C. albicans strains 
 
To investigate the effect of Ece1 on erythrocyte lysis, different C. albicans wild type strains and 
mutants were incubated in the presence of red blood cells under hypha-inducing conditions. An 
8 ml YPD overnight culture of each strain was harvested and after washing and counting, the cells 
were adjusted to a concentration of 1x108/ml in clear RPMI. 500 μl of this cell suspension were 
mixed with 100 μl of an erythrocyte suspension at 5x108 cells/ml (preparation see part 2.2.6.1), 
giving an MOI of 1. The samples were then incubated at 37°C and 50 rpm. After 16h, 24h and 
48h, samples were taken out, centrifuged and 100 μl of the supernatant were transferred onto a 
96-well plate. The amount of released haemoglobin in each sample was determined by measuring 
the supernatants spectrophotometrically at 541 nm in a microplate reader. 
 
2.2.7 Lipid Binding Assay 
 
To test the ability of the synthetic peptides Ece1-III62-93, Ece1-III62-93RÆA, and Ece1-III62-93KRÆAA to 
bind to different phospholipids, PIP Strips™ [Echelon Biosciences, Salt Lake City/USA] were 
incubated with 10 μg of the respective synthetic peptide in Tris-buffered saline (TBS) containing 
3% bovine serum albumin (BSA) for 16h at 4°C. Afterwards, the strips were incubated with a 
polyclonal rabbit anti-Ece1-III antibody [Eurogentec, Seraing/Belgium] as primary antibody and 
an HRP-conjugated anti-rabbit antibody [Dako, Glostrup/Denmark] as secondary antibody. The 
signals were visualised by chemiluminescence using ECL Western Blotting substrate [Pierce, 
Rockford/USA].  
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2.2.8 E. coli transformation 
 
In order to recombinantly express a His-tagged Ece1 protein, the plasmid pECE1 (see Figure 7) 
was first transformed into competent cells of the strain E. coli DH5α. This strain is characterised 
by the property to methylate inserted plasmids, thereby protecting the plasmid from degradation 
by E. coli DNAses. Afterwards, the plasmid was isolated and transformed into the desired 
overexpression strain E. coli BL21(DE3). This strain carries the T7 RNA polymerase gene and 
lacIq on the λ prophage DE3 and T7 promoter driven expression on transformed plasmids can be 
induced with IPTG. 
For transformation, approximately 50 ng of plasmid DNA were added to frozen competent cells 
and the mixture was incubated on ice for 20 min. Cells were then heat-shocked by transfer to 
42°C for 60 s, followed by a further 1 min incubation on ice. After the addition of 900 μl of pre-
warmed SOC-medium, the cells were incubated for 45 min at 37°C in a shaking incubator. 
Different dilutions of the transformation mixture were then plated onto selective LB-plates, 
containing 50 μg/ml ampicillin, and plates were incubated at 37°C overnight. 
 
 
Figure 7: Expression vector used for overexpression of recombinant Ece1 in E. coli BL21(DE3). 
The plasmid consists of the commercial vector pET100/DTOPO (Invitrogen) with the ECE1 sequence 
including an N-terminal His-Tag inserted after the T7 promoter. This vector was created by O. Bader 
(2008). 
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2.2.9 Isolation of plasmid DNA from E. coli 
 
Plasmid DNA was isolated from E. coli using a no-column plasmid preparation protocol. E. coli 
cells were harvested from an overnight LB-culture by centrifugation (13000 rpm, 1 min) and 
resuspended in 300 μl of resuspension buffer P1 (50 mM Tris-HCl, 10 mM EDTA, 100 μg/ml 
RNase A, pH 8) by vortexing. After the addition of 300 μl of lysis buffer P2 (200 mM NaOH, 
1% SDS, pH 12.5), samples were carefully mixed and incubated at RT for 5 min. Finally, 300 μl 
of neutralisation buffer P3 (3M KOAc, pH 5.5) were added and the samples centrifuged for 5 min 
at 13000 rpm. The resulting supernatant was transferred into a new test tube and mixed with half 
the volume of isopropanol in order to precipitate the plasmid DNA. Following another 
centrifugation step (10 min at 13000 rpm), the supernatant was discarded and the pellet washed 
with 500 μl of cold 70% ethanol. After air-drying, the pellet was dissolved in 30 μl ddH2O and 
stored at -20°C. 
 
2.2.10 Overexpression of recombinant Ece1 (rEce1) 
 
For overexpression of rEce1, 100 ml of LB medium containing 50 μg/ml ampicillin were 
inoculated with 1 ml of an overnight culture of E. coli BL21(DE3) carrying the ECE1-plasmid. 
The culture was incubated at 37°C and 180 rpm and after an OD600 of 0.4 was reached, protein 
expression was induced by the addition of IPTG to a final concentration in the culture of 1 mM. 
After incubation for a further 4h, cells were harvested by centrifugation and stored at -80°C. 
 
2.2.11 Protein isolation from E. coli 
 
To isolate E. coli proteins, frozen cell pellets were thawed on ice and resuspended in two pellet 
volumes of cold PBSKMT buffer containing a protease inhibitor cocktail [Roche]. After the 
addition of one pellet volume glass beads, cells were lysed for 2x30 s at 5500 rpm with a 30 s 
break in a Precellys 24 homogeniser [Peqlab], followed by a centrifugation step at 13,000 rpm for 
10 min at 4°C. The protein-containing supernatant was transferred into a fresh 1.5 ml eppendorf 
reaction tube.  
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2.2.12 Purification of recombinant Ece1 
 
The His-tagged rEce1 protein was purified by metal chelate affinity chromatography using High 
Density Zinc Agarose His-Columns [Jena Bioscience]. After initial equilibration of the column 
with binding buffer, protein-containing E. coli cell lysate was applied and kept on the column for 
at least 15 min to facilitate protein binding and yield. The column was then washed several times 
with binding buffer and the desired protein eluted by application of elution buffer.   
 
2.2.13 Overexpression of recombinant S. cerevisiae Kex2 (ScKex2) 
 
ScKex2 was overexpressed using a P. pastoris strain. P. pastoris is a methylotrophic yeast species 
and therefore capable of metabolising methanol. The oxidation of methanol to formaldehyde is 
the first step in the metabolism of methanol and is catalysed by the enzyme alcohol oxidase 
(AOX). Due to a poor O2 affinity, large amounts of this enzyme are produced, making the AOX 
promoter an ideal promoter for the overexpression of recombinant proteins. The cells of the 
overexpression strain were first grown in Buffered Minimal Glycerol (BMG) medium for two 
days, before protein expression was induced by transferring the cells into Buffered Minimal 
Methanol (BMM) medium. The P. pastoris strain was constructed to secrete heterologous 
proteins into the medium, and therefore ScKex2 was harvested by centrifugation and disposal of 
the cell pellet. 
 
2.2.14 Purification of recombinant ScKex2 
 
As mentioned above, ScKex2 was secreted into the medium during overexpression. Due to very 
low levels of endogenous proteins being secreted by P. pastoris, a secreted heterologous protein 
represents the majority of the total protein concentration in the medium. Using Amicon Ultra 
concentrator columns [Merck Millipore] with a molecular-weight cut-off of 30 kDa, possible 
endogenous proteins were removed and the spent medium changed against PBS buffer.   
 
2.2.15 Determination of protein concentration 
 
Protein concentrations inside cell lysates and purified samples were determined using a Protein 
Assay Kit [Pierce]. A BSA standard, ranging from 0 (blank) to 2 mg/ml was prepared following 
the manufacturer’s instructions. 25 μl of each standard concentration and each sample were 
pipetted in a 96-well plate and mixed with 200 μl of a 50:1 dilution of solutions A and B. After 
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30 min of incubation at 37°C, absorbance was measured at 562 nm using a microplate reader. The 
kit is based on the Biuret reaction and Cu2+ present in solution B is getting reduced to Cu+ by the 
proteins present in the sample. The subsequent chelation of one cuprous ion by two molecules of 
bicinchoninic acid (BCA), contained in solution A, will lead to the formation of a purple-coloured 
reaction product which exhibits a strong absorption at 562 nm.  
 
2.2.16 ScKex2-mediated digestion of rEce1 
 
Recombinant ScKex2 obtained from overexpression in P. pastoris was utilised for in vitro 
digestion of recombinantly expressed Ece1 to verify processing of Ece1 by this protease. For 
digestion experiments, 100 μg of rEce1 were mixed with 2 μg of ScKex2. On account of the 
Kex2-activity being dependent on calcium, CaCl2 was added to a final concentration of 10 mM in 
the test reaction. Incubation of the digestion samples was carried out at 37°C for either 1 min, 
5 min, 10 min or 20 min. Afterwards, samples were directly put on ice and a small volume of each 
sample was used for analysis via SDS gel electrophoresis. The remaining volume was stored at 
-80°C until needed for experiments. 
 
2.2.17 Erythrocyte lysis by rEce1 digestion products  
 
Digestion products obtained from ScKex2-mediated digestion of rEce1 were tested for their lytic 
properties via utilisation in an erythrocyte lysis assay. Considering that digestion might have been 
incomplete due to a reduced efficiency, digestion products were added to the erythrocytes in a 
final concentration of 0.3 mg/ml (10 μM), 0.6 mg/ml (20 μM) and 1.2 mg/ml (40 μM), 
corresponding to a concentration of fully processed Ece1-III of 10 μM, assuming that digestion 
efficiency was 100%, 50%, or 25%, respectively. The samples were incubated for 1h at 37°C and 
haemoglobin release from erythrocytes was determined by a spectrophotometrical measurement at 
541 nm.  
 
2.2.18 SDS-PAGE 
 
Proteins were analysed by using sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE). The protein gels containing 12% acrylamide were prepared according to Laemmli 
and run in a Mini-PROTEAN® Tetra Vertical Electrophoresis Cell [Bio-Rad]. Prior to 
electrophoresis, the protein samples were mixed with 1x Laemmli buffer (+ ß-mercaptoethanol) 
and denatured at 95°C for 5 min. In addition to the samples, 5 μl of Page Ruler™ Prestained 
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Protein ladder [Fermentas] were applied to every gel as a molecular weight marker. The gels were 
run in Tris-glycine buffer for ~2h at 120V. Following separation of the proteins via SDS-PAGE, 
the gels were either stained with Coomassie or used for subsequent Western Blotting.  
 
2.2.19 Coomassie staining 
 
After a quick rinse in ddH2O, SDS gels were transferred into Coomassie Brilliant Blue R-250 
staining solution [Bio-Rad] for 2h. Background staining was removed by thorough washing in a 
destaining solution containing H2O, methanol and acetic acid in a ratio of 50:40:10 (v/v/v). 
 
2.2.20 Western Blot 
 
Using a PerfectBlue semi-dry blot system [Peqlab], proteins were transferred from SDS gels onto 
nitrocellulose membranes [Millipore]. After blotting of the proteins, the membrane was blocked 
by incubation with 5% milk powder in TBST for 1h at RT. Afterwards the membrane was probed 
with a primary antibody in 2% milk powder in TBST, either overnight at 4°C or for 2h at RT. 
Following three washes with TBST, a secondary horseradish-peroxidase-conjugated antibody 
(swine anti-rabbit-IgG-HRP; 1:1700; [Dako/Denmark]) in 2% milk powder in TBST was added 
and incubated for 2h at RT. Detection of the signals was performed using ECL Western blotting 
substrate [Pierce/USA] according to the manufacturer’s instructions. 
 
2.2.21 Induction of hyphal growth 
 
To induce the switch from growth as a budding yeast to the filamentous hyphal growth form in a 
liquid culture, RPMI medium was inoculated with 5x105 C. albicans cells per ml and incubated 
for 16-24h at 37°C in a shaking incubator. For the induction of hyphal growth on plastic, 5x104 
C. albicans cells per well were seeded into a 12-well plate and incubated for up to 16h at 37°C in 
a humidified incubator. 
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2.2.22 Statistical analyses 
 
Mean values and standard deviations were calculated from repeated independent experiments 
using the programme GraphPad Prism 5. For calculation of significance, the one-way Anova test 
was used and p-values < 0.05 were considered as significant differences. If not otherwise 
mentioned, at least three independent experiments were performed. 
 
2.2.23 Databases and in silico analyses 
 
Candida gene and protein sequences were obtained from the Candida Genome Database (CGD). 
This database was also used for sequence comparisons and homology analyses using the BLAST 
function. For the prediction of 3D peptide structures, the PHYRE2 Protein Fold Recognition 
Server was used. Sequence alignments were performed with the ESPript 3 Multiple Sequence 
Alignment tool. Molecular weights of peptides and proteins were calculated using the ExPASy 
Compute pI/Mw tool. For the prediction of transmembrane regions within the Ece1 protein, the 
HMMTOP prediction programme was used, while information about the physiochemical 
properties of peptides was obtained from PepCalc.com.  
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3 Results 
 
3.1 In silico analyses 
 
Although the hypha-associated gene ECE1 had been identified in 1993, the function of the protein 
remained unknown until today. The strong up-regulation during hypha formation, however, 
suggests that this protein may play an important role in the infection process. To gain further 
insight into the function of Ece1, in silico analyses were performed to learn more about 
evolutionary conservation within the Candida genus, to obtain a possible 3D structure of the 
protein and to find similar proteins present in other species.   
 
3.1.1 ECE1 conservation 
 
The search for orthologous genes in other Candida species using the Candida Genome Database 
showed that orthologues to Ece1 of C. albicans SC5314 can be found in the C. albicans strain 
WO-1, as well as in C. dubliniensis (Cd36_43260) and in C. tropicalis (CTRG_00476) (Figure 8), 
two other members of the CTG-clade of Candida species. These species translate the codon CTG 
as serine instead of leucine under laboratory growth conditions and most of the pathogenic 
Candida species belong to this group. Therefore, Ece1 orthologues can only be found among the 
pathogenic species of the Candida genus.  
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Figure 8: Orthologues of C. albicans ECE1 within the CTG clade. Apart from C. albicans, 
orthologues for ECE1 can only be found in C. dubliniensis and C. tropicalis.  
 
 
3.1.1.1 Similarity between Ece1 orthologues from different Candida species 
 
Alignment of the Ece1 orthologues from different species showed that the identity between 
C. albicans Ece1 (orf 19.3374) and the C. dubliniensis orthologue (CD36_43260) is 68.6%, while 
the C. tropicalis orthologue CTRG_00476 still only shows an identity of 32.5% to the C. albicans 
gene (Figure 9 A, B). These differences are also reflected in the length of the amino acid 
sequences of the proteins. While the Ece1 protein of C. albicans SC5314 is composed of 271 
amino acids, the amino acid sequence of the Ece1 orthologue from C. dubliniensis (268 amino 
acids) is almost identical in length, while a greater variation does exist in the lengths of the 
C. albicans and C. tropicalis (282 amino acids) orthologues. Interestingly, the lysine-arginine 
motifs, which have been shown to play a role in Kex2-mediated processing of the C. albicans 
protein, seem to be highly conserved within all four different orthologues (see Figure 9 B). 
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Figure 9: Phylogenetic relationship and identity between the different Ece1 orthologues. (A) 
Identity between Ece1 orthologues from different Candida species. (B) Alignment of protein 
sequences of Ece1 orthologues.  
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3.1.2 Predicted structure of Ece1 
 
Using the HMMTOP server for the prediction of transmembrane helices, it was found that only a 
short part of the amino acid sequence is predicted to adopt an α-helical conformation. According 
to the in silico data, the helix is composed of the amino acids 63 to 85 (Figure 10 A). This is in 
accordance to the predicted transmembrane domain for this protein and noticeably correlates to 
peptide Ece1-III62-93, comprising the amino acids 62 to 93. Analysing peptide Ece1-III62-93 for a 
predicted 3D structure using the PHYRE2 protein fold recognition server, supported this 
prediction, although confidence in the model is low (24.8%) (Figure 10 B). While the 
corresponding peptide from C. dubliniensis is also predicted to form a transmembrane helix, no 
α-helical structure is formed by the matching peptide from C. tropicalis. 
 
Figure 10: In silico prediction for the structure of Ece1. (A) Only a small part of the protein (amino 
acids 63-85) is predicted to be localised in the membrane. (O/o: extracellular localisation, 
I/i: intracellular localisation, H: part of α-helix) (B) The predicted 3D-structure of peptide Ece1-III62-93.  
 
 
3.1.3 Similarity between Ece1-III and the peptide melittin 
 
Due to the striking structure of peptide Ece1-III62-93 in comparison to the other seven peptides, this 
peptide was analysed in more detail. It was found that this peptide is structurally similar to the 
peptide melittin, which is the active component of the venom of the European Honey Bee (Apis 
mellifera) and represents more than 50% of the venom’s dry weight [312]. Both peptides are of 
approximately the same length (26 amino acids for melittin versus 32 amino acids for 
Ece1-III62-93) and are of amphipathic nature. They possess a hydrophilic N- and C-terminus, while 
the middle parts of both peptides are highly hydrophobic, resulting in a poor solubility in water. 
Results | 49 
 
These hydrophobic peptide regions are predicted to insert into a membrane as an α-helix (Figure 
11, A, B). Melittin is a well-known pore-forming toxin and has been studied in great detail. This 
peptide effectively binds to erythrocytes and induces the release of haemoglobin. 
 
Figure 11: Structural similarities between melittin from bee venom and the C. albicans peptide 
Ece1-III62-93. (A) Both peptides contain a hydrophilic N- and C-terminus, while the middle part 
consists mainly of hydrophobic amino acids. Top: hydrophilic, bottom: hydrophobic. Light green: 
aromatic, cyan blue: basic, grey: aliphatic, dark green: polar (B) The hydrophobic parts of the peptides 
are predicted to form a transmembrane α-helix (H), while the N- and C-termini are predicted to be 
localised extracellularly (O/o) and intracellularly (i), respectively. 
 
3.2 Properties of the ece1Δ/Δ mutant versus the wild type 
 
In order to establish an infection, it is important for C. albicans to be able to adhere to and invade 
into the host cells. Both processes are highly dependent on hypha formation, due to the expression 
of adhesins, invasins and hydrolytic enzymes associated with this morphological form. A mutant 
being defective in any of these processes could hint to the deleted gene being involved in the 
exertion of any of these virulence traits. Therefore, the ece1Δ/Δ mutant was tested in comparison 
to its parental wild type for its ability to form hyphae and to adhere to and invade into epithelial 
cells. 
 
3.2.1 Impact of ECE1 deletion on C. albicans growth  
 
To initially characterise the ece1Δ/Δ mutant, growth was assessed by incubating the mutant as 
well as two wild type strains and the revertant strain in YPD medium for 50h. The resulting 
growth curve demonstrated that no differences in growth exist between the mutant and parental 
strain. All tested strains exhibited a similar growth trend, with a short lag phase followed by a 
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rapid log phase and all strains reached their growth plateau at the same time with an OD600 of 
approximately 1.2 (Figure 12).  
 
Figure 12: Impact of ECE1 deletion on C. albicans growth. No differences in growth can be 
observed between the ece1Δ/Δ mutant, revertant strain (ece1Δ+ECE1) and the parental wild type 
BWP17/CIp30.  
 
 
3.2.2 Hypha formation of the ece1Δ/Δ 
 
The ability of the ece1Δ/Δ mutant to form proper hyphae was tested either by the incubation 
under hypha inducing conditions on plastic and in RPMI medium at 37°C, or via the infection of 
epithelial monolayers for 6h and subsequent differential staining and fluorescence microscopy. 
When grown on plastic, hypha formation of the parental wild type BWP17/CIp30, ece1Δ/Δ and 
the revertant strain ece1Δ+ECE1 were examined after 3h, 5h and 24h with an inverse microscope. 
At all time points, the hyphal growth that could be observed was similar between the three strains 
(Figure 13A). The mutant also formed hyphae similar to the wild type during an infection of oral 
epithelial cells. Differential staining performed after the incubation period also illustrated, that the 
mutant is capable of invading the host cells (Figure 13B). 
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Figure 13: Hyphal growth of the ece1Δ/Δ in comparison to the parental wild type BWP17/CIp30 
on plastic and during infection of an epithelial monolayer. (A) Cells were grown under hypha-
inducing conditions in RPMI medium and hyphal growth assessed after 3h, 5h and 24h. (B) When 
infecting a monolayer, ece1Δ/Δ mutant cells formed hyphae to the same extent as the parental wild 
type and invasion into epithelial cells could be observed. (Blue: invasive parts of the hyphae; purple: 
extracellular parts of the hyphae; green: epithelial cells) 
 
3.2.3 Adhesion and invasion properties of the ece1Δ/Δ mutant 
 
To examine the adhesion properties of the ece1Δ/Δ strain, the mutant as well as the parental wild 
type BWP17/CIp30 and the revertant strain ece1Δ+ECE1 were co-incubated with the oral 
epithelial cell line TR-146 for 1h. After the incubation period, the adhesion rates were calculated 
using fluorescence microscopy. Although it was found that adhesion rates of the mutant and 
revertant strain were slightly lower compared to that of the wild type, the differences were not 
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significant. Approximately 23% of all wild type cells adhered to the epithelial cells, compared to 
20% and 17% of ece1Δ/Δ and ece1Δ+ECE1 cells, respectively (Figure 14A). 
The ability of the same strains to invade oral epithelial cells was determined by co-incubation 
with TR-146 cells for 3h and 6h. In addition to the determination of invasion rates, the lengths of 
the invasive hyphae were measured and compared. After 3h of co-incubation, 61% of all wild 
type cells had invaded. Again, both, the mutant and the revertant strain behaved similarly, 
exhibiting invasion rates of 64% (ece1Δ/Δ) and 58% (ece1Δ+ECE1). Furthermore, no differences 
in the lengths of the invasive hyphae could be detected. The average lengths of the hyphae ranged 
between 26-28 μm for all strains. After an incubation period of 6h on TR-146 epithelial cells, an 
invasion rate of 92% could be observed for the wild type, while 90% of ece1Δ/Δ cells and 87% of 
ece1Δ+ECE1 cells were invasive. The average lengths of the hyphae of invasive wild type and 
mutant hyphae were almost identical (89 μm for wild type versus 90 μm for ece1Δ/Δ), while the 
hyphae of the revertant strain were slightly, but not significantly shorter (80 μm). Therefore, 
ECE1 is dispensable for the formation of proper hyphae, adhesion to and invasion into host cells. 
The invasion rates and hyphal lengths of all strains are depicted in Figure 14 B and C. 
Figure 14: Adhesion, invasion and filament formation of BWP17/CIp30, ece1Δ/Δ and 
ece1Δ+ECE1 on oral epithelial cells. (A) Adhesion of C. albicans to TR-146 epithelial cells after 1h 
of co-incubation. (B) Invasion of C. albicans into TR-146 epithelial cells after 3h and 6h. (C) Lengths 
of invasive hyphae during co-incubation with TR-146 epithelial cells after 3h and 6h. 
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3.2.4 Epithelial damage caused by C. albicans on different cell lines 
 
Data produced in Dr Julian Naglik’s laboratory had demonstrated that the ece1Δ/Δ mutant does 
not activate the epithelial damage response pathway [301]. Given this finding, and the structural 
properties of Ece1, a possible role for Ece1 in epithelial damage was assessed. A cytotoxicity 
assay was performed, in which different epithelial cell lines (oral, vaginal and gastrointestinal) 
were co-incubated with C. albicans cells for 24h, followed by the measurement of released lactate 
dehydrogenase (LDH) as a marker for cell damage. It was found that on all three epithelial cell 
lines, the ece1Δ/Δ strain did not cause damage and in all cases damage was significantly reduced 
in comparison to the wild type and revertant strain (Figure 15). 
 
Figure 15: Epithelial damage caused by C. albicans strains on different epithelial cell lines. The 
ece1Δ/Δ mutant shows a highly reduced cytotoxicity level on all tested epithelial cell types and 
damage is significantly reduced in comparison to the wild type and revertant strain. 
 
 
3.3 Synthetic peptides 
 
As the full length Ece1 protein is predicted to be processed into eight short peptides, which may 
each exert a different function, these peptides were produced synthetically to test their effect on 
different cell types, such as epithelial cells and erythrocytes. Data obtained from co-workers and 
other collaboration partners during the course of the study showed that the peptide profile secreted 
in vivo may vary slightly from the hypothesised peptides. In particular, it was found that 
Ece1-III62-93 was likely to be secreted in vivo without the C-terminal arginine. Therefore, two 
versions of this peptide (Ece1-III62-93 and Ece1-III62-92) were tested simultaneously in most 
experiments. 
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3.3.1 Effect of synthetic peptides on epithelial damage 
 
To assess the effect that the single peptides, predicted to be present after cleavage by the protease 
Kex2, exert on epithelial cells, all peptides were incubated individually with oral epithelial cells 
for 24h at a concentration of 10 μM. The result of this experiment showed that the epithelial cells 
were strongly damaged by the peptide Ece1-III62-93 with an approximate lysis rate of 32% of the 
epithelial cells after 24h of co-incubation, while none of the other peptides caused any damage. 
Interestingly, when in addition to 10 μM of peptide the epithelial cells were infected with 
C. albicans, an obvious increase of damage could be observed compared to infection with the 
peptides or Candida strains alone. When epithelial cells were infected with a combination of 
synthetic peptide and the C. albicans wild type strain BWP17/CIp30, damage was measurable for 
all of the eight peptides. However, damage only significantly increased, compared to 
BWP17/CIp30 alone, for the peptides Ece1-III, Ece1-IV, Ece1-V and Ece1-VIII. In combination 
with wild type Candida cells, the damage observed to be caused by these peptides was higher 
than lysis caused by the C. albicans wild type alone. Remarkably, the highest increase of damage 
potential occurred in the combination of peptide Ece1-VIII with the wild type. While the peptide 
alone does not cause damage, a combinatorial infection with C. albicans resulted in an even 
higher lysis than that observed for the highly lytic peptide Ece1-III in combination with 
C. albicans. When infecting epithelial cells with a combination of 10 μM peptide and the ece1Δ/Δ 
strain, an increase of damage in comparison to the peptide alone could only be observed for 
peptides Ece1-III, Ece1-IV and Ece1-VIII. While none of these increases was significant, the 
relative increase of damage caused by ece1Δ/Δ in combination with peptide Ece1-VIII is greater 
than that caused by the mutant strain in combination with peptide Ece1-III. Nevertheless, it is 
noticeable, that the ece1Δ/Δ mutant, which alone does not cause any damage on epithelial cells, 
showed a lysis rate of 40% in combination with peptide Ece1-III, which is slightly higher than 
observed for peptide Ece1-III alone (Figure 16). Due to the striking cytolytic properties of 
Ece1-III62-93, all further experiments were mainly focussed on this peptide.  
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Figure 16: Epithelial damage caused by synthetic Ece1-peptides alone or in combination with 
C. albicans cells. Of all eight peptides, only Ece1-III causes damage to epithelial cells. When added in 
combination with the wild type BWP17/CIp30, an increase of damage can be observed for all 
peptides, while combination with the ece1Δ/Δ mutant results in an increased damage of only peptides 
Ece1-III, Ece1-IV and Ece1-VIII.  
 
 
Lysis by peptide Ece1-III62-93 could also be observed to occur rather rapidly in comparison to 
damage by C. albicans hyphae. Significant damage of various epithelial cell lines could already 
be detected after only 3h of co-incubation of the epithelial cells with the peptide. As no further 
damage could be detected after co-incubation with oral and vaginal epithelial cells for 6h, the 
cytotoxicity reached after 3h or possibly even reached earlier corresponds to the highest possible 
damage potential of Ece1-III62-93 for these cell lines. Damage exerted by Ece1-III62-93 on Caco-2 
cells after 3h on the other hand was noticeably lower compared to the other epithelial cell lines 
and a further increase in damage could be observed after 6h (Figure 17). Epithelial damage caused 
by the C. albicans cells was undetectable at 3h post-infection, and only rose above background 
levels at 6h post-infection for BWP17/CIp30-infected Caco-2 cells and ece1Δ+ECE1-infected 
A-431 epithelia. 
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Figure 17: Damage of different epithelial cell lines after 3h and 6h. Peptide Ece1-III62-93 rapidly 
induces lysis of epithelial cells, with 15-30% (depending on cell line) of the host cells being damaged 
after only 3h. In contrast, initial damage by C. albicans strains can first be observed after 6h. 
 
 
By infecting epithelial cells with different concentrations (5-20 μM) of peptide Ece1-III62-93 and 
peptide Ece1-III lacking the C-terminal arginine (Ece1-III62-92), it could be shown that the 
damaging effect of both peptides is concentration dependent. While at a concentration of 5 μM 
Ece1-III62-93 causes 18% of the epithelial cells to lyse after 24h of co-incubation, damage 
significantly increases at higher peptide concentrations, reaching the highest observed lysis rate of 
epithelial cells of 51% when added in a concentration of 20 μM. Peptide Ece1-III62-92 elicited a 
less lytic effect on epithelial cells than Ece1-III62-93. While only little damage (~ 6%) can be 
observed at a peptide concentration of 5 μM, the cytotoxicity continuously rises with an 
increasing concentration of added peptide. However, a maximum lysis rate of only 24% can be 
observed after the addition of 20 μM of peptide Ece1-III62-92. As a means of comparison and due 
to the structural similarity to peptide Ece1-III, epithelial cells were also exposed to the same 
concentrations of the potent cytolytic toxin melittin. The obtained results demonstrated that 
melittin exerts a much stronger lytic effect on the epithelial cells than Ece1-III62-93. When present 
Results | 57 
 
in a concentration of at least 10 μM, 100% of the epithelial cells could be observed to be lysed by 
this peptide (Figure 18). 
 
 
Figure 18: Concentration-dependency of Ece1-III-induced epithelial lysis. Co-incubation of 
epithelial cells with different concentrations of Ece1-III62-93 and Ece1-III62-92 demonstrated that lysis 
by these peptides is concentration-dependent. Melittin, used as a positive control peptide of known 
toxicity, exerted a very high lysis even at low concentrations.  
 
 
As already shown in Figure 16, a combinatorial infection of epithelial cells with synthetic 
Ece1-III62-93 together with viable C. albicans cells, results in an increased damage potential 
compared to an infection with either peptide or strain alone. Interestingly, when comparing the 
effects of the strains BWP17/CIp30, ece1Δ/Δ and ece1Δ+ECE1 on the damage potential of 
Ece1-III62-93 and Ece1-III62-92, it was found that in combination with the strains BWP17/CIp30 and 
ece1Δ+ECE1, peptide Ece1-III62-92 resulted in a higher damage of epithelial cells, even though 
this peptide alone has a less lytic effect than Ece1-III62-93. This effect could not be observed when 
Ece1-III62-92 was added to the epithelial cells in combination with the ece1Δ/Δ mutant strain. 
While damage in comparison to the peptide alone measurably increased (24% versus 16%), it was 
significantly lower than damage caused by the combination of peptide Ece1-III62-93 with the 
ece1Δ/Δ strain (41%)  (Figure 19).  
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Figure 19: Combinatorial infection of epithelial cells with different versions of Ece1-III. The 
damage caused by both Ece1-III62-93 and Ece1-III62-92 alone is increased when epithelial cells are 
infected in combination with C. albicans strains. While damage by Ece1-III62-92 alone is lower 
compared to Ece1-III62-93, combination with either BWP17/CIp30 or ece1Δ+ECE1 results in a higher 
lysis rate than the respective combinations with Ece1-III62-93. 
 
 
3.3.1.1 Importance of hypha formation for the cytotoxicity of synthetic peptides 
 
To investigate the role that hypha formation may play in enhancing the cytolytic effect of the 
synthetic peptides alone, oral epithelial cells were incubated with a combination of peptides and 
non-hypha-forming yeast species or C. albicans mutant strains. The budding yeasts C. glabrata 
(strain ATCC2001) and S. cerevisiae (strain BY4741) were chosen for this experiment, as well as 
the two C. albicans mutant strains eed1Δ/Δ and cph1Δ/efg1Δ. The protein Eed1 is involved in 
filamentation and epithelial escape and while a strain lacking the EED1 gene is capable of 
initially inducing hyphal growth, it is unable to maintain this growth form and eventually switches 
back to yeast cell growth. The eed1Δ/Δ mutant, therefore, is able to invade epithelial cells, but 
will revert back to yeast growth inside the host cell. The cph1Δ/efg1Δ mutant on the other hand is 
completely yeast-locked, as the lack of the two important hypha-inducing transcription factors 
Cph1 and Efg1 precludes the formation of hyphae. In addition to these viable yeast strains and 
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mutants, heat-killed yeast cells of the C. albicans wild type BWP17/CIp30 and the C. glabrata 
and S. cerevisiae wild types ATCC2001 and BY4741 were tested for their ability to increase the 
damage potential of the synthetic peptides. Similar to the experiment described in part 3.3.1, all 
strains were incubated in combination with 10 μM of peptide Ece1-III62-93 or Ece1-III62-92 for 24h 
at 37°C.  
It was found that all tested non-hypha forming strains showed a significantly higher damage on 
epithelial cells when added in combination with either of the synthetic peptides. However, the 
observed damage was never higher than that of the equivalent peptide concentration alone, 
ascribing this increase in cytotoxicity to the peptide alone. The only exception, however, was the 
C. glabrata strain ATCC2001. While this strain alone causes practically no damage on oral 
epithelial cells, a combinatorial infection with the C. glabrata strain and synthetic peptide resulted 
in a highly increased damage potential and the observed damage was considerably higher than the 
sum of the damage potentials of the strain and the peptide alone. This effect could be noted with 
either peptide Ece1 III62 93 or Ece1-III62-92 (Figure 20). 
 
Figure 20: Cytotoxicity of synthetic peptides added in combination with different yeast strains. 
C. albicans mutant strains locked in the yeast-form, as well as non-hyphae forming yeast strains and 
heat-killed (HK) C. albicans strains do not increase the damage of synthetic peptides during a 
combinatorial infection. The only exception within the tested strains was the C. glabrata wild type 
ATCC2001.   
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3.3.2 Erythrocyte damage induced by synthetic Ece1 peptides  
 
As melittin has long been known to effectively bind to erythrocytes and induce the release of 
haemoglobin, the question arose whether any of the synthetic Ece1-peptides may exhibit a 
haemolytic effect too. Therefore, a mixture of the peptides predicted to result from Kex2 cleavage 
(Ece1-I – Ece1-VIII) was added to human erythrocytes in different concentrations and incubated 
for 1h at 37°C. Haemoglobin release occurring during the incubation was measured 
spectrophotometrically at 541 nm, corresponding to the absorption peak of this molecule. The 
peptide mixture was added to the blood cells in a final concentration ranging from 3-15 μM with 
all peptides in the mixture being present at the same molar ratio. The result of this experiment 
showed that erythrocyte lysis by this peptide mixture is very efficient and red blood cells are 
completely lysed after the addition of peptides in the concentration of 9-15 μM. At a peptide 
concentration of 6 μM, erythrocyte lysis is still very effective (90%), while only after the addition 
of the lowest tested peptide concentration of 3 μM a significantly decreased lysis of erythrocytes 
(14%) could be observed (Figure 21A). 
 
Similarly to the experiments carried out using oral epithelial cells, the eight peptides were tested 
for their individual effects on erythrocytes by adding the single peptides to the red blood cells in a 
concentration of 9 μM each. As can be seen in Figure 21B, a highly lytic effect could only be 
observed for peptide Ece1-III62-93, which caused an erythrocyte lysis of almost 90%. All other 
peptides were completely unharmful to the erythrocytes. Red blood cell lysis by peptide 
Ece1-III62-93 was also confirmed microscopically. After the 1h incubation period, erythrocytes in 
the sample containing the peptide were visually depleted, while in the control sample the cells 
were still intact (Figure 21 C). 
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Figure 21: Erythrocyte lysis by synthetic Ece1-peptides. (A) Erythrocytes are efficiently lysed by a 
mixture of the eight synthetic peptides Ece1-I – Ece1-VIII. Only at a concentration 3 μM lysis of red 
blood cells is significantly reduced. (B) Of the eight Ece1-peptides, only Ece1-III causes lysis of 
erythrocytes, while the other peptides do not damage. (C) After 1h incubation with Ece1-III, 
erythrocytes are visibly depleted in comparison to the control (incubation in PBS only). 
 
 
During the course of the study, mass spectrometry results suggested that Ece1-III62-93 was further 
cleaved by Kex1, removing the C-terminal arginine residue, resulting in secretion of the peptide 
Ece1-III62-92. Therefore, this alternative peptide was included into all further experiments using 
red blood cells. In a preliminary experiment, the lytic effects of both peptide Ece1-III62-93 and 
Ece1-III62-92 were tested for their concentration dependency. It was found for both peptides, that 
erythrocyte lysis increased in a concentration-dependent manner. Lysis exhibited by peptide 
Ece1-III62-92, however, was reduced compared to Ece1-III62-93. Considerable red blood cell 
damage (35%) through peptide Ece1-III62-93 could already be observed at a peptide concentration 
of 6 μM, with damage increasing proportionally up to 96% at a peptide concentration of 15 μM. 
In comparison, only 7% of erythrocytes were lysed by Ece1-III62-92 in a concentration of 6 μM, 
and at the highest tested concentration of 15 μM a total of approximately 30% of erythrocytes had 
been damaged (Figure 22). 
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Figure 22: Erythrocyte damage caused by two versions of Ece1-III at different concentrations. 
Erythrocyte damage by both peptides increases concentration-dependently. While lysis by Ece1-III62-93 
is very efficient (96% at 15 μM), damage by Ece1-III62-92 is considerably lower (30% at 15 μM). 
 
 
To analyse how rapid lysis of erythrocytes occurs, a time course experiment was carried out, 
surveying haemoglobin release at different time points ranging from 2 min to 180 min. Due to the 
short incubation times, the 2 min, 5 min and 10 min samples were incubated at room temperature, 
while all other samples were incubated at 37°C. The result clearly shows that lysis by peptide 
Ece1-III62-93 occurs almost instantly after the addition to the red blood cells. After only 2 min at 
room temperature, almost 20% of all erythrocytes are already lysed. Lysis by this peptide 
continuously increases with longer incubation periods and reaches its maximum after 45 min, 
when 98% of the erythrocytes are lysed. On the other hand, lysis by peptide Ece1-III62-92 is not 
only lower, but also much slower. The first measurable lysis (~7%) was observed after 15 min. 
During the course of 180 min, the lysis rate of this peptide slowly but steadily increases, reaching 
its highest lysis rate of 33% at the latest measured time point of 180 min (Figure 23). 
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Figure 23: Time course of erythrocyte lysis by Ece1-III62-93 and Ece1-III62-92. While lysis by 
Ece1-III62-93 is induced instantly and reaches its maximum of 98% after only 45 min, erythrocyte 
damage by Ece1-III62-92 is induced much slower and maximal damage does not exceed 33%.  
 
 
As many peptide toxins are only active at very specific pH values, lysis efficiency of Ece1-III62-93 
and Ece1-III62-92 was tested at different pH values. Due to the sensitivity of red blood cells to 
extremes of pH, peptide lysis was only tested in samples ranging in pH from 5-8. It was found 
that neither peptide was influenced in its lytic activity by any of the tested pH values. Both 
peptide Ece1-III62-93 and Ece1-III62-92 reached their maximum lysis rates of approximately 100% 
and 30%, respectively, which could already be observed in earlier experiments (Figure 24). The 
very slight decrease of damage by Ece1-III62-93 at pH 7 was ascribed to normal experimental 
variations, as this condition corresponds most closely to the natural environment of erythrocytes 
at a pH of ~7.4 in the blood. 
 
64 | Results 
 
 
Figure 24: Influence of the pH on erythrocyte lysis by Ece1-III. Damage of erythrocytes by 
Ece1-III62-93 and Ece1-III62-92 is not influenced by the pH value in the range from pH 5 to pH 8. 
 
3.3.2.1 Effect of human serum and serum albumin on Ece1-III-induced erythrocyte lysis 
 
During a C. albicans bloodstream infection, the Ece1-peptides will be secreted into whole blood. 
While erythrocytes represent the most abundant blood cell type, a total of ~55% of whole blood is 
made up of plasma. To examine whether any of its components may influence red blood cell lysis 
by Ece1, human blood serum (plasma devoid of the clotting factor fibrinogen) was prepared and 
lysis efficiency of the peptides analysed in the presence of different serum concentrations. Indeed 
it was found that human serum exhibits a highly inhibitory effect on red blood cell lysis by 
Ece1-III62-93 and Ece1-III62-92. While incubation of the erythrocytes with peptide Ece1-III62-93 
alone resulted in the lysis of 92% of all red blood cells after 1h, the presence of human serum in a 
dilution of 1:100 caused a strong decrease of the lysis rate, with only 23% of the erythrocytes 
being lysed after the incubation period. When added in lower concentrations, i.e. in a 1:200 and 
1:500 dilution, human serum still negatively affected the cell lysis, but to a lower extent compared 
to the higher serum concentration. When added in a 1:200 dilution, 36% of the erythrocytes were 
found to be lysed, while a 1:500 diluted serum resulted in a lysis rate of 53%. Erythrocyte lysis by 
peptide Ece1-III62-92, which already causes much less lysis compared to Ece1-III62-93, was 
completely abolished by the addition of human serum in a 1:100 and 1:200 dilution. Even when 
added in a 1:500 dilution, only 3% lysis of erythrocytes by this peptide could be detected (Figure 
25A). 
Human blood serum contains 91% of water and 7% of proteins [313, 314]. Of these proteins the 
major component (60%) is albumin [314]. To test whether this serum component may be 
responsible for the inhibitory effect exhibited by the serum, human serum albumin in different 
concentrations was added to the samples. For Ece1-III62-93, no inhibitory effect on lysis was 
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observed for any of the tested albumin concentrations. The lysis rate of Ece1-III62-92 on the other 
hand continuously decreased with increasing concentrations of serum albumin present. While the 
peptide alone caused lysis of 37% of the erythrocytes, only 17% of erythrocytes were lysed in the 
presence of the highest tested albumin concentration of 2 mg/ml. However, while noticeable, this 
decrease in lysis was not significant (Figure 25B).  
 
Figure 25: Influence of human serum and human serum albumin on erythrocyte lysis. (A) The 
addition of human serum (hS) effectively inhibits lysis of red blood cells by Ece1-III62-93 and 
Ece1-III62-92. (B) Addition of human serum albumin did not decrease Ece1-III induced erythrocyte 
lysis, demonstrating that this serum component is not responsible for the inhibitory effect of serum. 
 
 
3.3.2.1 Influence of ion-chelation on Ece1-III-induced erythrocyte lysis  
 
Hypothesising that in accordance to many other lytic peptides the damage exerted by the Ece1-
peptides may also be ion-dependent, the majority of divalent ions present in the test samples was 
chelated using the potent chelating agent EDTA. The lack of free ions in the surrounding buffer 
may result in a reduced flow of ions inside the red blood cell, thereby preventing damage caused 
to the cell by dramatically changing intracellular ion concentrations and the connected triggering 
of damaging pathways. The addition of 20 mM of EDTA to the test samples only caused a slight 
decrease of lysis, while the presence of EDTA concentrations of 50 mM and higher resulted in a 
significantly reduced lysis rate for both peptides. Erythrocyte lysis by both peptides was observed 
to be halved in the presence of 50 mM in comparison to the damage caused by the respective 
peptide alone. At concentrations of 100 mM and 200 mM of EDTA, damage exerted by 
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Ece1-III62-93 was only minimal (11% and 3%, respectively), while damage by Ece1-III62-92 was 
completely abolished in the presence of 200 mM of EDTA (Figure 26A).  
To assess whether the observed effect of EDTA was caused by ion chelation or by a direct 
inhibition of the peptides, an excess amount of magnesium ions (as MgCl2) was added in addition 
to the EDTA, hypothesising that lysis inhibition by EDTA-induced ion-chelation should be 
restored. An inhibiting EDTA concentration of 100 mM was chosen, to obtain a significantly 
reduced rate of lysis. To restore the damaging capacity of the peptides, the samples were 
supplemented with either 50 mM or 100 mM of MgCl2. The lysis rate of 14% of Ece1-III62-93 in 
the presence of 100 mM could be restored to 34% by the addition of 50 mM MgCl2. Addition of 
100 mM MgCl2 resulted in lysis significantly increasing to 65%. Similar results could be 
observed for peptide Ece1-III62-92. The decreased lysis of 3% due to the inhibitory effect of EDTA 
could be gradually restored by the addition of increasing concentrations of MgCl2. 
Supplementation with 100 mM of MgCl2 even resulted in a higher lysis (19%) than the original 
lysis observed for the peptide alone (14%) (Figure 26B).     
 
Figure 26: Influence of EDTA on erythrocyte lysis. (A) Lack of free ions caused by addition of the 
chelating agent EDTA inhibits the damaging effect of Ece1-III. (B) Damage by Ece1-III can be 
restored by the addition of an excess amount of magnesium ions in the form of MgCl2. These results 
point to the damage-mechanism of Ece1-III being ion-dependent.  
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3.3.2.3 Impact of membrane cholesterol-content on Ece1-III-mediated erythrocyte lysis 
 
To examine whether cholesterol may play a modulatory role on the haemolytic activity of 
Ece1-III, cholesterol was specifically depleted from the erythrocytes using the compound methyl-
ß-cyclodextrin (MßCD). Cyclodextrins are cyclic oligosaccharides, containing a hydrophobic 
cavity which enables this molecule to bind various hydrophobic compounds. Exposure of cells to 
a high concentration of MßCD (5-10 mM) for a prolonged time (> 2h) results in the removal of 
80-90% of total cellular cholesterol [315, 316]. In this study, cholesterol-depletion was carried out 
by incubation of erythrocytes in 5 mM of MßCD for 30 min at 37°C.  Afterwards, these 
erythrocytes were used in haemolysis experiments comparing the Ece1-III-mediated lysis rates for 
both depleted and non-treated erythrocytes. To eliminate the possibility of MßCD exhibiting a 
damaging effect on the erythrocytes, a negative control without peptide was included and 
subtracted from the measured values. So far, only preliminary experiments were carried out using 
the peptide Ece1-III62-93 and it should be noted that the experiment has only been performed twice 
and in duplicate. 
The results obtained so far, however, indicate that cholesterol may exert a protective effect on the 
erythrocyte membrane, as MßCD-treated red blood cells are more easily lysed by Ece1-III62-93. 
Particularly at low peptide concentrations, e.g. 1.5 μM or 0.75 μM, the observed lysis rate of 
cholesterol-depleted erythrocytes is significantly higher compared to that of untreated 
erythrocytes (Figure 27). 
 
Figure 27: Impact of membrane cholesterol-content on Ece1-III-mediated erythrocyte lysis. 
Reduction of the cholesterol inside the erythrocyte membrane results in a higher lysis rate by 
Ece1-III62-93. Particularly at low peptide concentrations, cholesterol-depleted erythrocytes are more 
efficiently lysed than red blood cells of the untreated control. 
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3.3.3 Yeast growth in the presence of synthetic Ece1 peptides 
 
Discovering the highly lytic effect that peptide Ece1-III62-93 exerts on both epithelial cells and 
erythrocytes, the question arose whether high concentrations of the peptide in the surrounding 
medium could also exhibit an inhibitory effect on the growth of C. albicans itself or other yeast 
species, such as C. glabrata and S. cerevisiae. To analyse the influence of peptides Ece1-III62-93 
and Ece1-III62-92 on the growth of these yeast species, growth experiments were carried out in the 
presence of these peptides. The two C. albicans wild type strains SC5314 and BWP17/CIp30, the 
ece1Δ/Δ and revertant strain, the ece1Δ+ECE1[ΔEce1-III] strains (see part 3.4) and a wild type 
strain of both C. glabrata (ATCC2001) and S. cerevisiae (BY4741) were grown in the presence 
of 20 μM of either peptide Ece1-III62-93 or Ece1-III62-92. As a means of comparison, growth of 
these strains was also tested in the presence of the same concentration of melittin. After 50h of 
incubation at 37°C, however, no differences in growth could be detected for any of the strains in 
the presence of either Ece1-III62-93, Ece1-III62-92 or melittin. All strains showed a growth 
comparable to that in medium without added peptide and reached the same final OD, which was 
OD600 of 1.2 for all tested C. albicans strains, OD600 of 1.4 for C. glabrata and OD600 of 1.1 for 
S. cerevisiae (Figure 28). 
 
Figure 28: Impact of peptides on the growth of different yeast species. The presence of 20 μM of 
either Ece1-III62-93, Ece1-III62-92 or melittin did not influence the growth of the tested C. albicans 
strains, C. glabrata and S. cerevisiae compared to growth in YPD only (Ctrl).  
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Furthermore, all C. albicans strains were subjected to growth in the presence of a higher 
concentration of the three peptides, i.e. 70 μM. Even at this high peptide concentration in the 
surrounding medium, growth characteristics in the presence of Ece1-III62-93 and Ece1-III62-92 were 
observed to be similar to the control, with all strains reaching the same final OD. On the contrary, 
growth in the presence of 70 μM of melittin resulted in a slight initial drop of OD, which was 
most prominent for the C. albicans wild type BWP17/CIp30. No further influences of melittin on 
C. albicans growth could be observed however (Figure 29). 
 
 
Figure 29: Impact of higher peptide concentration on the growth of different C. albicans strains. 
While the presence of 70 μM of Ece1-III62-93 and Ece1-III62-92 did not influence the growth of the 
tested C. albicans strains, this concentration of melittin caused a prolonged lag phase, which could be 
observed for all tested strains. 
 
3.3.4 Interaction of Ece1-III with the host cell membrane 
 
The previously obtained results pointed in the direction of Ece1-III acting as a pore-forming 
peptide. Trying to identify possible binding partners acting as a receptor in the host cell 
membrane, a lipid binding assay was performed by overlaying the synthetic peptide onto 
PIP Strips™ Membranes. These membranes contain 15 spots containing 100 picomoles of 
different membrane lipids (Figure 30A). Incubation of synthetic Ece1-III with the PIP Strips™ 
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Membranes and subsequent antibody detection was performed to identify membrane lipids that 
may allow localisation of Ece1-III to the membrane via direct binding. Hypothesising that the C-
terminal positively charged lysine-arginine-motif of Ece1-III62-93 may be involved in mediating 
binding to the negatively charged head groups of the membrane lipids, synthetic Ece1-III peptides 
with a slight variation of this motif were tested for their binding capacity as well. These included 
peptide Ece1-III62-93RÆA and Ece1-III62-93KRÆAA, in which one or both amino acids of the C-
terminus were substituted with the nonpolar amino acid alanine. 
Antibody detection revealed that Ece1-III62-93 did readily bind to several of the present 
phospholipids. The strongest binding could be observed between this peptide and the 
phospholipids phosphatidylinositol-4-phosphate, phosphatidic acid and phosphatidylserine. 
Binding to phosphatidylinositol, phosphatidylinositol-3-phosphate, phosphatidylinositol-6-
phosphate and phosphatidylinositol-3,5-bisphosphate was weaker, but still noticeable. Exchange 
of the positively charged amino acid arginine at the C-terminus of peptide Ece1-III62-93 with 
alanine resulted in a remarkable loss of binding capacity to the tested phospholipids. 
Ece1-III62-93RÆA only bound to one of the spotted lipids, phosphatidic acid. Curiously, this strong 
reduction in binding capacity was not observed when both positively charged amino acids of the 
peptide’s C-terminus (lysine and arginine) were substituted with alanine. The binding pattern that 
could be observed after incubation of the PIP Strips™ Membranes with Ece1-III62-93KRÆAA was 
similar to that of Ece1-III with the intact C-terminus, albeit binding to the respective 
phospholipids was perceivably weaker for most lipids. Aberrant to peptide Ece1-III62-93 however, 
the peptide with the completely nonpolar C-terminus did bind most strongly to the phospholipid 
phosphatidylinositol-3-phosphate. The results of the lipid binding assay for all three tested 
peptides are depicted in Figure 30B.     
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Figure 30: Identification of possible Ece1-III binding partners within the cell membrane via lipid 
binding assay. (A) Schematic of a PIP Strips™ Membrane and table of the phospholipids spotted on 
each strip at a concentration of 100 picomoles (images taken from Thermofisher). (B) Binding of the 
Ece1-III peptides with varying C-terminal endings to the different phospholipids.  
 
 
3.4 Single peptide knockout-mutants 
 
Seeing that of the eight Ece1-peptides predicted to result from complete cleavage of the protein 
only Ece1-III demonstrated a damaging effect on host cells, a mutant strain was created in our 
laboratory, in which the ECE1 allele, including promoter and coding sequence, but specifically 
lacking the Ece1-III-encoding DNA was reinserted in the mutant lacking ECE1 (resulting in the 
strain ece1Δ+ECE1[ΔEce1-III]). Hypothesising that the other seven peptides are negligible for 
the effects carried out by Ece1, a mutant deficient in only this one peptide should behave similarly 
to the ece1Δ/Δ null mutant. Three different clones of this mutant were tested in parallel for their 
ability to form hyphae and to cause damage of oral epithelial cells. 
The ece1Δ+ECE1[ΔEce1-III] strains were incubated in RPMI medium at 37°C to induce the 
yeast-to-hypha transition. The formation of hyphae was assessed after 3h, 5h and 24h, 
respectively. As shown in Figure 31, the cells of all tested clones showed the development of 
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germ tubes and short hyphae after 3h of incubation. Continued hyphal growth could be observed 
after 5h, while after 24h of incubation, the Candida cells had formed a dense layer of long, 
interwoven hyphae. Therefore, hypha formation of the ece1Δ+ECE1[ΔEce1-III] strains is in 
accordance to that of the ece1Δ/Δ null mutant, which shows a similar hyphal growth at the 
respective time points (compare Figure 13). 
 
Figure 31: Hyphal growth of the ece1Δ+ECE1[ΔEce1-III] mutants on plastic. Cells were grown 
under hypha-inducing conditions in RPMI medium and hyphal growth was assessed after 3h, 5h and 
24h. All three clones showed normal hypha-forming abilities.  
 
 
The damaging capacity of the ece1Δ+ECE1[ΔEce1-III] strains was tested via a cytotoxicity assay 
on oral epithelial cells in comparison to the parental wild type strain BWP17/CIp30, the ece1Δ/Δ 
mutant and the ece1Δ+ECE1 strain. After 24h of co-incubation with the epithelial cells, damage 
was determined via measurement of LDH release. The results showed that all three strains 
deficient in Ece1-III behaved similarly to the ece1Δ/Δ mutant, i.e. no damage was caused by these 
strains. However, four clones of an Ece1-VII-deficient strain (ece1Δ+ECE1[ΔEce1-VII]) that had 
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been constructed and included into this experiment as a control, did not exert any damage on the 
oral epithelial cells either. As expected, the highest damage was caused by the wild type (~20% 
lysis), while the revertant strain ece1Δ+ECE1 caused an intermediate damage of approximately 
5% (Figure 32). 
 
Figure 32: Impact of single peptide deletion on damage of epithelial cells. The three clones of the 
ece1Δ+ECE1[ΔEce1-III] strain, which are only deficient in the Ece1-III encoding gene sequence, 
behave similarly to the ece1Δ/Δ mutant and do not cause damage of oral epithelial cells. The four 
clones of the ece1Δ+ECE1[ΔEce1-VII] strain however did not damage the epithelial cells either. 
 
 
3.5 Lysis of erythrocytes by C. albicans 
 
C. albicans wild type and mutant strains were tested for their ability to lyse red blood cells by co-
incubation for different periods of time (16h, 24h and 48h) and subsequent determination of 
erythrocyte lysis determined by measuring absorbance of released haemoglobin at 541 nm. The 
tested strains included two C. albicans wild types (SC5314 and BWP17/CIp30), the ece1Δ/Δ, 
ece1Δ+ECE1, all three clones of the mutant lacking Ece1-III62-93, the clones lacking Ece1-VII, 
kex2Δ/Δ, eed1Δ/Δ and cph1Δ/efg1Δ. Co-incubation was carried out under hypha-inducing 
conditions, i.e. at 37°C and in RPMI 1640 medium. 
After 16h of co-incubation, 24% and 30% of the erythrocytes were lysed by the wild type strains 
SC5314 and BWP17/CIp30, respectively, while a lysis rate of 18% could be observed for the 
revertant strain ece1Δ+ECE1. For all of these three strains, damage gradually increased with an 
elongated co-incubation time. While both wild types had caused approximately 80% lysis after 
48h, lysis by the revertant strain was overall less and reached a maximum of 53% after 48h of 
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incubation. No damage was exerted by the ece1Δ/Δ and all three clones of the 
ece1Δ+ECE1[ΔEce1-III] mutant. Likewise, no damage of erythrocytes could be observed after 
co-incubation with the strain lacking the gene encoding for the Kex2 protease (kex2Δ/Δ) and with 
the strains eed1Δ/Δ and cph1Δ/efg1Δ, which are characterised by switching back to the yeast 
form after initial hypha formation or by being locked in the yeast form, respectively. While the 
synthetic peptide Ece1-VII did not show a lytic effect on red blood cells, the loss of the gene 
sequence encoding this single peptide resulted in an abolished damage effect of the respective 
strains on erythrocytes. After a co-incubation for 48h, only a very small percentage of blood cells 
(4-5%) had been lysed by the clones ece1Δ+ECE1[ΔEce1-VII] K6 and ece1Δ+ECE1[ΔEce1-VII] 
K12 (Figure 33). This result may hint to a more prominent function of Ece1-VII in vivo, but 
further experiments would be needed to confirm this role. 
 
 
 
Figure 33: Erythrocyte lysis by different C. albicans wild type and mutant strains. While both 
tested wild types (SC5314 and BWP17/CIp30) and the ece1Δ+ECE1 strain are able to lyse red blood 
cell, no haemoglobin release could be observed after incubation with the ece1Δ/Δ, the 
ece1Δ+ECE1[ΔEce1-III] strains, most ece1Δ+ECE1[ΔEce1-VII] strains, kex2Δ/Δ, eed1Δ/Δ and 
cph1Δ/efg1Δ. Very low lysis was caused by the two ece1Δ+ECE1[ΔEce1-VII] clones K6 and K12 
after 48h.    
 
3.6 ScKex2-mediated in vitro digestion of rEce1 
 
In order to determine the importance of processing of the full length Ece1 protein into single 
peptides, a His-tagged version of the full length protein was recombinantly expressed in E. coli 
BL21(DE3), followed by isolation and purification of the protein utilising the His-tag. In parallel, 
the protease Kex2, which had already been shown to process Ece1 in vitro, was overexpressed 
Results | 75 
 
using a P. pastoris strain. Subsequently, digestion of the produced recombinant Ece1 (rEce1) with 
the recombinant Kex2 (ScKex2) and comparison of damage efficiency between the full length 
rEce1 and the digest products was carried out in order to identify a possible increase of 
cytotoxicity coming along with the processing into single peptides.      
 
3.6.1 Protein overexpression 
 
Both rEce1 and ScKex2 were successfully overexpressed using the described expression systems. 
After purification and concentration of the proteins from E. coli cell lysates and P. pastoris 
culture supernatants, respectively, protein solutions containing > 2 mg/ml protein could be 
obtained (Figure 34).  
 
 
Figure 34: Overexpression of recombinant Ece1 (rEce1) and recombinant Kex2 (ScKex2). 
(A) SDS-PAGE of purified and concentrated rEce1. The His-tagged Ece1 protein has a molecular 
weight of approximately 30 kDa. (B) SDS-PAGE of overexpressed ScKex2. While the protein 
concentration was very low in the supernatant (unconcentrated), it was increased by using concentrator 
columns (concentrated). The ScKex2 protein has a molecular weight of approximately 90 kDa. 
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3.6.2 In vitro digestion of rEce1 
 
To digest full length rEce1, the protein was co-incubated with ScKex2 in the presence of CaCl2 
for either 1 min, 5 min, 10 min or 20 min at 37°C. Afterwards, the samples were directly put on 
ice until loading on an SDS-gel for examination of a successful digest. It was found, that digestion 
had occurred rapidly, as the previously strong protein band of rEce1 was noticeably reduced in the 
digestion samples, while an increase of lower bands, corresponding to smaller protein products, 
was observed. After 20 min of co-incubation, digestion had progressed to a point where no 
individual proteins could be detected. The lowest detectable band after the shortest incubation 
times was below 10 kDa, but did not appear to correspond to the molecular weight of single Ece1-
peptides, as it resolved at a higher molecular weight than synthetic Ece1-III. This was identical 
for all samples incubated between 1 to 10 min. Blotting of the protein gel revealed, that a great 
proportion of rEce1 had seemingly formed dimers or trimers, as strong bands were detectable at 
60 kDa and 90 kDa, corresponding to multiples of the molecular weight of the full length Ece1 
protein. Therefore, only a small fraction of the present protein seems to have been digested by 
ScKex2, explaining the very weak band of the lower weight proteins. Blotting however also 
revealed very weak bands, which in comparison to the synthetic Ece1-III correlate to fully 
processed rEce1 (Figure 35). 
 
 
Figure 35: In vitro digestion of rEce1. (A) SDS-PAGE of rEce1, ScKex2 and the digestion products 
after 1 min, 5 min, 10 min and 20 min of co-incubation. Synthetic Ece1-III was added as a control. 
(B) Western Blot of the protein gel using a polyclonal antibody against Ece1-III. While strong 
detection can be observed for the full length rEce1 protein and multiples thereof (30 kDa, 60 kDa, 
90 kDa), detection of lower weight peptides, including synthetic Ece1-III, is only weak. Arrow: 
peptides with molecular weights corresponding to fully processed rEce1.  
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3.6.3 Erythrocyte lysis by rEce1 digestion products 
 
Digestion products resulting from ScKex2-mediated cleavage of rEce1 were tested for their 
ability to lyse erythrocytes. Different concentrations (0.3 mg/ml, 0.6 mg/ml, 1.2 mg/ml) of the 
digestion products were added to the erythrocyte samples, corresponding to 10 μM of free 
Ece1-III, assuming digestion efficiencies of 100%, 50%, or 25%, respectively. Both unprocessed 
rEce1 and ScKex2, in concentrations correlating to their presence in the digestion samples, were 
used as controls. 
Haemoglobin release observed after the incubation period revealed that no lysis occurred 
following incubation with ScKex2. While no erythrocyte lysis could be observed after incubation 
with 10 μM and 20 μM of unprocessed rEce1 either, the addition of 40 μM of undigested rEce1 
resulted in 13% erythrocyte lysis. No erythrocyte lysis, however, could be detected after the 
incubation with rEce1 digestion products. Only the addition of 40 μM of digested rEce1, 
corresponding to 10 μM of free Ece1-III at an assumed digestion efficiency of 25%, caused 
minimal lysis (2%) of the red blood cells. In comparison, synthetic Ece1-III62-93 at a concentration 
of 10 μM led to complete lysis of the erythrocytes, while the same concentration of Ece1-III62-92 
resulted in 22% haemolysis. 
 
 
Figure 36: Erythrocyte lysis by rEce1 digestion products. While moderate lysis (13%) of red blood 
cells is caused by 40 μM of undigested rEce1, the highest concentration of digested rEce1 only caused 
lysis of 2% of the erythrocytes. In comparison, synthetic Ece1-III62-93 and Ece1-III62-92 cause lysis of 
100% and 22% of erythrocytes, respectively. 
78 | Discussion 
 
4 Discussion 
 
C. albicans is the cause for a variety of infections in humans, ranging from harmless, albeit 
unpleasant, superficial infections of the skin and mucosa to life-threatening systemic infections. 
Especially in light of the constantly increasing number of immunocompromised persons due to 
HIV infection, anti-cancer chemotherapy and organ transplantation, a high percentage of persons 
are at risk of developing a Candida infection. Therefore, the identification of new virulence 
factors and the development of novel antifungal drugs is an important step in preventing and 
treating infections by this fungal pathogen. 
Yeast-to-hypha transition represents an important virulence mechanism of C. albicans during 
infection of its human host [74]. Hyphae are responsible for excessive tissue invasion and damage 
and hypha formation is also accompanied by the expression of various hypha-associated proteins, 
which contribute to the three main steps during an infection: adhesion to, invasion into and 
damage of the host cell [15, 72, 76]. These proteins include, for example, adhesins and invasins of 
the Als family as well as secreted aspartic proteases. However, with over 70% of the C. albicans 
ORFs still being uncharacterised, a high number of possibly important virulence factors remain to 
be discovered. 
The aim of this work was to identify the function of the hypha-associated protein Ece1, as 
previously performed experiments hinted at this protein playing an important role in inducing 
epithelial damage. Even though Ece1 has already been characterised over two decades ago and is 
regularly used as a marker for hyphal growth, the exact function of this protein during a fungal 
infection remained to be elucidated. Ideally, this work would result in the identification of Ece1 
function and provide a possible mode of action. 
 
4.1 Involvement of Ece1 in host cell damage 
 
Upon recognition of C. albicans yeast or hyphal cells by the host’s immune system, activation of 
the three main MAPK pathways p38, JNK and ERK1/2, the PI3K and the NF-κB pathway is 
initiated [226, 270–272]. While this initial activation is independent of the morphological form of 
C. albicans, only hyphal cells do trigger a second, much stronger response of these pathways, 
eventually resulting in the activation of the transcription factor c-Fos and ERK1/2-mediated 
phosphorylation of the MAPK phosphatase MKP1 [97]. Activation of c-Fos is characterised by an 
up-regulated production of cytokines, chemokines and other inflammatory mediators, while the 
phosphatase MKP1 functions as a negative feedback regulator by contributing to the inhibition of 
MAPK signalling via deactivation of JNK and p38 [97]. As previous work had showed, the 
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ece1Δ/Δ mutant is unique in its ability to form proper hyphae, but not activating the epithelial 
danger response pathway, therefore ascribing an important function to the Ece1 protein in the 
discrimination between C. albicans colonisation and invasion [301]. Furthermore, in silico 
analysis revealed that orthologues of the ECE1 gene can only be found in two other members 
within the CTG clade of Candida species, i.e. in C. dubliniensis and C. tropicalis. Both species 
are medically relevant, with C. tropicalis presenting a quickly emerging non-albicans Candida 
species, which has recently been identified as the most common species associated with 
candidaemia in Asia [317, 318]. While C. dubliniensis is primarily associated with OPC, it is the 
causative agent of 2-5% of all IC cases, with a crude mortality rate similar to C. albicans [66, 68, 
319–321]. Finding that ECE1 orthologues are not present in the less pathogenic Candida species 
demonstrates that this gene may be an important determinant of pathogenicity by influencing the 
severity of an infection. 
 
4.1.1 ece1Δ/Δ mutant versus wild type 
 
The examination of adhesion and invasion properties performed in this study revealed that no 
differences in these attributes do exist between the ece1Δ/Δ mutant strain and the parental wild 
type BWP17/CIp30. This shows that although the expression of Ece1 is tightly correlated to the 
formation of hyphae, the protein is not important for the hypha formation per se and neither does 
it function as an adhesin or invasin, as attachment to and invasion into the host cell are not 
impaired in the deletion strain. On the contrary, the ability to damage host epithelial cells is 
completely abolished in the ece1Δ/Δ mutant, emphasising the contribution of this protein to 
C. albicans-induced tissue damage. Considering this distinctive phenotype of the mutant, the 
question arises how this strain is able to invade epithelial cells without damaging them during the 
process. As invasion so far has only been proven by differential staining and subsequent 
fluorescent microscopy, it is possible that instead of actually piercing the host cell membrane, 
ece1Δ/Δ induces an invagination of the membrane, thereby creating a membrane pocket, which 
tightly surrounds the elongating hyphal cell. Given the fact that the single Ece1 peptides are 
secreted after the processing step, such a membrane pocket would also prevent diffusion of these 
secreted peptides into the surrounding environment and instead allow the accumulation of the 
peptides, resulting in an increased peptide concentration in close proximity to the host cell 
membrane, thereby leading to an enhanced effectiveness.   
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4.1.2 Ece1 is cleaved into single peptides of which Ece1-III is responsible for Ece1-
mediated epithelial damage 
 
Bader et al. identified Ece1 as a substrate of the proprotein-converting protease Kex2 by 
performing in vitro digestion experiments [296]. This protease is localised in the late trans-Golgi 
network, indicating that in vivo processing of Ece1 occurs intracellularly. The resulting cleavage 
products, i.e. the individual Ece1 peptides, therefore represent the functionally active form of 
Ece1 and have been hypothesised to end up secreted into the surrounding environment, given the 
localisation of the Kex2 protease within the secretory pathway. Indeed, LC-MS/MS analysis, 
performed at a later time point during this study at our institute, identified Ece1-derived peptides 
in culture supernatants of a C. albicans wild type strain grown under hypha-inducing conditions 
[301]. 
Assuming these individual peptides to be responsible for the Ece1-induced damage during 
infection, synthetically produced peptides were obtained and analysed for their cytolytic 
properties on both epithelial cells and red blood cells. 
Infection of oral epithelial cells with the individual synthetic peptides clearly demonstrated that 
peptide Ece1-III is responsible for the damaging effect of the Ece1 protein. While co-incubation 
of the epithelial cells with 10 μM of this peptide resulted in a lysis rate of over 30% after 24h, the 
remaining peptides could not be observed to exert an effect on the host cells. This result is in 
accordance to in silico analyses predicting only peptide Ece1-III to adopt an α-helical 
conformation and to localise inside plasma membranes. When added to epithelial cells in 
combination with a C. albicans wild type strain, however, all peptides caused noticeable lysis of 
the epithelial cells, often exceeding the lysis rate of the wild type alone. On the contrary, such an 
increase of peptide-induced lysis could not be observed when epithelial cells were co-incubated 
with a combination of synthetic peptide and the ece1Δ/Δ mutant strain. This may suggest that 
peptides Ece1-I, Ece1-II and Ece1-IV - Ece1-VIII are involved in Ece1-mediated damage, but that 
the presence of the other peptides, particularly Ece1-III, is needed for these peptides to actively 
contribute to the damaging effect. While secretion of all Ece1-peptides is given in the presence of 
a C. albicans wild type strain, but not in the presence of the ece1Δ/Δ mutant strain, only the 
combinatorial infection of synthetic peptides with the wild type strain caused a drastic increase of 
the peptides’ damage potential. Elucidation of the exact function of these other peptides therefore 
is of great interest and remains the work of further research. Combinatorial infection of epithelial 
cells with the ece1Δ/Δ mutant and Ece1-III resulted in a noticeably increased damage compared 
to infection with the ece1Δ/Δ strain alone and caused a slight increase in damage compared to 
peptide Ece1-III alone (37% versus 32%). This might be due to the hypha formation of the 
C. albicans mutant enhancing the activity of the peptide, possibly by facilitating membrane 
interaction through the formation of a membrane pocket by the invading hyphae. 
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Interestingly, it was shown that while Ece1-III62-92, which lacks the C-terminal arginine, does 
cause an overall much lower lysis than Ece1-III62-93, combinatorial infection of this peptide with 
either the C. albicans wild type or ece1Δ+ECE1 strain resulted in a higher lysis of epithelial cells 
(75% and 67%, respectively) compared to an equivalent infection using Ece1-III62-93 (67% and 
56%, respectively). The finding that less lysis is caused by Ece1-III62-92 than Ece1-III62-93 in case 
of a combinatorial infection with the ece1Δ/Δ mutant strain might be a hint that full activity of 
this peptide requires the presence of other Ece1 peptides. This demonstrates that while this 
peptide alone may be less effective in causing damage on host cells than the peptide with the C-
terminal lysine-arginine-motif, lysis by Ece1-III62-92 might be superior under certain conditions. 
This may include an environment more closely resembling in vivo conditions, i.e. in the presence 
of a C. albicans strain expressing all Ece1 peptides. 
 
4.1.3 Ece1-III induced damage is rapid and concentration-dependent 
 
Examining how fast lysis by synthetic Ece1-III occurs in comparison to C. albicans-induced 
damage, a C. albicans wild type strain, the ece1Δ/Δ and reconstituted ece1Δ+ECE1 strain as well 
as 10 μM of synthetic peptide were co-incubated with different epithelial cell lines for 3h and 6h, 
respectively. The result showed that lysis by synthetic Ece1-III is rapid, with 13 – 32% of the 
epithelial cells being lysed within three hours, depending on the cell line. While lysis of both oral 
and vaginal epithelial cells seems to be initiated immediately, lysis of gastrointestinal epithelial 
cells was observed to happen more slowly, with a total of 22% of the host cells being lysed after 
6h, compared to an averaged 30% of oral and vaginal cells being lysed in the same time frame. 
On the contrary, first damage induced by the C. albicans wild type and reconstituted strain was 
detectable after 6h. However, considering that first ECE1 transcripts are found 30 min after the 
stimulation of hyphal growth, and the production of active peptides includes further steps such as 
translation, processing and secretion, damage being detectable within 6h also appears rather rapid. 
The fact that Ece1 is expressed and secreted in such a fast manner underscores the relevance of 
this protein in infection-associated epithelial damage during a C. albicans infection. 
Incubation of epithelial cells with different concentrations of synthetic Ece1-III also showed that 
damage is induced concentration-dependently. Peptide-induced lysis proportionally increased for 
both Ece1-III62-93 and Ece1-III62-92 with rising concentrations. Using melittin as a positive control 
demonstrated that Ece1-III is less cytotoxic than the bee-venom derived toxin, as melittin caused 
a remarkably higher lysis of epithelial cells than either of the Ece1-III variations. This may be due 
to the molecular mechanism underlying the lytic activity of the peptides. It is, for example, 
possible that melittin is better adapted to the lipid composition present in the plasma membrane of 
human epithelial cells and might preferentially bind to lipids that are ubiquitous. Moreover, it 
82 | Discussion 
 
might be of importance that Ece1-III is produced by an opportunistic pathogen and therefore its 
evolutionary purpose may originally lie in accessing nutrients or competing against other 
microorganisms inside the fungus’ environmental niche, while bee venom is actively produced to 
ward off enemies, therefore requiring a stronger toxicity. 
It could be observed that at a concentration of 20 μM, melittin did cause less lysis than at a 
concentration of 15 μM. This may indicate that peptide saturation is eventually reached and that a 
higher peptide concentration will result in an oversaturation favouring peptide-peptide interaction 
instead of peptide-membrane interaction. Such an effect could not be observed for either peptide 
Ece1-III62-93 or Ece1-III62-92 in the respective concentrations, demonstrating that even at high 
micromolar concentrations peptide efficiency is not impaired. 
 
4.1.4 Influence of hypha formation and cell viability on peptide-induced epithelial damage 
 
As has been shown in previous experiments, C. albicans hyphae contribute to an increase of 
peptide-induced epithelial damage, even if the hypha-forming strain itself is not causing damage, 
as in the case of the ece1Δ/Δ mutant strain. By using C. albicans mutants that are locked in the 
yeast form (cph1Δ/efg1Δ) or unable to maintain hyphal growth (eed1Δ/Δ) this could be 
confirmed. Combinatorial infection of epithelial cells with neither of these strains together with 
Ece1-III did result in an elevated lysis rate compared to infection with only the peptide. The same 
result was found for the budding yeast S. cerevisiae, which is also non-pathogenic. C. glabrata, a 
yeast species which is evolutionary more closely related to S. cerevisiae than C. albicans, could 
also be shown not to bring about damage of epithelial cells. Interestingly, when epithelial cells 
were co-incubated with a combination of C. glabrata and synthetic Ece1-III, lysis rates 
comparable to equivalent experiments using a C. albicans wild type strain were reached. 
Therefore, C. glabrata so far represents the only known non-hypha forming yeast enhancing 
Ece1-III-induced damage of epithelial cells. This indicates that also in case of C. albicans factors 
other than hypha formation alone might be involved in augmenting peptide-induced damage. 
Such factors may for example include hydrolytic enzymes that aid in the disintegration of 
epithelial cell-cell contacts, leading to the loss of epithelial integrity and possibly facilitating 
Ece1-III activity. As, in contrast to the rest of the Candida species, C. glabrata does not produce 
secreted proteases which are released into the extracellular space [322, 323], hydrolytic enzymes 
of a different kind can be expected to be involved in C. glabrata-mediated enhancement of 
Ece1-III activity, e.g. phospholipases or lipases. Furthermore, C. glabrata, among other non-
albicans Candida species, has been shown to be able to degrade haemoglobin via the utilisation of 
haemolysins. In C. glabrata, the haemoglobin-like protein (HLP) gene has been associated with 
haemolytic activity exhibited by this fungus [324]. Having shown that the C. albicans peptide 
Discussion | 83 
 
Ece1-III itself is able to induce erythrocyte lysis (see part 4.1.5), the assumption of a C. glabrata 
haemolysin enhancing its activity may be plausible. 
Performing combinatorial infections of a reconstituted human vaginal epithelium (RHVE) with 
both C. albicans and C. glabrata, Alves et al. were able to demonstrate that both colonisation and 
invasion of the epithelium by C. glabrata is significantly enhanced in the presence of a 
C. albicans strain [325]. Even though only half the inoculum of C. albicans cells was used for a 
co-infection as opposed to an infection with C. albicans alone, tissue damage was found to be 
higher during a co-infection of the epithelium with C. glabrata and the C. albicans strain ATCC 
90028 than with the C. albicans strain alone [325]. Additionally, quantitative RT-PCR revealed 
that the relative expression of EPA genes, a major group of C. glabrata adhesins [326], is down-
regulated or absent during a co-infection with C. albicans, suggesting that the increase of 
C. glabrata colonisation and invasion is mediated by C. albicans-associated factors. Indeed, 
expression of the SAP4-10 genes as well as genes of the ALS family could be shown to be up-
regulated in C. albicans during a co-infection [325]. As these results indicate that pathogenicity of 
C. glabrata is enhanced through the epithelial damage induced by C. albicans, studies on the 
relative expression of ECE1 during a co-infection with C. glabrata may prove to generate 
interesting results. The increased damage potential of C. glabrata observed during co-incubation 
with Ece1-III indicates that a highly up-regulated expression of only ECE1 may already be 
sufficient to enhance C. glabrata pathogenicity. In vivo, however, the expression of a variety of 
C. albicans virulence factors may contribute to enabling C. glabrata to better colonise and invade 
host cells. RT-PCR performed in our laboratory for example showed that expression of ECE1 is 
strikingly correlating to the expression of different SAP proteases, showing that the expression of 
different virulence factors is precisely coordinated.   
An indicator for the involvement of enzymatic factors in the augmentation of Ece1-III-induced 
damage is the finding that this effect is lost in heat-killed cells of both C. albicans and 
C. glabrata. Confirmation for this hypothesis could be obtained via simultaneous co-incubation of 
epithelial cells with both synthetic Ece1-III and various purified hydrolytic enzymes from both 
C. albicans and C. glabrata. An involvement of C. albicans Saps might furthermore be verified 
by co-incubation of synthetic Ece1-III and a C. albicans wild type strain in the presence of the 
Sap inhibitor pepstatin A. 
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4.1.5 Ece1-III induces erythrocyte damage 
 
C. albicans has long been known to produce and secrete a haemolytic factor which is involved in 
iron acquisition from host erythrocytes [327, 328]. While Watanabe et al. were able to 
characterise this factor as a sugar moiety of a C. albicans mannoprotein, the exact identity of this 
protein and the molecular mechanism underlying erythrocyte lysis could not be determined [174]. 
They did, however, conclude that the activity of secreted aspartic proteases is not involved in 
erythrocyte lysis, as the addition of the potent aspartic protease inhibitor pepstatin A did not 
influence the haemolytic activity of C. albicans. Additionally, enzymatic activity could be ruled 
out as being responsible for erythrocyte lysis by incubation of the culture supernatant at 100°C. 
Heat-inactivation did not affect the haemolytic properties of C. albicans, providing further 
evidence that haemolysis is not mediated by proteolytic enzymes [174]. 
Given the structural similarity between the Ece1-derived peptide Ece1-III and the bee venom 
toxin melittin that has been found through in silico analysis, it was hypothesised that Ece1 may 
very well represent the C. albicans haemolytic factor, as melittin is a pore-forming toxin which 
efficiently integrates into and disrupts erythrocyte membranes [329–331]. The involvement of 
Ece1 in the lysis of erythrocytes is further supported by the finding that ECE1 expression is 
induced in the presence of haemoglobin [332]. 
It could be shown in this study, that synthetic Ece1-III does indeed exert a potent cytolytic effect 
on human erythrocytes. Using different peptide concentrations and performing a time course 
experiment, it could be demonstrated that both Ece1-III62-93 and Ece1-III62-92 do rapidly and 
efficiently lyse red blood cells, with Ece1-III62-93 being active at much lower concentrations than 
Ece1-III62-92 though. The peptide featuring the C-terminal lysine-arginine-motif was also found to 
induce haemolysis more rapidly, with almost 100% of the erythrocytes already being lysed after 
45 minutes of incubation. Ece1-III62-92-induced lysis in contrast is still increasing after 180 min, 
indicating that a higher lysis rate may be reached at some point. Considering the fact that a 
concentrated erythrocyte suspension as well as micromolar concentrations of the synthetic 
peptides have been used for these experiments, it is rather unlikely that the haemolytic activity of 
Ece1-III does play a significant role in vivo in the bloodstream. This peptide may, however, be a 
possible candidate for the production of haemocidins in the vaginal niche through the lysis of 
haemoglobin present in the menstrual discharge. Haemocidins are a group of microbicidal 
peptides arising from haem-binding proteins such as haemoglobin [333]. In vivo, such peptides 
can be found in tick guts [334–336], in human post-partum uterine fluid [337] or in the menstrual 
discharge [338, 339]. In the latter, these peptides might strongly influence the composition of the 
vaginal microflora and therefore contribute to a C. albicans overgrowth, eventually resulting in 
vaginal candidiasis. Even though Bocheńska et al. could demonstrate that C. albicans secreted 
aspartic proteases are able to liberate bactericidal haemocidins from haemoglobin, with the 
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liberated peptides showing a strong killing activity against Lactobacillus acidophilus and, to a 
lower degree, against E. coli [340], the exact process underlying the generation of menstrual 
haemocidins remains to be elucidated. Hence, a role of Ece1-III in the production of these 
bactericidal peptides cannot be excluded. 
 
4.1.6 Impact of the pH on Ece1-III-mediated erythrocyte lysis 
 
As C. albicans encounters a variety of environmental niches when colonising or infecting its 
human host, an effective virulence factor needs to be active in a broad range of different pH 
values. In isotonic media a decrease of the pH over the range of 9.4-4.8 has been shown to result 
in an increased erythrocyte volume, a decrease in density and a more spherical shape of these 
blood cells [341]. Therefore, the haemolytic properties of Ece1-III have only been tested at a pH 
between 5-8, to prevent the occurrence of false-positive results arising from pH-induced 
impairment of erythrocyte viability. No differences in lysis efficiency could be observed at the 
tested pH values, demonstrating that at least in the range that has been tested the pH value does 
not influence the haemolytic activity of Ece1-III. This is not surprising, as many known toxins 
have been shown to be active among a wide range of pH values. The VacA toxin released from 
Helicobacter pylori for example is activated by a short exposure to acidic solutions (pH 1.5-5.5) 
and once activated remains stable at pH 1.5 and can even resist pepsin digestion at pH 2 at 37°C 
[342]. In the case of H. pylori VacA, a low pH also mediates the disassembly from an oligomeric 
structure into monomers, resulting in the exposure of hydrophobic patches that are crucial for 
insertion into a host membrane [343, 344]. This transition only takes place at a very specific pH 
around 5.2 [342, 344], illustrating how tightly toxin function can be dependent on an 
environmental cue. Given the fact that only a low range of pH values could be tested in this study 
due to the above mentioned viability issues of the erythrocytes, this may explain the differences 
that could be observed between Ece1-III62-93 and Ece1-III62-92, as the optimal pH for a more 
efficient haemolysis by Ece1-III62-92 might be outside the tested range. Hypothesising a role of 
Ece1-III in the generation of menstrual haemocidins, as discussed in part 4.1.5, full activity may 
very well be reached at more acidic pH values, such as pH 4, corresponding to the vaginal pH and 
to the finding that Sap-mediated hydrolysis of haemoglobin, resulting in the production of 
haemocidins, was also most effective at pH 4 [340]. 
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4.1.7 Ece1-III induced erythrocyte lysis is inhibited by human serum 
 
Haemolysis experiments carried out in the presence of human blood serum demonstrated that the 
serum exerts a highly inhibiting effect on Ece1-III-induced erythrocyte lysis. In the presence of 
0.2% human serum, lysis by Ece1-III62-93 was reduced by 50%, while at a concentration of 1%, 
lysis reduction reached 75%. Lysis induced by Ece1-III62-92 could even be completely abolished 
by the addition of human serum in a concentration of 1% and 0.5%. Based on the fact that 
C. albicans must acquire the essential micronutrient iron from the host and assuming that Ece1-III 
is the main factor responsible for erythrocyte lysis, inactivation of this peptide by human serum 
will result in an iron deficiency and eventually lead to an impaired growth and ultimately death of 
the fungal cell, as the iron-binding haem cannot be released from the erythrocytes. This is in 
accordance with the results of earlier studies that demonstrated a growth inhibition of C. albicans 
in the presence of human serum [345–348]. Regarding the fact that serum makes up an 
approximate 55% of whole blood, Ece1-III function should be effectively inhibited in vivo, 
thereby preventing C. albicans iron sequestration from the host and inhibiting fungal growth. 
Human blood serum is composed of approximately 91% of water, 7% of proteins and 2% of 
electrolytes and low molecular substances. Albumins represent the majority of serum proteins, 
making up 60% of the total serum protein content [314]. Therefore, in the attempt to identify the 
Ece1-III-inhibiting serum component, serum albumin was chosen to be tested for its effect on 
Ece1-III-induced haemolysis. Different albumin concentrations were tested, ranging from 
40 μg/ml to 2 mg/ml. While even at the highest concentrations albumin could not be observed to 
exert an inhibiting effect on red blood cell lysis by Ece1-III62-93, a minor inhibition of 
Ece1-III62-92-induced erythrocyte lysis could be detected. However, in comparison to the 
inhibitory effect of whole serum in which albumins are present in a much lower concentration, the 
effect of purified albumins is very low and it therefore appears unlikely that these proteins 
represent the serum component responsible for the inhibiting effect on Ece1-III. Previous studies 
demonstrated an involvement of serum transferrin in the inhibition of C. albicans growth in 
human serum [347, 349–351]. This iron-chelating protein makes up 4% of the serum proteins and 
is responsible for the binding of free serum iron and iron transport. “Nutritional immunity”, 
resulting from the binding of iron within proteins, effectively prevents microbial growth [166, 
167]. Indeed, addition of free iron at a concentration exceeding transferrin saturation could be 
shown to diminish the inhibitory effect of human serum on C. albicans growth [349]. Usually, 
iron is bound to approximately 30% of the available iron-binding sites within the transferrin 
molecules. This means that residual binding sites are available to bind additional iron that may be 
released from erythrocytes by Ece1-III. Whether nutritional immunity is responsible for the 
inhibitory effect of human serum on Ece1-III-induced erythrocyte lysis may be verified by 
repeating the lysis experiment in the presence of human serum and simultaneously adding free 
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iron in a concentration leading to transferrin oversaturation. Additional iron resulting from 
erythrocyte lysis and subsequent breakdown of haem could then not be effectively sequestered by 
transferrin, thereby enabling growth of C. albicans. 
 
4.1.8 An ion-dependent mechanism is involved in Ece1-III-induced haemolysis 
 
Ece1-III-induced erythrocyte lysis could be shown to be significantly reduced in the presence of 
the potent chelating agent EDTA. This chelator is known to form stable complexes with divalent 
cations, e.g. calcium, magnesium or zinc ions. As removal of such ions from the surrounding 
medium was shown to impair erythrocyte lysis, it can be assumed that the molecular mechanism 
underlying Ece1-III-mediated haemolysis is ion-dependent. Divalent cations play an important 
role in various processes connected to microbial toxins. Heavy metal ions for example represent 
essential cofactors for the activity of metalloproteases, which often act as receptors for pore-
forming toxins [352]. Ion-chelation would therefore impair receptor activity, resulting in a 
reduced toxin function. The strong effect that EDTA-mediated ion-chelation was shown to exert 
on Ece1-III activity suggests that the cytotoxic mechanism of this peptide may involve the activity 
of a metalloprotease. As the majority of known metalloproteases is zinc-dependent, it would be 
beneficial to repeat this experiment using a metalloprotease inhibitor such as o-Phenanthroline 
instead of EDTA, as this compound exhibits a considerably higher stability constant for zinc than 
for calcium [353]. A further possibility explaining the ion-dependency of Ece1-III-mediated 
cytotoxicity would be the initiation of cellular signalling pathways within the host cell in response 
to Ece1-III. Divalent cations are potent second messengers involved in the activation of various 
cellular processes. Particularly calcium has been shown to be responsible for many intracellular 
signalling pathways [354]. As Mg2+ is chelated as well as Ca2+ by EDTA, Ece1-III-induced 
signalling may, however, also be dependent on Mg2+. Indeed, it was shown that the addition of an 
excess amount of Mg2+-ions to cells pre-treated with EDTA restored the cytotoxicity of Ece1-III.  
In case of Ece1-III62-92, the addition of 100 mM of MgCl2 to the sample pre-treated with EDTA 
even resulted in a lysis rate higher than that of the peptide alone, supporting the hypothesis that 
Ece1-III may induce Mg2+-concentration-dependent pathways. Due to the experimental setup, 
unfortunately no comparative experiment could be performed with calcium ions. The dependency 
of cytotoxic function on divalent cations has also been demonstrated for bacterial toxins, e.g. the 
Bacillus thuringiensis Cry1Aa and Cry1Ab toxins [352, 355]. Furthermore, Kirouac et al.showed 
that the inhibition of B. thuringiensis Cry1Aa by EDTA was reversed by addition of an excess 
amount of calcium, magnesium or barium [352], while the cytotoxicity of Cry1Ab was only 
restored with magnesium, but not calcium ions [355]. 
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4.1.9 Role of membrane cholesterol for Ece1-III activity  
 
Preliminary results obtained from haemolysis experiments using cholesterol-depleted erythrocytes 
indicated this membrane lipid to exhibit a protective effect against lysis by Ece1-III. Red blood 
cells that were pre-treated with the cholesterol-depleting compound methyl-ß-cyclodextrin clearly 
demonstrated a decreased resistance to Ece1-III-mediated damage. A similarly protective effect of 
cholesterol could be observed for the bee venom-derived toxin melittin [356, 357]. The 
haemolytic activity was shown to increase ~3-fold when cholesterol within the erythrocyte 
membranes was depleted by ~55% [358]. Furthermore, the antifungal agent syringomycin E had 
been demonstrated to exhibit an increased pore-forming activity on erythrocyte membranes when 
these were depleted of cholesterol [359]. Erythrocyte membranes contain high amounts 
(~45 mol%) of cholesterol [360], which is an essential component of eukaryotic membranes. This 
lipid is involved in membrane organisation and dynamics and has been suggested to play a role in 
the maintenance of lipid rafts [360–362]. As cholesterol is known to induce tight phospholipid 
acyl chain packing in cell membranes, depletion of this lipid may facilitate the insertion of peptide 
toxins into the then loosened structure of the membrane, thus enhancing toxin activity [360, 363]. 
In addition to cholesterol, bacterial lipopolysaccharides (LPS) could be shown to also exert a 
protective effect against melittin, possibly due to a similarly tight packing of the lipid acyl chains 
that can be observed for cholesterol [364]. Hypothesising that LPS might also reduce the activity 
of Ece1-III, gram-negative bacteria should prove more resistant against this fungal peptide toxin 
than gram-positive bacteria, given the fact that only those contain LPS in their outer membrane 
structure.  
On the other hand, however, there are also toxins whose activity is dependent on the presence of 
cholesterol and in which case cholesterol depletion results in a decreased cytotoxicity. Such 
examples are the large clostridial cytotoxins toxin A and toxin B from Clostridium difficile. 
Giesemann et al. were able to show that treatment of membranes with MßCD resulted in a 
reduced pore formation, as was determined by a decreased efflux of the radioactive cation 86Rb+, 
which was used to preload the cells prior to their exposure to the toxins [365]. 
Given the structural similarity between melittin and the C. albicans peptide Ece1-III, as well as 
the first results obtained from experiments utilising cholesterol-depleted erythrocytes, it is 
tempting to speculate that cholesterol exhibits the same effect on Ece1-III than it does on melittin. 
Further experiments are, however, needed to gain a more detailed knowledge about the 
importance of the membrane cholesterol content on Ece1-III activity. Moreover, it needs to be 
verified that the observed sensitivity of cholesterol-depleted erythrocytes to Ece1-III-mediated 
lysis is not caused by an overall alteration of the membrane composition induced by MßCD. 
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4.1.10 ECE1 deletion results in the inability to lyse red blood cells 
 
The importance of Ece1 during growth with erythrocytes as the only nutrient source was also 
demonstrated by erythrocyte lysis experiments using the ece1Δ/Δ mutant strain. While the null 
mutant with both ECE1 alleles deleted was not able to release haemoglobin from the erythrocytes, 
efficient haemoglobin release by both tested wild type strains (SC5314 and BWP17/CIp30) was 
observed. Through reintegration of one of the ECE1 alleles, haemoglobin release from the blood 
cells was restored. The finding that all ece1Δ+ECE1[ΔEce1-III] mutants, which are only deficient 
in the Ece1-III-encoding part of ECE1, exhibit the same phenotype as the ece1Δ/Δ null mutant, 
confirms the previous results of only Ece1-III being able to lyse erythrocytes. Besides ece1Δ/Δ, 
three other C. albicans mutants were tested for their ability to release haemoglobin from red blood 
cells, namely the kex2Δ/Δ, eed1Δ/Δ and cph1Δ/efg1Δ mutants. As expected, due to the 
involvement of Kex2 in Ece1 processing, the kex2Δ/Δ mutant did not induce haemoglobin 
release. As an active Kex2 protease, however, is important for a plethora of proteolytic processes 
in the fungal cell, deletion of the KEX2 gene has a strong impact on C. albicans growth and a 
homozygous mutant is not capable of proper hypha formation, but instead shows a pleomorphic 
growth. Therefore, the inability of the kex2Δ/Δ mutant to release haemoglobin from erythrocytes 
cannot solely be ascribed to the importance of Kex2 activity for Ece1 function. Furthermore, 
neither the eed1Δ/Δ nor the cph1Δ/efg1Δ mutant was able to lyse erythrocytes. That can however 
be attributed to the fact that both mutants lack the ability to form hyphae. While cph1Δ/efg1Δ is 
completely locked in the yeast form, eed1Δ/Δ does induce an initial hypha formation but switches 
back to yeast growth eventually. Furthermore, Martin et al. showed that in the eed1Δ/Δ mutant 
expression of ECE1, among several other hypha-associated genes, was down-regulated during 
growth on plastic and infections of reconstituted human epithelia [366]. Down-regulation of 
ECE1 expression may also be expected for the cph1Δ/efg1Δ mutant. Although Cph1 is not 
required for ECE1 expression, deletion of EFG1 results in an abrogation of ECE1 expression 
[298, 367]. 
 
4.1.11 Cytolytic activity of peptides obtained through in vitro digestion of rEce1 
 
A different approach to examine the cytolytic activity of single Ece1 peptides was taken by 
overexpressing both Ece1 and Kex2 and utilising the recombinant proteins for in vitro digestion 
and subsequent use of the digestion products in haemolysis assays. Both proteins could be 
successfully overexpressed and purified using the respective expression systems E. coli 
BL21(DE3) and P. pastoris ScKex2. Likewise, Kex2-mediated digestion of rEce1 was verified. 
Digestion efficiency, however, was observed to be very low, as a large amount of the full length 
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protein remained intact. This might be due to different reasons, including the finding that the 
recombinant Ece1 seems to be prone to the formation of multimers. In fact, protein bands 
correlating to multiples of the molecular weight of rEce1 were detected in rEce1 preparations in 
this study. Low digestion efficiency and the formation of multimers might also be caused by the 
His-tag attached to the N-terminus of the protein. The additional amino acids constituting the tag 
might negatively influence the activity of the Kex2 protease, resulting in an impaired or 
incomplete digestion of the substrate. Furthermore, the protein’s His-tag may lead to a stronger 
interaction between several protein molecules, thereby facilitating the formation of rEce1-
multimers. Additionally, it has to be considered that an S. cerevisiae-derived Kex2 protease was 
utilised for these experiments, instead of the orthologous C. albicans protease, as attemps to 
express this enzyme in P. pastoris failed [296]. Even though CaKex2 is a functional homologue 
of ScKex2 [304], processing of C. albicans proteins might be carried out more successfully in its 
native host. 
SDS-PAGE of the rEce1 digestion products clearly showed proteins of low molecular weight 
(~10-20 kDa) to result from Kex2 cleavage. These products, however, were not detected in 
Western Blots. Blotting was performed using a polyclonal anti-Ece1-III antibody, meaning that 
polypeptides present after Kex2 processing are only detectable as long as Ece1-III is part of these 
polypeptides. The fact that none of the protein bands in this size range was detectable with the 
antibody may indicate that the release of Ece1-III may happen early during the cleavage process. 
Peptides with a molecular weight below 10 kDa on the contrary were detected by Western 
Blotting and their location on the membrane in comparison to synthetic Ece1-III suggests these 
peptides were the result of complete Kex2 cleavage, i.e. to be present as single Ece1 peptides with 
a molecular weight of approximately 1.5-4.5 kDa. 
Haemolysis experiments performed with peptides derived from in vitro digestion of rEce1 
unfortunately remained inconclusive. Only a low erythrocyte lysis rate (13%) was observed after 
the addition of 40 μM of rEce1, while lysis induced by 40 μM of digested rEce1 was only 
minimal (2%). The reason why erythrocyte lysis could be detected to be carried out by the full 
length rEce1 protein, which in principle should not act cytolytically, may be based on 
spontaneous disaggregation of the polypeptide within the sample. Proteolytically digested rEce1 
should then however be expected to induce at least as much lysis as the full length protein in the 
same concentration. The determination of the exact concentration of digested protein, however, is 
difficult, as protein assays do not provide information about the molecular weight of the proteins 
present inside the sample. Moreover, the Kex2 protease is still present in the digested samples and 
may exert an unknown influence on the activity of the peptides. More experiments and modified 
methods for in vitro purification of Ece1 peptides therefore are needed to further examine the 
haemolytic activity of peptides derived from recombinantly expressed Ece1. 
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4.1.12 Single peptide knockout-mutants 
 
Given that of the eight synthetic Ece1-peptides only Ece1-III was found to exert damage on both 
epithelial cells and red blood cells, a knockout mutant had been constructed which, in contrast to 
the ece1Δ/Δ strain, is not deficient in the complete ECE1 encoding sequence, but only lacks the 
part of the gene sequence coding for Ece1-III. Three different clones of this strain were used in 
this study to examine whether this partial deletion would sufficiently abolish Ece1-induced 
damage. Analysis of the cytotoxicity exerted by these ece1Δ+ECE1[ΔEce1-III] strains was 
performed by monitoring damage of oral epithelial cells and through quantifying erythrocyte 
lysis. Both assays revealed that the cytotoxicity exerted by all three clones was similar to that of 
the ece1Δ/Δ null mutant. To exclude the possibility that this impaired cytotoxicity might be due to 
morphological restrictions, the ability of the clones to form proper hyphae was verified via hypha 
induction experiments. Expression studies performed in our laboratory furthermore confirmed 
that the altered Ece1 protein is actually expressed and that the expression rate is comparable to 
that observed for the reconstituted strain ece1Δ+ECE1. Therefore, the loss of the ability of the 
ece1Δ+ECE1[ΔEce1-III] strain to damage host cells is likely to arise from the lack of peptide 
Ece1-III. Nevertheless, a single peptide knockout mutant deficient in Ece1-VII instead of 
Ece1-III, which had been constructed as a means of comparison, exhibited an identical phenotype, 
i.e. no damage of host cells was caused by this strain, even though hypha formation and 
expression of the altered Ece1 protein were not impaired. This demonstrates that although the 
peptides besides Ece1-III may not be directly involved in the induction of host cell damage, a 
completely intact Ece1 protein is crucial for full activity. Considering that the protein needs to be 
proteolytically cleaved, alteration of the primary amino acid structure via the deletion of single 
peptides might result in a faulty cleavage process. Furthermore, the other peptides may exert a 
chaperoning function by shielding the cytotoxic peptide Ece1-III until after secretion and lack of 
these chaperones might result in the degradation of Ece1-III to protect the own cell. Ece1-III has 
so far been shown to not act cytolytically on C. albicans or other yeast species, as demonstrated 
by growth experiments in the presence of 70 μM of the peptide, a concentration which is rather 
unlikely to be reached under in vivo conditions. However, as experiments have only been carried 
out with exogenously added peptide, the effect of free intracellular Ece1-III on C. albicans 
viability is not known. Given the different composition of fungal versus mammalian and bacterial 
plasma membranes, particularly characterised by the presence of the lipid ergosterol instead of 
cholesterol, a protective mechanism of C. albicans against its own lytic peptide may be assumed, 
but remains to be elucidated. 
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4.2 Interaction of Ece1-III with the host cell membrane 
 
In order for a peptide to elicit damage on host cells, the first step is interaction with the host’s cell 
membrane. In the case of all bacterial PFTs, this is achieved via binding to specific receptors, e.g. 
lipids, proteins, or sugars [275]. Interaction with these host membrane components will result in 
an increased concentration on the host cell surface and facilitate peptide oligomerisation and pore 
formation. Examination of Ece1-III interaction with various phospholipids revealed that this 
peptide strongly binds to several lipids that can be found as part of the host cell’s membrane, i.e. 
phosphatidylinositol-4-phosphate, phosphatidic acid and phosphatidylserine. As a distinctive 
binding between Ece1-III62-93 and phosphatidylserine was observed in three replicate experiments, 
the focus was directed to the interaction with this specific membrane lipid. This phospholipid is 
typically localised in the inner leaflet of a bilayer membrane and while it sporadically gets 
externalised to the outer leaflet, it usually is rapidly relocated to the inner leaflet by flippases 
[368]. Different studies, however, have demonstrated that rapid externalisation of 
phosphatidylserine, independent of apoptotic processes, can be induced via interaction of different 
types of bacteria with the host plasma membrane. Murata-Kamiya et al. were able to show, that 
interaction of the oncoprotein CagA of H. pylori with phosphatidylserine does play a key role in 
mediating delivery, localisation and the pathophysiological action of CagA [369]. They could 
observe that externalised phosphatidylserine remained at the position of bacterial attachment, 
suggesting that bacterial contact may result in an inhibition of the host flippase. Accordingly, 
shielding of the surface-exposed phosphatidylserine by annexin V or an anti-phosphatidylserine 
antibody successfully impaired CagA delivery into the host cell [369]. An earlier study also 
observed phosphatidylserine externalisation on the host cell’s surface during a Chlamydia 
infection [370]. A similar mechanism of active phosphatidylserine externalisation may therefore 
be hypothesised for Ece1-III of C. albicans. Indeed, initial biophysical experiments using 
artificial membranes of different lipid composition revealed that membranes containing 
phosphatidylserine are faster and more effectively lysed by Ece1-III than membranes lacking this 
phospholipid (unpublished data, personal communication with T. Gutsmann). Another membrane 
lipid that has been suggested to influence the activity of Ece1-III is cholesterol (see part 4.1.9). 
However, while the interaction between Ece1-III and phosphatidylserine seems to induce the 
binding to the host cell membrane, the amount of cholesterol present inside the membrane rather 
affects the efficiency of membrane insertion, due to the impact of this lipid on membrane fluidity. 
While binding to phosphatidylserine seems to be involved in establishing an initial cell-cell 
contact, it may be assumed that proper binding and induction of monomer oligomerisation is 
mediated via interaction with a receptor molecule, such as a lipid raft component, a GPI-anchored 
protein or a metalloprotease present in the host cell membrane. Experiments using oral epithelial 
cells and erythrocytes have demonstrated that micromolar concentrations of Ece1-III are needed 
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in vitro to obtain efficient lysis of those cells. Considering that invading C. albicans hyphae form 
a membrane pocket, which may prevent excessive diffusion of the secreted peptides, such 
concentrations may indeed be accomplished in vivo. For the alpha-haemolysin (Hla) of S. aureus, 
a well-known PFT with haemolytic properties, it has been shown that toxin concentrations 
exceeding 1 μM are needed to initiate significant binding and haemolysis of human erythrocytes 
[371]. Nevertheless, a high-affinity receptor-mediated host cell binding would be beneficial at low 
peptide concentrations. The dependency of Ece1-III activity on the presence of divalent cations, 
which could be shown via chelation experiments using EDTA (see part 4.1.8), might hint at a 
metalloprotease as a proteinaceous receptor. A metalloprotease often found to act as a receptor for 
bacterial toxins such as S. aureus Hla is a disintegrin and metalloprotease 10 (ADAM10) [283]. 
This enzyme contains an extracellular zinc-dependent metalloprotease domain, which catalyses 
the cleavage of a variety of host proteins [372]. E-cadherin, a protein present in the adherens 
junctions of epithelial cells and conveying cell-cell contact, represents a substrate of ADAM10 
[372]. S. aureus Hla has been shown to enhance this ADAM10-mediated cleavage of E-cadherin, 
thereby inducing the loss of epithelial integrity and promoting bacterial virulence [373–375]. 
However, not all PFTs do interact with specific receptors. The bee venom-derived peptide 
melittin, for example, is proposed to interact with membrane lipids rather than a specific protein 
receptor, since there are 1.8x107 binding sites for this peptide per erythrocyte [330]. Verification 
of receptor-mediated Ece1-III-binding and the identification of the specific membrane component 
acting as receptor therefore should be the aim of future research. 
 
4.3 Ece1-III is a pore forming toxin  
 
Several findings about peptide Ece1-III led to the conclusion that this peptide does act as a pore-
forming toxin. This includes the short length and amphipathic nature of the peptide as well as the 
in silico prediction of the peptide to form an α-helical structure and to localise inside the 
membrane. Furthermore, binding of Ece1-III to several phospholipids that are present in host cell 
membranes could be demonstrated in this study. The cytotoxic effect of most pore-forming 
proteins is induced via changes of the ion concentration within the host cell. Once the membrane 
barrier is disrupted by a pore, the ions can flow freely, creating an intracellular imbalance 
eventually leading to the death of the cell. By using the potent ion chelator EDTA, the damaging 
mechanism of Ece1-III was shown to be ion-dependent too, further supporting the view that this 
peptide indeed induces pores in host cell membranes. Biophysical experiments using artificial 
membranes, carried out by our collaborating partner T. Gutsmann and his colleagues, also 
demonstrated that Ece1-III shows characteristics of a pore-forming toxin. 
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Summarising all of the above results, a model of Ece1-III-induced pore formation was established 
(Figure 37). Whether the type of pore formed corresponds more closely to the toroidal or barrel 
stave model cannot be predicted at this time point. Given the structural similarity to melittin, lysis 
might occur analogous for Ece1-III. The honeybee toxin is proposed to induce lysis by a colloid 
osmotic mechanism, resulting in the formation of membrane lesions [330]. This lysis mechanism 
is characterised by an equilibration of ions through the pore inside the host cell, followed by the 
influx of water and subsequent cell swelling and finally cell lysis. While the elucidation of the 
exact molecular mechanism of Ece1-III-induced lysis remains the work of future research, enough 
data have been gathered to this point to demonstrate that Ece1-III is in fact the first known peptide 
toxin of a human fungal pathogen. Due to its toxin nature, this peptide is now referred to as 
“Candidalysin” [301]. 
Considering that C. albicans mainly exists as a harmless coloniser of human mucosal surfaces, the 
main function of this pore-forming toxin may have been the exploitation of nutrients in its natural 
environment. While in vitro the expression of ECE1 is invariably connected to the formation of 
hyphae, an attribute highly associated to fungal virulence, a different picture may arise under in 
vivo conditions. It has, for example, been demonstrated that inside the murine intestinal tract high 
levels of Ece1 are also expressed by C. albicans yeast cells during commensal colonisation [300]. 
Additionally, as has been shown by Moyes et al., colonising C. albicans cells can also exist in the 
hyphal form without triggering a pro-inflammatory response pathway, when the number of cells 
does not exceed a certain threshold [226]. Therefore, it can be assumed that the original function 
of Candidalysin may have served the task of nutrient acquisition and competition with other 
colonising microorganisms in the commensal stage, while in the case of C. albicans overgrowth 
or impairment of the host’s immune system the expression of this peptide toxin inevitably results 
in the damage of host tissue. 
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Figure 37: Model of Candidalysin-induced pore-formation. After expression of the Ece1 
polypeptide precursor, the protein is hypothesised to be successively processed by the proteases Kex2 
and Kex1. The resulting peptides will then get secreted and while the Candidalysin monomers interact 
with the host membrane, finally inserting and forming pores, the remaining peptides may influence 
pore formation, enter the host cell through the Candidalysin pore and exert an as yet unknown function 
inside the host cell or may have other unknown functions. 
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4.4 Ece1-III62-93 versus Ece1-III62-92 
 
Ece1-III with a C-terminal lysine-arginine motif (Ece1-III62-93) was predicted to result from 
processing by the protease Kex2. At a later time point of the study, however, data obtained from 
liquid chromatography/mass spectrometry indicated, that the peptide may rather be secreted 
without the C-terminal arginine. Repetition of the experiments including this slightly different 
version of the peptide showed that, while this peptide is still causing noticeable damage on both 
epithelial cells and erythrocytes, damage is strongly reduced in comparison to the peptide 
featuring the intact KR-motif. Utilising different mutant strains deficient in one of various 
proteases, a member of our laboratory later identified the protease Kex1 to be responsible for the 
final digestion leading from Ece1-III62-93 to Ece1-III62-92, as a kex1Δ/Δ secreted the expected 
peptides ending with a KR-motif [301]. Given the fact that Kex1 is an intracellular protease, it can 
be concluded that this final processing step has to occur intracellularly. Previous hypotheses of 
C. albicans detoxifying its own peptide in response to the extracellular concentration exceeding a 
certain threshold level did therefore proof wrong and the question arose, why this fungal pathogen 
would attenuate the effectiveness of such a potent toxin as Ece1-III62-93 by a further processing 
step. Growth experiments in the presence of very high concentrations (70 μM) of both 
Ece1-III62-93 and Ece1-III62-92 showed, that even at such high concentrations, which are rather 
unlikely to occur in vivo, growth of all tested C. albicans strains was not influenced, while host 
cells are already strongly damaged at peptide concentrations around 10 μM. However, while 
C. albicans may have originally secreted the more toxic version of Ece1-III, different 
evolutionary developments could have contributed to the additional processing step, resulting in a 
less potent toxin. It needs to be kept in mind, that C. albicans is an opportunistic human pathogen, 
which is mostly found as a harmless coloniser of mucosal surfaces. In these natural habitats, 
C. albicans interacts with a plethora of other microorganisms, and while many of these 
interactions may be antagonistic, several beneficial interactions between C. albicans and various 
bacterial strains are known today. Different Streptococci species, e.g. Streptococcus gordonii, are 
regularly co-isolated with C. albicans [376, 377]. While the fungus is able to attach to the 
bacterial cells, thereby avoiding the competition for adhesion sites, and can use the S. gordonii 
metabolic waste product lactate as a carbon source for growth, the streptococci benefit from a 
reduction of the oxygen tension to a lower and more favourable level [376, 378, 379]. Other 
examples include the formation of polymicrobial biofilms, which results in an increased tolerance 
against antimicrobial agents and resistance to host clearance mechanisms. Such beneficial 
interactions with other microbial species might have eventually led to the change in toxin 
secretion, as Ece1-III62-93 might as rapidly lyse bacterial cells as it does its human host cells. 
Indeed, co-incubation of the Ece1-III peptide with different lactobacilli and E. coli strains were 
observed to have an inhibitory or lethal effect on several bacterial species (unpublished data, 
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personal communication with T. Förster). However, further experiments including a variety of 
other bacterial strains need to be performed to obtain a clearer picture about the influence of 
C. albicans peptide Ece1-III on bacterial growth. Moreover, expression studies on KEX1 might 
prove useful to show whether this protease gets down-regulated during mucosal infections. This 
would allow the fungus to secrete the more toxic peptide product after a shift from commensalism 
to pathogenicity.  
 
4.5 Ece1 as a potential anticandidal drug target 
 
The results obtained in this study clearly demonstrated that the hypha-associated protein Ece1 is 
essential for C. albicans-induced damage of different epithelial cell types and erythrocytes, as 
damage was completely abolished by deletion of the ECE1 gene. Considering these data, Ece1 
presents an attractive possible target for the development of novel anticandidal drugs. As the 
damaging effect of this protein is exerted through the pore-forming, toxin-like nature of peptide 
Ece1-III, an antibody directed against this part of the protein may help preventing epithelial 
damage during C. albicans infections. As experiments showed, the ece1Δ+ECE1[ΔEce1-III] 
strains, which are only deficient in this one peptide but still express all other Ece1-peptides, 
behaved similar to the ece1Δ/Δ null mutant, demonstrating that the role of these other peptides 
can possibly be neglected when considering Ece1 as a potential drug target. Preliminary 
experiments were carried out in this study, examining different antibodies directed against 
Ece1-III for an abolishing effect against peptide-mediated damage. Unfortunately, no protecting 
effect on erythrocytes was observed with the antibodies used, indicating that an antibody to be 
used for the treatment of infections most probably needs to be highly specific. As human serum 
was shown to be an efficient inhibitor of damage induced by Ece1-III, identification of the active 
serum component, however, might be a first step in finding an effective antagonist. 
In addition to an Ece1-directed antibody, attenuation of Ece1-III-induced damage could be 
accomplished via inhibition of receptor binding on the host cell membrane. This might be realised 
by designing small drug molecules targeting a site of the PFT that is known to be involved in 
membrane binding. For PFTs of the aerolysin family, synthetic GPI molecules and GPI analogues 
for example have been proposed to inhibit pore assembly by impeding attachment of the PFT to 
the plasma membrane [380]. In case of Ece1-III, targeting the positively charged C-terminus of 
the peptide could prove as effective, because changes of the C-terminal amino acids significantly 
influence the membrane binding capacity of this peptide, as has been shown in this study. A 
different approach to prevent PFT-receptor binding could be to target the receptor rather than the 
PFT itself, as has been shown for S. aureus α-haemolysin (Hla) by targeting its receptor 
ADAM10 with a metalloprotease inhibitor [374]. While phosphatidylserine was already identified 
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as a binding partner of Ece1-III within the cell membrane, a potential protein receptor remains to 
be discovered though. 
However, even with a potent antibody against Ece1, the problem of a timely diagnosis and 
initiation of treatment would still remain. Expression studies showed that expression of ECE1 is 
rapidly and highly up-regulated, once hypha formation is induced. Furthermore, results obtained 
in this study revealed that epithelial damage, as detected with the protocols used in this study, 
occurs only several hours after the addition of Ece1-III. Therefore, a successful anticandidal 
therapy targeting Ece1 would have to be initiated at an early time point of the infection, in order 
to directly inactivate Ece1-III after the processing of the full length Ece1 protein and secretion of 
the single peptides. 
Regarding the high cytolytic effect of Candidalysin on different human cell lines, this toxin might 
also be considered for application in anti-cancer therapy, once the molecular mechanism is 
completely elucidated. Binding of the PFT to specific receptors up-regulated in cancer cells and 
subsequent pore formation would result in a suicide response and thereby killing of the malignant 
cells. Such a strategy has already been successfully applied to target tumours expressing 
claudin 3, claudin 4 and claudin 6 [381, 382]. 
 
4.6 Conclusions and outlook 
 
The data gathered in this study identify peptide Ece1-III of C. albicans as the first known peptide 
toxin of a human fungal pathogen and demonstrate the importance of this peptide for the 
mediation of infection-associated epithelial damage. This peptide, which is now referred to as 
Candidalysin, was shown to effectively lyse epithelial cells as well as human red blood cells and 
the physiological properties elucidated in this work led to the proposition of a possible mode of 
action for this toxin. This model hypothesises that Candidalysin monomers attach to the host 
membrane via binding of specific phospholipids, such as phosphatidylserine. An increased 
peptide concentration on the membrane surface will result in the aggregation of monomers and 
insertion into the host membrane as a pore-like structure. Subsequent changes in the intracellular 
ion composition and the ion-dependent activation of signalling pathways will eventually result in 
the death of the host cell. Elucidation of the exact molecular mode of action remains the work of 
future studies and includes the identification of a possible receptor molecule within the host 
membrane, which may facilitate membrane binding and oligomerisation. Moreover, the role of 
the remaining seven Ece1 peptides should be more closely examined, as several experiments 
indicated that while these peptides do not play a role in mediating direct damage, the presence of 
these peptides contributes to an overall more effective lysis process.  
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Elucidating the function of this protein, which has so far been unknown, underlines the 
importance of further characterisation of the many unidentified ORFs of the C. albicans genome, 
as this may result in the identification of essential virulence factors. More detailed knowledge of 
the molecular mechanisms underlying infection-associated damage will lead to a better 
understanding of the host-pathogen interaction during C. albicans infections and may eventually 
contribute to the development of new therapeutic antifungal options. 
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5 List of Abbreviations 
 
BSA   Bovine Serum albumin 
CIp30   Candida Integration plasmid 30 
DMEM   Dulbecco’s Modified Eagle’s Medium 
DNA   Deoxyribonucleic acid 
EC   epithelial cell 
ECL   enhanced chemiluminescence 
FBS   Foetal Bovine Serum 
HIV   human immunodeficiency virus 
IPTG   Isopropyl-ß-D-thiogalactopyranosid 
(k)Da   (kilo)Dalton 
KOAc   potassium acetate 
LC-MS/MS  Liquid Chromatography-mass spectrometry 
LDH   lactate dehydrogenase 
LB   Luria Bertani 
M   Molar 
MOI   Multiplicity of Infection 
nm   nanometer 
OD600   optical density at 600 nm 
ORF   open reading frame 
PAGE   polyacrylamide gel electrophoresis 
PAMP   pathogen-associated molecular pattern 
PBS   Phosphate Buffered Saline 
PFP/PFT  pore forming protein/pore forming toxin 
PRR   pattern recognition receptor 
ROS   reactive oxygen species 
rpm   rotations per minute 
RPMI   Roswell Park Memorial Institute 
RT   room temperature 
SDS   sodium dodecyl sulphate 
SOC   Super Optimal Broth with Catabolite Repression 
TBS   Tris Buffered Saline 
v/v   volume per volume 
w/v   weight per volume 
YNB   yeast nitrogen base 
YPD   Yeast Peptone Dextrose 
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